
<html lang="en"     class="pb-page"  data-request-id="9e57484b-c51c-47b3-9f79-9b4f5653f3a1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2016.59.issue-20;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01128;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4" /></meta><meta name="dc.Creator" content="Andrew W.  Brown" /></meta><meta name="dc.Creator" content="Matthew  Fisher" /></meta><meta name="dc.Creator" content="Gillian M.  Tozer" /></meta><meta name="dc.Creator" content="Chryso  Kanthou" /></meta><meta name="dc.Creator" content="Joseph P. A.  Harrity" /></meta><meta name="dc.Description" content="The combretastatins are an important class of tubulin-binding agents. Of this family, a number of compounds are potent tumor vascular disrupting agents (VDAs) and have shown promise in the clinic f..." /></meta><meta name="Description" content="The combretastatins are an important class of tubulin-binding agents. Of this family, a number of compounds are potent tumor vascular disrupting agents (VDAs) and have shown promise in the clinic f..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 7, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01128" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01128" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01128" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01128" /></link>
        
    
    

<title>Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01128" /></meta><meta property="og:title" content="Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0017.jpeg" /></meta><meta property="og:description" content="The combretastatins are an important class of tubulin-binding agents. Of this family, a number of compounds are potent tumor vascular disrupting agents (VDAs) and have shown promise in the clinic for cancer therapy. We have developed a modular synthetic route to combretastatin analogs based on a pyrazole core through highly regioselective alkyne cycloaddition reactions of sydnones. These compounds show modest to high potency against human umbilical vein endothelial cell proliferation. Moreover, evidence is presented that these novel VDAs have the same mode of action as CA4P and bind reversibly to β-tubulin, believed to be a key feature in avoiding toxicity. The most active compound from in vitro studies was taken forward to an in vivo model and instigated an increase in tumor cell necrosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01128"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01128">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01128&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01128&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01128&amp;href=/doi/10.1021/acs.jmedchem.6b01128" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9473-9488</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01127" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01217" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+W.++Brown">Andrew W. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Fisher">Matthew Fisher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gillian+M.++Tozer">Gillian M. Tozer</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chryso++Kanthou">Chryso Kanthou</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.+A.++Harrity">Joseph P. A. Harrity</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University of Sheffield, Dainton Building, Brook Hill, Sheffield S3 7HF, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.</span></div><div class="corresp-info"><strong>*</strong>G.M.T.: e-mail, <a href="/cdn-cgi/l/email-protection#33541d475c49564173405b5655555a565f571d52501d4658"><span class="__cf_email__" data-cfemail="bcdb92c8d3c6d9cefccfd4d9dadad5d9d0d892dddf92c9d7">[email protected]</span></a>; phone, (0)114 215 9028.</div><div class="corresp-info"><strong>*</strong>C.K.: e-mail, <a href="/cdn-cgi/l/email-protection#1e7d30757f706a76716b5e6d767b7878777b727a307f7d306b75"><span class="__cf_email__" data-cfemail="f497da9f959a809c9b81b4879c9192929d919890da9597da819f">[email protected]</span></a>; phone, (0)114 215 9052.</div><div class="corresp-info"><strong>*</strong>J.P.A.H.: e-mail, <a href="/cdn-cgi/l/email-protection#43296d2b2231312a373a03302b2625252a262f276d22206d3628"><span class="__cf_email__" data-cfemail="8be1a5e3eaf9f9e2fff2cbf8e3eeedede2eee7efa5eae8a5fee0">[email protected]</span></a>; phone, (0)114-22-29496.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01128&amp;href=/doi/10.1021%2Facs.jmedchem.6b01128" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9473–9488</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 2, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 July 2016</li><li><span class="item_label"><b>Published</b> online</span>7 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 October 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01128" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01128</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9473%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrew%2BW.%2BBrown%252C%2BMatthew%2BFisher%252C%2BGillian%2BM.%2BTozer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D20%26contentID%3Dacs.jmedchem.6b01128%26title%3DSydnone%2BCycloaddition%2BRoute%2Bto%2BPyrazole-Based%2BAnalogs%2Bof%2BCombretastatin%2BA4%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9488%26publicationDate%3DOctober%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01128"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1477</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01128" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;W. Brown&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Fisher&quot;},{&quot;first_name&quot;:&quot;Gillian&quot;,&quot;last_name&quot;:&quot;M. Tozer&quot;},{&quot;first_name&quot;:&quot;Chryso&quot;,&quot;last_name&quot;:&quot;Kanthou&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. A. Harrity&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9473-9488&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01128&quot;},&quot;abstract&quot;:&quot;The combretastatins are an important class of tubulin-binding agents. Of this family, a number of compounds are potent tumor vascular disrupting agents (VDAs) and have shown promise in the clinic for cancer therapy. We have developed a modular synthetic route to combretastatin analogs based on a pyrazole core through highly regioselective alkyne cycloaddition reactions of sydnones. These compounds show modest to high potency against human umbilical vein endothelial cell proliferation. Moreover, evidence is presented that these novel VDAs have the same mode of action as CA4P and bind reversibly to β-tubulin, believed to be a key feature in avoiding toxicity. The most active compound from in vitro studies was taken forward to an in vivo model and instigated an increase in tumor cell necrosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01128&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01128" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01128&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01128" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01128&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01128" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01128&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01128&amp;href=/doi/10.1021/acs.jmedchem.6b01128" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01128" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01128" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01128%26sid%3Dliteratum%253Aachs%26pmid%3D27690431%26genre%3Darticle%26aulast%3DBrown%26date%3D2016%26atitle%3DSydnone%2BCycloaddition%2BRoute%2Bto%2BPyrazole-Based%2BAnalogs%2Bof%2BCombretastatin%2BA4%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D20%26spage%3D9473%26epage%3D9488%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291240" title="Cyclization">Cyclization</a>,</li><li><a href="/action/doSearch?ConceptID=290740" title="Monolayers">Monolayers</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/jmcmar.2016.59.issue-20/20161027/jmcmar.2016.59.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The combretastatins are an important class of tubulin-binding agents. Of this family, a number of compounds are potent tumor vascular disrupting agents (VDAs) and have shown promise in the clinic for cancer therapy. We have developed a modular synthetic route to combretastatin analogs based on a pyrazole core through highly regioselective alkyne cycloaddition reactions of sydnones. These compounds show modest to high potency against human umbilical vein endothelial cell proliferation. Moreover, evidence is presented that these novel VDAs have the same mode of action as CA4P and bind reversibly to β-tubulin, believed to be a key feature in avoiding toxicity. The most active compound from in vitro studies was taken forward to an in vivo model and instigated an increase in tumor cell necrosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tumor growth and metastasis are dependent upon a functional blood vessel network,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and since tumor blood vessels are abnormal, they represent an attractive target for cancer therapy.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Tumor vascular disrupting agents (VDAs) cause a rapid and selective collapse of tumor blood vessels leading to widespread tumor cell death via necrosis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The most well-studied class of VDAs are the tubulin binding microtubule depolymerizing agents. The tumor vascular disrupting properties of colchicine, the classic tubulin binding agent of this type, have been known since the 1930s, but these effects are only seen near the maximum tolerated dose (MTD) in mice.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> The structurally related stilbene compounds, the combretastatins, were isolated from the Cape Bush Willow tree, <i>Combretum caffrum</i> in the late 1980s.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These compounds were initially studied for their potential as antimitotic agents.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, it later became apparent that the combretastatins had great potential as VDAs.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The lead compound, combretastatin A-4 (CA4), was shown to be effective at causing selective tumor vascular collapse, within minutes, at nontoxic doses.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was swiftly developed into the water-soluble, sodium phosphate salt prodrug, disodium combretastatin A-4 3-<i>O</i>-phosphate (CA4P).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CA4P is not active as a tubulin binding agent but is rapidly cleaved in plasma to CA4.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The lower toxicity (and thus higher MTD) of CA4 compared to colchicine is attributed to CA4 binding reversibly to the β-tubulin subunit, as opposed to colchicine that binds pseudoirreversibly.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> CA4P is currently undergoing phase II/III clinical trials in combination with bevacizumab.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Although CA4P is a promising clinical candidate, it does have a number of issues associated with it. First, the cis orientation of the olefinic linker is key to activity, with the trans isomer being essentially inactive,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> an issue further emphasized by the tendency of cis stilbenes to undergo cis–trans isomerization in heat, light, and protic media.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A promising strategy to overcome this issue has been the incorporation of heterocyclic motifs to replace the olefinic linker.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23">(17-23)</a> This strategy allows the cis configuration of the combretastatins to be “fixed”, inhibiting metabolic decomposition (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). However, any compound design would have to take into account the result of molecular docking studies that clearly indicate the need for appropriately disposed electron rich aryl rings, such as those in colchicine and CA4, which are key pharmacophores for tubulin polymerization inhibition.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tubulin-binding VDAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although a number of significant contributions have been made in the field of rigid combretastatin analogs, only limited examples of this approach using a pyrazole core have been documented.<a onclick="showRef(event, 'ref16 ref20 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref16 ref20 ref27 ref28">(16, 20, 27, 28)</a> To the best of our knowledge, there are no examples of simple (without extra substitution of the pyrazole core), pyrazole-bridged CA4 analogs reported and there has not been a systematic evaluation into the effect of substitution pattern. The pyrazole motif is an important fragment in the pharmaceutical industry and is present in a number of commercial medicines and agrichemicals.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> However, synthetic routes to these structurally important diazoles are often linear or suffer from regioselectivity issues during the heterocycle forming step. In this regard, we felt that sydnones could represent convenient and potentially versatile starting materials to access these desirable therapeutic analogs. Sydnones belong to the mesoionic family of compounds, and they undergo [3 + 2] cycloaddition–retrocycloaddition reactions with alkynes to form pyrazoles.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> These cycloadditions can be highly regioselective and offer access to a wide range of pyrazoles.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36 ref37">(32-37)</a> In the context of developing novel VDAs, we envisaged that the sydnone cycloaddition strategy could be exploited to access a broad range of pyrazole templated combretastatin analogs from similar starting materials (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). However, we recognized that a number of synthetic challenges needed to be met in order to achieve this goal: (1) access to 1,5-substituted pyrazoles theoretically required high temperature cycloaddition with acetylene gas; (2) 4,5-disubstituted pyrazoles required the innate regioselectivity of the cycloaddition with terminal alkynes to be reversed (typically, the largest substituent is incorporated at the <i>C</i>3); (3) the cycloaddition of biaryl alkynes for the preparation of 3,4-substituted pyrazoles was unlikely to proceed with regiocontrol, thereby delivering isomeric mixtures.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Sydnone Cycloaddition Strategy to Pyrazole-Based Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42142" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42142" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Preparation of 1,5-Disubstituted Analogs</h3><div class="NLM_p">Our investigations began with the preparation of 1,5-disubstituted pyrazoles. We proposed a strategy that exploited our previously developed direct arylation of sydnones to furnish the key diaryl intermediates (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> We then envisaged that trimethylsilylacetylene could act as a high-boiling point acetylene equivalent in the cycloaddition to provide the target pyrazoles after protodesilylation.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy for the Synthesis of 1,5-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sydnone starting materials were readily prepared by established routes of N-nitrosation of amino acids, followed by cyclodehydration with trifluoroacetic anhydride (TFAA).<a onclick="showRef(event, 'ref31 ref38'); return false;" href="javascript:void(0);" class="ref ref31 ref38">(31, 38)</a> The synthesis began with the coupling of sydnone <b>1</b> affording diaryl sydnone <b>2</b> in moderate yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Pleasingly, sydnone <b>2</b> underwent successful cycloaddition with trimethylsilylacetylene to afford TMS-substituted pyrazoles <b>3a</b> and <b>3b</b> in good yield and excellent (but inconsequential) regioselectivity. Previous experience had suggested that 3-silyl pyrazoles could be particularly resistant to hydrolysis. Fortunately, however, a refluxing solution of TBAF in THF afforded the desilated product <b>4</b> in useful yield. Finally, simple hydrogenation of the benzyl ether afforded CA4 analog <b>5</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrazole <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Preparation of the isomeric 1,5-pyrazole <b>10</b> required a slight modification to the route. Sydnone <b>6</b> was subjected to direct arylation conditions, followed by benzyl protection of the phenol (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Surprisingly, benzyl protection of the phenol prior to direct arylation resulted in a sydnone that decomposed when subjected to various direct arylation conditions. Sydnone <b>7</b> underwent cycloaddition in very good yield and regioselectivity. TBAF deprotection of the trimethylsilyl group proceeded in moderate yield. The resulting pyrazole <b>9</b> was contaminated with a small amount of an inseparable, unknown byproduct. Fortunately, analog <b>10</b> was isolated cleanly after benzyl hydrogenation.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrazole <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Preparation of 4,5-Disubstituted Analogs</h3><div class="NLM_p">We next turned our attention to the preparation of 4,5-disubstituted pyrazoles. Elegant work by Taran et al. demonstrated that copper catalysis can reverse the natural regioselectivity of sydnone cycloadditions.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Recently, the chemistry has been improved to tolerate bromide substituents at the sydnone <i>C</i>4 position, which could then be further elaborated by cross-coupling.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, this chemistry is currently limited to <i>N</i>-aryl sydnones. As our interest lay with <i>N</i>-alkylsydnones, a new methodology was needed. We proposed to extend the strategy used for the synthesis of 1,5-substituted pyrazoles to borylated trimethylsilylacetylene (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). We have previously reported the cycloaddition of alkynylboranes with sydnones to be highly regioselective and importantly, tolerant of <i>N</i>-alkylsydnones.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In the case of disubstituted alkynes, the boron substituent is generally incorporated at the pyrazole <i>C</i>4 position.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Strategy for the Synthesis of 4,5-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis began with the direct arylation of <i>N</i>-methyl- and <i>N</i>-benzylsydnone, which proceeded smoothly on gram scale affording <i>C</i>4-arylated sydnones <b>11</b>–<b>14</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). We were delighted to find all substrates successfully underwent cycloaddition, and the corresponding pyrazoles were isolated as single regioisomers, <b>15</b>–<b>18</b>, albeit contaminated with varying amounts of protodeborylated byproduct. The Suzuki–Miyaura reaction required some optimization but was successfully achieved using Buchwald’s XPhosPdG2 precatalyst to afford <b>19</b>–<b>22</b>. The products were again contaminated with varying amounts of protodeborylated byproduct. Pleasingly, subjection of <b>23</b>–<b>26</b> to refluxing TBAF successfully resulted in silyl deprotection, and <b>23</b>–<b>26</b> were readily separable from their corresponding byproducts at this stage. Benzyl hydrogenation afforded the 4,5-disubstituted analogs of CA4, <b>27</b>–<b>32</b>. In the case of <i>N</i>-benzylpyrazoles <b>24</b> and <b>26</b>, incomplete hydrogenation afforded separable mixtures of <i>N</i><i>H</i>-pyrazoles <b>28</b> and <b>31</b> and <i>N</i>-benzylpyrazoles <b>29</b> and <b>32</b>, respectively.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 4,5-Disubstituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Preparation of 3,4-Disubstituted Analogs</h3><div class="NLM_p">The final analogs to prepare were the 3,4-disubstituted pyrazoles. It was originally anticipated that we could utilize alkynylboronate cycloaddition chemistry to access these compounds (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>A).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, we found that alkynes bearing these particularly electron rich aromatic rings were prone to protodeborylation, and pyrazole boronic esters could not be obtained under a variety of conditions. We proposed an alternative route whereby the innate regioselectivity of the sydnone cycloaddition was exploited, followed by bromination and subsequent cross-coupling (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>B).</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Strategy for the Synthesis of 3,4-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The route began with the cycloaddition of <i>N</i>-methyl and <i>N</i>-benzylsydnone with arylacetylenes. The reactions proceeded in good yield and high regioselectivity to afford pyrazoles <b>33</b>–<b>36</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). We were pleased to find that <i>N</i>-bromosuccinamide (NBS) in acetonitrile rapidly and selectively brominated the pyrazoles. After basic workup, the brominated products could be subjected without further purification to Suzuki–Miyaura coupling, affording products <b>37</b> and <b>39</b> in good yield over two steps. Products <b>38</b> and <b>40</b> were isolated after subjection of the crude Suzuki–Miyaura products to silyl deprotection conditions of potassium carbonate in refluxing methanol in useful yield over three steps. In the case of <i>N</i>-methyl analogs <b>37</b> and <b>39</b>, this route represents rapid access to the compounds in effectively two pots. Compounds <b>38</b> and <b>40</b> were subjected to hydrogenation to afford the free <i>NH</i>-pyrazole analogs <b>28</b> and <b>31</b>, thus providing an alternative, shorter route to these analogs from the alkynylboronate strategy above.</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 3,4-Disubstituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Biological Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With a library of 12 pyrazole-based analogs of CA4 in hand, attention turned to evaluating their potential as anticancer agents. Studies within our laboratories have previously shown that for CA4P, vascular disruptive effects dominate rather than direct targeting of cancerous cells.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Therefore, we proposed that the primary target of VDAs, endothelial cells, would provide an accurate insight into the activity of the pyrazole-based analogs.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Initial Screens</h3><div class="NLM_p">CA4 is a tubulin binding agent; therefore we proposed that a convenient method for the rapid assessment of activity was to study the effects of compounds on endothelial cell proliferation, which is inhibited by disruption of the microtubule-rich mitotic spindle. It is important to note that the action of CA4 as a VDA is not due to effects on HUVEC proliferation or prevention of mitotic spindle formation. However, the analysis of drug-induced effects on cell proliferation provides a useful insight into microtubule targeting potential. Screening results are depicted in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Values for Growth Inhibition of HUVECs by Pyrazole Anologs vs CA4P and Colchicine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0016.gif" alt="" id="GRAPHIC-d7e630-autogenerated" /></img><div></div></div><div class="NLM_p">The variation observed in the activities of the compounds was quite remarkable given that all of the compounds screened were direct analogs of CA4, differing only in their location on the pyrazole core. The most active compounds <b>5</b>, <b>27</b>, <b>30</b>, and <b>31</b> (entries 1, 3, 6, and 7) exhibited low nanomolar activity. The most active compound <b>31</b> showed similar activity to CA4P (entry 7 vs 13). However, a number of compounds only showed low micromolar activities (entries 4, 9, and 12). Further studies were undertaken on the two most active compounds <b>5</b> and <b>31</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0020.jpeg" id="GRAPHIC-d7e665-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Most active pyrazole analogs from initial screen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Immunofluorescence Studies</h3><div class="NLM_p">To confirm that the drug effects were due to microtubule disruption, drug-induced changes in the endothelial cell cytoskeleton and morphology were studied via immunofluorescence for compounds <b>5</b> and <b>31</b>. The microtubule disruption associated with CA4P treatment is also accompanied by changes in cell shape and morphology brought about by the rapid remodeling of the actin cytoskeleton.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Therefore, endothelial cells in culture were stained for actin filaments using phalloidin, microtubules using an antibody to β-tubulin, and nuclei stained with 4′,6-diamidino-2-phenylindole (DAPI).</div><div class="NLM_p">In cells that are in interphase, polymers of α-tubulin and β-tubulin originate from the centrosome and radiate to the edge of the cell as tubular filaments referred to as microtubules (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), whereas actin is mostly pericellular (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Upon treatment with 250 nM CA4P for 30 min, interphase microtubules became disrupted (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C), leading to changes in cell morphology. Disruption of microtubules led to the formation of actin stress fibers across the cells (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). Interestingly, a longer (90 min) treatment at a higher dose of 1 μM was required for similar effects to be observed with colchicine (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>E and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>F). A 250 nM treatment with <b>5</b> resulted in the disruption of interphase microtubules and significant changes in endothelial cell shape and morphology (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>G and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>H). Similarly, a 250 nM treatment with <b>31</b> also caused pronounced effects on endothelial cell shape and morphology (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>I and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>J).</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug effects on HUVEC cytoskeletal structures. Cells were treated with a single dose of either vehicle (A, B), 250 nM CA4P (C, D), 1 μM colchicine (E, F), 250 nM drug <b>5</b> (G, H), or 250 nM drug <b>31</b> (I, J). Drug treatments were for 30 min with CA4P, drug <b>5</b>, and drug <b>31</b> and 90 min with colchicine. Cells were fixed and stained with an antibody to β-tubulin (A, C, E, G, I) and F-actin (B, D, F, H, J) and nuclei stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Recovery Experiments</h3><div class="NLM_p">CA4P is thought to be a potent VDA at well below its maximum tolerated dose due to the reversibility of its binding to tubulin.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Therefore, we tested the reversibility of the tubulin binding of compounds <b>5</b> and <b>31</b> using immunofluorescence in parallel with CA4P and colchicine.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, a 30 min treatment with 250 nM of either CA4P, <b>5</b>, or <b>31</b> was sufficient to produce a profound effect on cellular morphology. A 30 min treatment with CA4P followed by removal of the drug and 60 min incubation led to significant recovery of the cells (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). There was a clear recovery of microtubules and a reduction in actin stress fibers. Importantly, cells treated with colchicine did not show signs of recovery within the same time frame (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D). Indeed, recovery was not observed, even after a 120 min incubation upon removal of the drug (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>E and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>F). Our interpretation of these data is as follows. First, the binding of colchicine was indeed pseudo-irreversible whereas CA4 bound reversibly, and second, its action was slower than that of CA4. It is also interesting to note that this slower action was not due to a decreased rate of diffusion through the cell membrane. If it were the case, removal of the drug after 30 min would prevent microtubule disruption. Furthermore, <b>5</b> appeared to have a similar profile to CA4P with the cells also showing full recovery after 60 min (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>G and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>H). Intriguingly, cells treated with <b>31</b> did not recover significantly 60 min after drug removal (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>I and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>J). However, early signs of recovery were apparent at this time point, because microtubules were beginning to radiate from the centrosome (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>I). Full recovery of the cytoskeleton was nevertheless seen 120 min after drug removal (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>K and <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>L). This slower recovery than CA4P was particularly interesting because we felt it could be an indicator to either a wider therapeutic window or toxicity. Either result would add value to this assay in assessing the viability of compounds as VDAs in vitro. Such a model has been quite elusive thus far. Therefore, we sought to further probe the potential of <b>31</b> as a VDA.</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Recovery of cytoskeletal structures after drug removal. HUVECs were treated with a single dose of 250 nM CA4P (A, B), 1 μM colchicine (C–F), 250 nM drug <b>5</b> (G, H), or 250 nM drug <b>31</b> (I–L). Drug treatments were for 30 min. Cells were then washed with serum containing medium and allowed to recover for 60 min (A–D, G–J) or 120 min (E, F, K, L). Cells were fixed and stained with an antibody to β-tubulin (A, C, E, G, I, K) and F-actin (B, D, F, H, J, L) and nuclei stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Analysis of Rho-GTPase/Rho Kinase Signaling Pathway Activation</h3><div class="NLM_p">We focused on the most active compound from the initial screens, <b>31</b>, and compared its activity to CA4P in assays linked to mode of action and vascular disruption. Previous studies had revealed that activation of the RhoA-GTPase signal pathway was involved in actin remodeling and monolayer disruption caused by CA4P.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> Activated Rho-GTPase causes contractility and stress fiber formation through polymerization of actin and the phosphorylation of myosin light chain (MLC). The latter activity is dictated through the activation of serine/threonine Rho kinases (ROCKs). Thus, we investigated both <b>31</b> and CA4P induced effects on the phosphorylation of MLC (pMLC) in HUVECs. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, both compounds instigated significant increases in pMLC over a range of concentrations, indicating that both compounds were acting via a similar pathway. Compound <b>31</b> induced significant phosphorylation of MLC at the lower tested concentration of 50 nM, while CA4P was less active at this dose. To further confirm the involvement of ROCK in the induction of MLC phosphorylation by compound <b>31</b>, cells were treated with the specific ROCK inhibitor Y-27632. Similar to what was previously published for CA4P,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> the induction of MLC phosphorylation by compound <b>31</b> was abrogated by Y-27632, confirming the involvement of ROCK in this process (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C).</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Drug-induced induction of phosphorylation of Rho kinase target MLC. HUVECs were treated with increasing concentrations of CA4P or drug <b>31</b> for 15 min after which proteins were extracted and analyzed for phosphorylation of ROCK target MLC (pMLC) by Western blotting using an antibody specific to the phosphorylated form of the protein (A). Immunoblots were reprobed with an antibody to actin to confirm equal loading. In part B, pMLC band intensities were analyzed by ImageJ and results expressed as fold-change over control cells treated with vehicle alone. Each column represents the mean of 3–4 independent cell culture experiments ± SEM. ∗ represents <i>P</i> < 0.05 for the significance of differences between drug treatment groups and controls (one-way ANOVA followed by a Tukey post-test). In C, HUVECs were incubated with Rho kinase inhibitor Y-27632 (5 μM) for 5 min and then treated with 500 nM drug <b>31</b> for 15 min. Proteins were extracted and analyzed for pMLC as in part A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Endothelial Monolayer Permeability Experiments</h3><div class="NLM_p">Rapid disruption of the endothelial cell monolayer is key to the activity of VDAs.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Therefore, studies on the effects of compound <b>31</b> and CA4P on cell monolayer permeability to fluorescent dextran were undertaken. Confluent HUVEC monolayers were treated for 30 min before removal of the drug and addition of fluorescent dextran for a further 30 min. Since <b>31</b> was shown above to be effective at triggering induction of Rho signaling at a concentration of 50 nM (see <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), both CA4P and compound <b>31</b> were tested at this dose. Both drugs instigated a significant increase in monolayer permeability at this low dose (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Importantly, however, <b>31</b> led to a significantly larger increase in monolayer permeability than CA4P at this dose. This correlated with the increased activity of compound <b>31</b> over CA4P in stimulating pMLC phosphorylation.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Drug-induced changes in endothelial monolayer permeability comparing CA4P and <b>31</b>. Confluent monolayers of cells grown on microporous filter inserts were treated with vehicle control, CA4P (50 nM, 30 min), or compound <b>31</b> (50 nM, 30 min). Drugs were removed and replaced with FITC-dextran for a further 30 min. The passage of FITC-dextran through the monolayer was quantified and expressed as a percentage of FITC that passed through a filter without cells. Results are a mean of three independent experiments ± SEM. ∗∗ represents <i>P</i> < 0.01 and ∗∗∗ represents <i>P</i> < 0.001 for the significance of differences between groups (one-way ANOVA followed by a Tukey post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Studies</h3><div class="NLM_p">The maximum tolerated dose (MTD) of <b>31</b> in SCID (severe combined immunodeficiency) mice was found to be greater than 162 mg/kg (0.454 mmol/kg; data not shown). We next investigated whether <b>31</b> showed efficacy in a tumor model. SCID mice were implanted with 5 × 10<sup>6</sup> SW1222 (human colorectal adenocarcinoma) cells via subcutaneous injection. Tumors were allowed to reach 8 mm in diameter and then treated with vehicle (50% Na<sub>2</sub>CO<sub>3</sub>/NaCl), CA4P (100 mg/kg, 0.227 mmol/kg), or a solution of <b>31</b> (81 mg/kg, 0.227 mmol/kg). Tumors were excised 24 h later and necrosis levels calculated in H&E stained 5 μm thick sections by a random point scoring microscopy method using a “Chalkley” eyepiece graticule.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, CA4P treated tumors were significantly more necrotic than the untreated tumors, with % necrosis very similar for CA4P and <b>31</b> treated tumors. However, the tendency for necrosis to increase with <b>31</b> treatment just failed to reach significance with the animal numbers used (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). CA4P appeared to exhibit greater variability in necrosis levels with some tumors showing no response upon treatment. Maximum response was higher for CA4P, but over one-third of the treatment group failed to respond. In contrast, treatment with <b>31</b> resulted in much less variation, with 11% (a single tumor) failing to respond. It is of particular note that <b>31</b> showed signs of efficacy in vivo without further derivatization for water solubility and appeared to remain active in the circulation.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo study of drug-induced effects on tumor cell necrosis comparing CA4P and <b>31</b>. Each point represents the combined data from a single tumor. Five sections (cut at different tumor depths) were analyzed per tumor using a ×20 objective on a Nikon Eclipse TS100 microscope. The total section was analyzed and % necrosis calculated in each field from the relative number of points in a Chalkley eyepiece graticule coincident with necrotic versus viable tumor tissue. Bars represent the mean ± SEM of the combined data for each tumor. ∗ represents <i>P</i> < 0.05 for the significance of differences between groups (one-way ANOVA followed by a Tukey post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have successfully utilized highly regioselective cycloadditions of sydnones to access 12 direct pyrazole-based analogs of combretastatin A4. Two of the compounds display similar efficacy to CA4P in vitro. We have established that both compounds exhibit reversible binding and that the most active compound activates the RhoA-ROCK pathway, a characteristic of a CA4P-like mode of action. The most active compound also significantly increases cell monolayer permeability relative to CA4P at doses of 50 nM. Finally, evaluation of compound efficacy in vivo showed a tendency toward increased necrosis in a similar manner to CA4P at an equivalent dose, without the need for the incorporation of water solubilizing groups.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on a Bruker AVIII HD 400 (400 MHz), Bruker AVI 400 (400 MHz), or DPX-400 (400 MHz) supported by an Aspect 3000 data system. Chemical shifts are reported in parts per million (ppm) from tetramethylsilane with the residual protic solvent resonance as the internal standard (CHCl<sub>3</sub>, δ 7.26; DMSO, δ 2.50). <sup>13</sup>C NMR spectra were recorded on a Bruker AVIII HD 400 (100.6 MHz), Bruker AVI 400 (100.6 MHz), or DPX-400 (100.6 MHz) with complete proton decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the solvent as the internal reference (CDCl<sub>3</sub>, δ 77.16; DMSO, δ 39.52). High-resolution mass spectra (HRMS), recorded for accurate mass analysis, were obtained in electrospray mode (TOF ES+). Infrared (IR) spectra were recorded on a PerkinElmer Paragon 100 FTIR spectrophotometer, ν<sub>max</sub> in cm<sup>–1</sup>. Samples were recorded as solids using a solid probe. Bands were characterized as broad (br), strong (s), medium (m), and weak (w). All solvents and reagents were obtained from Acros, Fisher, Sigma, Alfa, or Fluorochem and used without purification unless specified. Flash chromatography was performed on silica gel (BDH silica gel 60 43-60). Thin layer chromatography (TLC) was performed on aluminum backed plates precoated with silica (0.2 mm, Merck DC-alufolien Kieselgel 60 F254) which were developed using ultraviolet (UV). HPLC chromatograms were obtained on a PerkinElmer series 200 HPLC system using a Waters XBridge C18 250 mm × 4.6 mm column and a gradient of 5–95% MeCN/H<sub>2</sub>O over 20 min. All compounds submitted for biological testing were recrystallized to consistent melting point and judged as >95% pure by HPLC and <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy.</div><div class="NLM_p"><i>N</i>-Methyl-, <i>N</i>-benzyl-, and <i>N</i>-(3,4,5-trimethoxyphenyl)sydnone (<b>1</b>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> were prepared by standard methods (cyclodehydration of <i>N</i>-nitrosoamino acid with trifluoroacetic anhydride), similar to <i>N</i>-(3-hydroxy-4-methoxyphenyl)sydnone (see below).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure A: Direct Arylation of Sydnones</h3><div class="NLM_p last">A mixture of sydnone (1 equiv), aryl halide (1.5 equiv), palladium acetate (5 mol %), XPhos (10 mol %), and potassium carbonate (2–3 equiv) in DMF (0.1–0.5 M) under an atmosphere of nitrogen was heated at 80–120 °C for 14 h before the reaction was allowed to cool to ambient temperature and water was added. The resulting mixture was extracted with ethyl acetate/40–60 petroleum ether (9:1), and the combined organic layers were dried over MgSO<sub>4</sub> and concentrated in vacuo. Flash silica chromatography (eluting solvent 20–100% ethyl acetate in 40–60 petroleum ether) afforded the target 3,4-disubstituted sydnones. The compounds could be further purified by recrystallization from ethanol or dichloromethane/petrol.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure B: Cycloaddition of Sydnones with Terminal Alkynes</h3><div class="NLM_p last">A Schlenk tube was charged with sydnone (1 equiv), alkyne (2–4 equiv), and xylenes (1 M). The tube was then sealed and heated at 160 °C for 24 h. The mixture was allowed to cool to ambient temperature and loaded onto a short plug of silica and washed with 40–60 petroleum ether before elution with ethyl acetate. Volatiles were removed in vacuo, and the crude residue was purified by flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 40% ethyl acetate in 40–60 petroleum ether) affording the target trisubstituted pyrazoles as mixtures of regioisomers. Only characterization for the major regioisomer is reported.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure C: Preparation of Pyrazole Boronic Esters</h3><div class="NLM_p last">A Schlenk tube was charged with sydnone (1 equiv), alkyne (2 equiv), and xylenes (1 M). The tube was then sealed and heated at 180 °C for 48 h. The mixture was allowed to cool to ambient temperature and loaded onto a short plug of silica and washed with 40–60 petroleum ether before elution with ethyl acetate. Volatiles were removed in vacuo and the crude residue was purified by flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 40% ethyl acetate in 40–60 petroleum ether) affording the target pyrazole boronic esters as an inseparable mixture of the target material and the product arising from protodeboronation. Only characterization for the target material is reported. <sup>13</sup>C NMR signals for C–B were not observed due to <i>T</i><sub>2</sub> broadening.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure D: Suzuki–Miyaura Coupling of Pyrazole Boronic Esters</h3><div class="NLM_p last">A flask equipped with a reflux condenser was charged with pyrazole boronic ester (1 equiv), XPhosPdG2 (0.1 equiv), sodium carbonate (2 equiv), and degassed 1,2-dimethoxyethane/water (1:1, 0.1 M) and heated at 80 °C under an inert atmosphere of nitrogen for 14 h. The mixture was allowed to cool to ambient temperature, poured into water, and extracted with ethyl acetate. The combined organic layers were dried over MgSO<sub>4</sub> and concentrated in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 40% ethyl acetate in 40–60 petroleum ether) afforded the target cross-coupled pyrazoles as an inseparable mixture of the target material and the product arising from protodeboronation. Only characterization for the target material is reported.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure E: Trimethylsilyl Group Cleavage</h3><div class="NLM_p last">A flask equipped with a reflux condenser was charged with pyrazole (1 equiv), and TBAF (10 equiv of 1 M solution in THF) and heated at reflux under an inert atmosphere of nitrogen for 24 h. The mixture was allowed to cool to ambient temperature, poured into water, neutralized with NaHCO<sub>3</sub>, and extracted with ethyl acetate. The combined organic layers were dried over MgSO<sub>4</sub> and concentrated in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 60% ethyl acetate in 40–60 petroleum ether) afforded the target desilated pyrazoles.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure F: Bromination and Subsequent Suzuki–Miyaura Coupling of Pyrazoles</h3><div class="NLM_p">(i) To a flask containing pyrazole was added a solution of <i>N</i>-bromosuccinamide (1 equiv) in acetonitrile (0.2 M). The resulting mixture was stirred for 1 h at ambient temperature before being poured into water. The mixture was extracted with ethyl acetate, and the combined organic layers were washed with aqueous sodium hydroxide (1 M). The organic layer was dried over MgSO<sub>4</sub>, filtered, and volatiles were removed in vacuo. The crude material was concentrated into a flask. The flask was then charged with aryl boronate (1.5 equiv), XPhosPdG2 (10 mol %), sodium carbonate (2–3.5 equiv), and thoroughly degassed 1,2-dimethoxyethane/water (1:1, 0.1 M). The mixture was heated at 80 °C for 14 h, cooled to ambient temperature, poured into water, and extracted with ethyl acetate. The combined organic layers were dried over MgSO<sub>4</sub>, filtered and volatiles removed in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 100% ethyl acetate in 40–60 petroleum ether) afforded the target pyrazoles.</div><div class="NLM_p last">(ii) In cases where the products obtained were the TBS-protected phenols, the crude Suzuki product was subjected to potassium carbonate (3 equiv) in refluxing methanol for 3 h before the mixture was poured into water and extracted with ethyl acetate. The organic layers were dried over MgSO<sub>4</sub>, filtered and volatiles removed in vacuo, followed by purification.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure G: Benzyl Deprotection</h3><div class="NLM_p last">A flask was charged with pyrazole and Pd/C (10% wt/wt, 100 mg/mmol) and methanol (0.1 M). The flask was flushed with H<sub>2</sub> (balloon) and stirred for 24–72 h. The mixture was filtered through Celite and concentrated in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 100% ethyl acetate in 40–60 petroleum ether) afforded the target debenzylated pyrazoles.</div></div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(3-Phenylmethoxy-4-methoxyphenyl)-<i>N</i>-(3,4,5-trimethoxyphenyl)sydnone (<b>2</b>)</h3><div class="NLM_p last"><i>N</i>-3,4,5-Trimethoxyphenylsydnone (500 mg, 1.98 mmol) and 1-bromo-3-phenylmethoxy-4-methoxybenzene (872 mg, 2.97 mmol) were subjected general procedure A, affording <b>2</b> as a colorless solid (542 mg, 59%). Mp: 144–146 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.78 (6H, s), 3.87 (3H, s), 3.92 (3H, s), 4.97 (2H, s), 6.64 (2H, s), 6.81 (1H, d, <i>J</i> = 8.5 Hz), 6.92 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 6.98 (1H, d, <i>J</i> = 2.0 Hz), 7.27–7.35 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.7, 61.3, 71.0, 102.6, 108.0, 111.8, 112.6, 117.0, 120.9, 127.8, 128.1, 128.7, 130.0, 136.6, 140.7, 148.2, 150.2, 154.2, 167.1. FTIR: ν<sub>max</sub> 2939 (w), 1738 (m), 1602 (m), 1260 (s), 1234 (s), 1132 (s), 1016 (m), 993 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>7</sub>: 465.1656. Found: 465.1654.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(3,4,5-Trimethoxyphenyl)-3-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>3a</b>, Major) and 1-(3,4,5-Trimethoxyphenyl)-4-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>3b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>2</b> (136 mg, 0.293 mmol) and trimethylsilylacetylene (115 mg, 1.17 mmol) were subjected to general procedure B, affording an inseparable mixture of pyrazoles <b>3a</b> and <b>3b</b> as an orange oil (113 mg, 75%, 95:5). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.36 (9H, s), 3.69 (6H, s), 3.82 (3H, s), 3.87 (3H, s), 4.95 (2H, s), 6.51 (1H, s), 6.52 (2H, s), 6.76 (1H, d, <i>J</i> = 1.5 Hz), 6.81–6.88 (2H, m), 7.24–7.35 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.9, 56.0, 56.1, 61.0, 71.1, 103.3, 111.5, 113.4, 114.6, 122.0, 123.3, 127.0, 127.9, 128.6, 136.1, 136.8, 137.3, 142.9, 147.8, 149.5, 153.2, 153.7. FTIR: ν<sub>max</sub> 2954 (w), 2836 (w), 1597 (m), 1505 (s), 1229 (s), 1125 (s), 1023 (m), 1005 (m), 979 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>29</sub>H<sub>35</sub>N<sub>2</sub>O<sub>5</sub>Si: 519.2310. Found: 519.2291.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(3,4,5-Trimethoxyphenyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>4</b>)</h3><div class="NLM_p last">Pyrazoles <b>3a</b> and <b>3b</b> (86 mg, 0.166 mmol, 95:5) and TBAF in THF (1.7 mL, 1.7 mmol) were subjected to general procedure E, affording pyrazole <b>4</b> as a yellow oil (50 mg, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.67 (6H, s), 3.84 (3H, s), 3.88 (3H, s), 4.97 (2H, s), 6.39 (1H, d, <i>J</i> = 2.0 Hz), 6.49 (2H, s), 6.77 (1H, s), 6.83–6.85 (2H, m), 7.26–7.34 (5H, m), 7.66 (1H, d, <i>J</i> = 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.2, 61.1, 71.3, 102.9, 107.3, 111.6, 114.8, 122.2, 123.1, 127.1, 128.1, 128.7, 135.9, 136.8, 137.3, 140.1, 142.9, 148.0, 149.9, 153.2. FTIR: ν<sub>max</sub> 2936 (w), 2836 (w), 1598 (m), 1508 (s), 1454 (m), 1415 (m), 1230 (s), 1118 (s), 1019 (m), 1002 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>27</sub>BN<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1925.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>5</b>)</h3><div class="NLM_p last">Pyrazole <b>4</b> (139 mg, 0.311 mmol) and Pd/C (31 mg) were subjected to general procedure G, affording pyrazole <b>5</b> as a colorless solid (75 mg, 68%). Mp: 102–103 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.68 (6H, s), 3.83 (3H, s), 3.86 (3H, s), 5.99 (1H, br), 6.42 (1H, d, <i>J</i> = 2.0 Hz), 6.53 (2H, s), 6.69 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 6.76 (1H, d, <i>J</i> = 8.5, Hz), 6.87 (1H, d, <i>J</i> = 2.0, Hz), 7.65 (1H, d, <i>J</i> = 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.0, 56.2, 61.1, 102.9, 107.9, 110.6, 115.2, 121.0, 123.8, 135.9, 137.2, 140.1, 142.9, 145.6, 146.8, 153.1. FTIR: ν<sub>max</sub> 3133 (br), 2933 (w), 2840 (w), 1601 (m), 1499 (s), 1458 (m), 1420 (m), 1272 (m), 1232 (s), 1118 (s), 1010 (m), 1002 (m), 933 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>5</sub>: 357.1445. Found: 357.1446. HPLC: <i>t</i><sub>R</sub> = 13.65 min; purity 96.3%.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(3-Hydroxy-4-methoxyphenyl)sydnone (<b>6</b>)</h3><div class="NLM_p last">2-((3-Hydroxy-4-methoxyphenyl)amino)acetic acid (0.97 g, 4.9 mmol) was dissolved in 1,2-dimethoxethane (20 mL), and isoamyl nitrite (0.58 g, 4.9 mmol) was added and the reaction stirred for 3 h at room temperature. Volatiles were removed in vacuo at <30 °C, and the crude material was triturated with petroleum ether/diethyl ether (20:1). <i>Caution: nitrosamines are highly toxic and carcinogenic.</i> The crude material was suspended in dichloromethane (20 mL) and cooled at 0 °C. Trifluoracetic anhydride (1.56 g, 7.41 mmol) was added and the reaction stirred for 1.5 h at rt. A small amount of water was added and the mixture basified with sodium bicarbonate and extracted with dichloromethane. The combined organic layers were dried over MgSO<sub>4</sub> and volatiles removed in vacuo. <b>6</b> was isolated as a brown solid (0.29 g, 28%). The product could be further purified by recrystallization from ethanol. Mp: 205–209 °C (dec). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.87 (3H, s), 7.18 (1H, d, <i>J</i> = 9.0 Hz), 7.30 (1H, d, <i>J</i> = 2.5 Hz), 7.36 (1H, dd, <i>J</i> = 2.5, 9.0 Hz), 7.66 (1H, s), 9.99 (1H, s). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 56.0, 94.3, 108.1, 112.2, 112.5, 127.4, 147.4, 150.8, 168.5. FTIR: ν<sub>max</sub> 3248 (br), 2924 (w), 1755 (s), 1720 (s), 1517 (s), 1285 (s), 1031 (m). HRMS calculated for C<sub>9</sub>H<sub>9</sub>N<sub>2</sub>O<sub>4</sub> (ES<sup>+</sup>)(+H<sup>+</sup>): 209.0562. Found: 209.0553.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-(3,4,5-Trimethoxyphenyl)-<i>N</i>-(3-hydroxy-4-methoxyphenyl)sydnone</h3><div class="NLM_p last"><i>N</i>-(3-Hydroxy-4-methoxyphenyl)sydnone (473 mg, 2.27 mmol) and 5-bromo-1,2,3-trimethoxybenzene (842 mg, 3.41 mmol) were subjected to general procedure A. affording 4-(3,4,5-trimethoxyphenyl)-<i>N</i>-(3-hydroxy-4-methoxyphenyl)sydnone as a colorless solid (402 mg, 47%). Mp: 196–197 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.67 (6H, s), 3.83 (3H, s), 4.00 (3H, s), 5.94 (1H, s), 6.59 (2H, s), 6.92–7.05 (2H, m), 7.09 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.5, 61.0, 104.7, 108.0, 111.0, 111.7, 117.2, 119.9, 127.8, 138.5, 147.0, 149.5, 153.3, 167.2. FTIR: ν<sub>max</sub> 3295 (br), 3082 (w), 2940 (w), 2836 (w), 1710 (s), 1600 (w), 1581 (m), 1509 (s), 1229 (s), 1125 (s) 1014 (m), 998 (m). HRMS calculated for C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>7</sub> (ES<sup>+</sup>)(+H<sup>+</sup>): 375.1192. Found: 375.1181.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(3,4,5-Trimethoxyphenyl)-<i>N</i>-(3-phenylmethoxy-4-methoxyphenyl)sydnone (<b>7</b>)</h3><div class="NLM_p last">A mixture of 4-(3,4,5-trimethoxyphenyl)-<i>N</i>-(3-hydroxy-4-methoxyphenyl)sydnone (402 mg, 1.07 mmol), benzyl bromide (368 mg, 2.15 mmol), and Hünig’s base (278 mg, 2.15 mmol) was heated at 130 °C for 2 h. The reaction was allowed to cool to ambient temperature, and water was added. The mixture was extracted with dichloromethane, and the combined organic layers were washed with saturated ammonium chloride and brine before drying over MgSO<sub>4</sub> and concentrating in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 40% ethyl acetate in 40–60 petroleum ether) afforded sydnone <b>7</b> as a yellow solid (296 mg, 60%). Mp: 58–60 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.62 (6H, s), 3.83 (3H, s), 3.96 (3H, s), 5.09 (2H, s), 6.51 (2H, s), 6.98–7.03 (2H, m), 7.09 (1H, dd, <i>J</i> = 8.5, 2.5 Hz), 7.29–7.36 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.6, 61.1, 71.6, 104.5, 107.8, 110.6, 111.7, 118.3, 119.9, 127.3 (×2 C), 128.6, 128.9, 135.5, 138.5, 149.1, 152.5, 153.4, 167.1. FTIR: ν<sub>max</sub> 2934 (w), 2836 (w), 1728 (s), 1581 (m), 1512 (s), 1226 (s), 1123 (s), 999 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>25</sub>H<sub>25</sub>N<sub>2</sub>O<sub>7</sub>: 465.1656. Found: 465.1668.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(3-Phenylmethoxy-4-methoxyphenyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>8a</b>, Major) and 1-(3-Phenylmethoxy-4-methoxyphenyl)-4-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>8b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>7</b> (290 mg, 0.624 mmol) and trimethylsilylacetylene (245 mg, 2.50 mmol) were subjected to general procedure B, affording an inseparable mixture of pyrazoles <b>8a</b> and <b>8b</b> as an orange oil (256 mg, 79%, 95:5). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.36 (9H, s), 3.65 (6H, s), 3.84 (3H, s), 3.87 (3H, s), 5.02 (2H, s), 6.38 (2H, s), 6.56 (1H, s), 6.83 (1H, d, <i>J</i> = 8.5 Hz), 6.88 (1H, dd, <i>J</i> = 8.5, 2.5 Hz), 6.95 (1H, d, <i>J</i> = 2.5 Hz), 7.27–7.34 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.9, 56.1, 56.4, 61.0, 71.3, 106.0, 111.5, 112.0, 113.3, 118.6, 126.3, 127.3, 128.1, 128.6, 133.6, 136.6, 137.8, 143.0, 148.3, 149.2, 153.1, 153.6. FTIR: ν<sub>max</sub> 2951 (w), 2834 (w), 1584 (m), 1514 (s), 1236 (s), 1126 (s), 1005 (m), 978 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>29</sub>H<sub>35</sub>N<sub>2</sub>O<sub>5</sub>Si: 519.2310. Found: 519.2314.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(3-Phenylmethoxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>9</b>)</h3><div class="NLM_p last">Pyrazoles <b>8a</b> and <b>8b</b> (256 mg, 0.494 mmol, 95:5) and TBAF in THF (5 mL, 5 mmol) were subjected to general procedure E, affording pyrazole <b>9</b> as a yellow oil (137 mg, 62%). Product was contaminated with ∼10% unknown byproduct. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.64 (6H, s), 3.83 (3H, s), 3.86 (3H, s), 5.01 (2H, s), 6.38 (2H, s), 6.45 (1H, d, <i>J</i> = 2.0 Hz), 6.81–6.84 (2H, m), 6.93–6.97 (1H, m), 7.25–7.36 (5H, m), 7.65 (1H, d, <i>J</i> = 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.0, 56.3, 61.0, 71.2, 106.0, 107.0, 111.3, 111.6, 118.3, 125.9, 127.2, 127.3, 128.0, 128.6, 133.3, 136.5, 139.9, 142.9, 148.2, 149.1, 153.0. FTIR: ν<sub>max</sub> 2934 (w), 2836 (w), 1584 (m), 1512 (s), 1414 (m), 1236 (s), 1121 (s), 1002 (m), 910 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>27</sub>BN<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1914.</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(3-Hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>10</b>)</h3><div class="NLM_p last">Pyrazole <b>9</b> (137 mg, 0.307 mmol) and Pd/C (31 mg) for 24 h were subjected to general procedure G, affording pyrazole <b>10</b> as a colorless solid (76 mg, 69%). Mp: 55–58 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.68 (6H, s), 3.85 (3H, s), 3.88 (3H, s), 5.98 (1H, br), 6.43 (2H, s), 6.46 (1H, d, <i>J</i> = 2.0 Hz), 6.75 (1H, dd, <i>J</i> = 8.5, 2.5 Hz), 6.78 (1H, d, <i>J</i> = 8.5, Hz), 6.97 (1H, d, <i>J</i> = 2.5, Hz), 7.66 (1H, d, <i>J</i> = 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.3, 61.1, 106.1, 107.0, 110.4, 112.7, 117.5, 126.0, 133.9, 138.0, 139.9, 143.1, 145.9, 146.3, 153.1. FTIR: ν<sub>max</sub> 3146 (br), 2941 (w), 2836 (w), 1585 (m), 1511 (s), 1498 (s), 1416 (m), 1239 (s), 1120 (s), 1000 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>5</sub>: 357.1445. Found: 357.1444. HPLC: <i>t</i><sub>R</sub> = 13.54 min; purity 95.2%.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(3,4,5-Trimethoxyphenyl)-<i>N</i>-methylsydnone (<b>11</b>)</h3><div class="NLM_p last"><i>N</i>-Methylsydnone (250 mg, 2.50 mmol) and 5-bromo-1,2,3-trimethoxybenzene (926 mg, 3.75 mmol) were subjected to general procedure A, affording <b>11</b> as a colorless solid (571 mg, 86%). Mp: 123–124 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.86 (3H, s), 3.87 (6H, s), 4.12 (3H, s), 6.74 (2H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 39.0, 56.5, 61.1, 105.7, 108.2, 119.6, 139.2, 153.9, 167.3. FTIR: ν<sub>max</sub> 2932 (w), 2858 (w), 1726 (s), 1585 (m), 1241 (m), 1225 (m), 1124 (s), 998 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>5</sub>: 267.0981. Found: 267.0970.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(3,4,5-Trimethoxyphenyl)-<i>N</i>-benzylsydnone (<b>12</b>)</h3><div class="NLM_p last"><i>N</i>-Benzylsydnone (500 mg, 2.84 mmol) and 5-bromo-1,2,3-trimethoxybenzene (1.05 g, 4.26 mmol) were subjected to general procedure A, affording <b>12</b> as a colorless solid (570 mg, 59%). Mp: 101 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.69 (6H, s), 3.84 (3H, s), 5.52 (2H, s), 6.52 (2H, s), 7.18–7.24 (2H, m), 7.37–7.43 (3H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 55.5, 56.2, 61.0, 106.1, 108.6, 119.4, 127.1, 129.5, 129.5, 132.0, 139.2, 153.8, 167.6. FTIR: ν<sub>max</sub> 2829 (w), 1727 (s), 1712 (s), 1578 (m), 1521 (m), 1223 (s), 1131 (s), 1000 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>5</sub>: 343.1294. Found: 343.1278.</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(3-Phenylmethoxy-4-methoxyphenyl)-<i>N</i>-methylsydnone (<b>13</b>)</h3><div class="NLM_p last"><i>N</i>-Methylsydnone (500 mg, 5.00 mmol) and 1-bromo-3-phenylmethoxy-4-methoxybenzene (2.2 g, 7.5 mmol) were subjected to general procedure A affording <b>13</b> as a tan solid (1.105 g, 71%). Mp: 99 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.83 (3H, s), 3.92 (3H, s), 5.19 (2H, s), 6.96 (1H, d, <i>J</i> = 8.5 Hz), 7.04 (1H, d, <i>J</i> = 2.0 Hz), 7.10 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.27–7.33 (1H, m), 7.34–7.40 (2H, m), 7.41–7.47 (2H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 38.6, 56.2, 71.2, 108.1, 112.2, 113.8, 116.7, 121.4, 127.4, 128.1, 128.8, 136.8, 148.3, 150.6, 167.4. FTIR: ν<sub>max</sub> 2970 (w), 1723 (s), 1532 (m), 1450 (m), 1380 (m), 1305 (m), 1230 (m), 1225 (m), 1150 (s), 990 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>: 313.1188. Found: 313.1185.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(3-Phenylmethoxy-4-methoxyphenyl)-<i>N</i>-benzylsydnone (<b>14</b>)</h3><div class="NLM_p last"><i>N</i>-Benzylsydnone (1.00 g, 5.68 mmol) and 1-bromo-3-phenylmethoxy-4-methoxybenzene (2.50 g, 8.51 mmol) were subjected to general procedure A, affording <b>14</b> as a tan solid (1.21 g, 55%). Mp: 144–145 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.90 (3H, s), 5.01 (2H, s), 5.34 (2H, s), 6.87 (1H, d, <i>J</i> = 2.0 Hz), 6.91 (1H, d, <i>J</i> = 8.5 Hz), 6.96 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.06–7.11 (2H, m), 7.27–7.40 (8H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 55.2, 56.2, 71.0, 108.0, 112.2, 114.1, 116.5, 122.4, 127.5, 127.6, 128.2, 128.8, 129.4, 129.5, 131.7, 136.6, 148.4, 150.8, 167.7. FTIR: ν<sub>max</sub> 3008 (w), 2836 (w), 1720 (s), 1703 (m), 1260 (m), 1226 (m), 1176 (m), 1023 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>: 389.1501. Found: 389.1519.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(Methyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>15a</b>, Major) and 1-(4-Methyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>15b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>11</b> (200 mg, 0.751 mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (337 mg, 1.50 mmol) were subjected to general procedure C, affording an inseparable mixture of pyrazoles <b>15a</b> and <b>15b</b> as a yellow oil (309 mg, 92% 5:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.36 (9H, s), 1.18 (12H, s), 3.80 (3H, s), 3.85 (6H, s), 3.90 (3H, s), 6.59 (2H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.4, 25.0, 37.2, 56.2, 61.1, 83.0, 107.8, 126.9, 138.1, 150.8, 152.6, 158.8. FTIR: ν<sub>max</sub> 2976 (m), 1585 (m), 1497 (s), 1411 (s), 1240 (s), 1128 (s), 1048 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>22</sub>H<sub>36</sub>N<sub>2</sub>O<sub>5</sub>Si: 447.2481. Found: 447.2488.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-(Benzyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>16a</b>, Major) and 1-(Benzyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>16b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>12</b> (200 mg, 0.584 mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (262 mg, 1.17 mmol) were subjected to general procedure C, affording an inseparable mixture of pyrazoles <b>16a</b> and <b>16b</b> that was isolated as a yellow oil (202 mg, 66%, 9:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.37 (9H, s), 1.19 (12H, s), 3.63 (6H, s), 3.87 (3H, s), 5.28 (2H, s), 6.40 (2H, s) 7.05 (2H, d, <i>J</i> = 7.0 Hz), 7.17–7.29 (3H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.3, 25.0, 53.1, 55.9, 61.0, 83.0, 107.7, 112.8, 127.0, 127.3, 128.5, 138.0, 138.5, 150.9, 152.4, 158.8. FTIR: ν<sub>max</sub> 2976 (w), 1585 (m), 1496 (m), 1236 (s), 1124 (s), 1038 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>28</sub>H<sub>40</sub><sup>11</sup>BN<sub>2</sub>O<sub>5</sub>Si: 523.2794. Found: 523.2801.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(Methyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>17a</b>, Major) and 1-(Methyl)-3-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>17b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>13</b> (200 mg, 0.640 mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (287 mg, 1.28 mmol) were subjected to general procedure C, affording an inseparable mixture of pyrazoles <b>17a</b> and <b>17b</b> as a yellow oil (230 mg, 73%, 4:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.37 (9H, s), 1.20 (12H, s), 3.57 (3H, s), 3.94 (3H, s), 5.18 (2H, s), 6.91–6.94 (3H, m) 7.28–7.32 (1H, m), 7.33–7.39 (2H, m), 7.41–7.46 (2H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.4, 25.0, 36.9, 56.1, 71.0, 82.9, 110.9, 116.5, 122.0, 123.6, 127.3, 128.0, 128.7, 137.1, 147.1, 149.7, 150.7, 158.7. FTIR: ν<sub>max</sub> 2977 (w), 1498 (m), 1311 (s), 1250 (s), 1139 (s), 1046 (m), 1026 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>27</sub>H<sub>38</sub><sup>11</sup>BN<sub>2</sub>O<sub>4</sub>Si: 493.2694. Found: 493.2718.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(Benzyl)-3-(trimethylsilyl)-4-(pinacolatoborolane)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>18a</b>, Major) and 1-(Benzyl)-3-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>18b</b>, Minor)</h3><div class="NLM_p last">Sydnone <b>14</b> (200 mg, 0.515 mmol) and 4,4,5,5-tetramethyl-2-[2-(trimethylsilyl)ethynyl]-1,3,2-dioxaborolane (231 mg, 1.03 mmol) were subjected to general procedure C, affording an inseparable mixture of pyrazoles <b>18a</b> and <b>18b</b> as a yellow oil (187 mg, 64%, 9:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.39 (9H, s), 1.19 (12H, s), 3.91 (3H, s), 4.90 (2H, s), 5.16 (2H, s), 6.78–6.82 (2H, m), 6.84 (1H, d, <i>J</i> = 8.0 Hz), 6.92–6.98 (2H, m), 7.18–7.24 (2H, m), 7.27–7.41 (6H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.3, 25.0, 52.9, 56.1, 70.7, 83.0, 110.9, 115.9, 123.6, 123.9, 127.1, 127.2, 127.4, 128.0, 128.4, 128.7, 137.1, 138.3, 147.2, 149.7, 150.8, 158.7. FTIR: ν<sub>max</sub> 2977 (w), 1497 (m), 1452 (m), 1250 (s), 1141 (s), 1029 (m) 908 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>33</sub>H<sub>42</sub><sup>11</sup>BN<sub>2</sub>O<sub>4</sub>Si: 569.3007. Found: 569.3010.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(Methyl)-3-(trimethylsilyl)-4-(3-phenylmethoxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>19</b>, Major) and 1-(Methyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>15b</b>, Minor)</h3><div class="NLM_p last">Pyrazoles <b>15a</b> and <b>15b</b> (498 mg, 1.12 mmol) and 1-bromo-3-phenylmethoxy-4-methoxybenzene (491 mg, 1.67 mmol) were subjected to general procedure D, affording an inseparable mixture of pyrazoles <b>19</b> and <b>15b</b> as a yellow oil (409 mg, 69%, 3:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.14 (9H, s), 3.68 (6H, s), 3.84 (3H, s), 3.87 (3H, s), 3.88 (3H, s), 5.00 (2H, s), 6.34 (2H, s) 6.68 (1H, d, <i>J</i> = 2.0 Hz), 6.71 (1H, d, <i>J</i> = 8.0, 2.0 Hz), 6.79 (1H, d, <i>J</i> = 8.0 Hz), 7.25–7.35 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.2, 37.7, 56.1, 56.2, 61.0, 71.1, 106.3, 107.3, 111.3, 112.6, 116.8, 123.8, 125.7, 127.1, 127.7, 127.9, 128.6, 137.2, 141.3, 147.5, 148.6, 150.5, 153.1. FTIR: ν<sub>max</sub> 2957 (w), 2934 (w), 1580 (m), 1237 (s), 1127 (s), 1008 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>5</sub>Si: 533.2472. Found: 533.2469.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(Benzyl)-3-(trimethylsilyl)-4-(3-phenylmethoxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>20</b>, Major) and 1-(Benzyl)-3-(trimethylsilyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>16b</b>, Minor)</h3><div class="NLM_p last">Pyrazoles <b>16a</b> and <b>16b</b> (307 mg, 0.587 mmol) and 1-bromo-3-phenylmethoxy-4-methoxybenzene (258 mg, 0.881 mmol) were subjected to general procedure D, affording an inseparable mixture of pyrazoles <b>20</b> and <b>16b</b> as a yellow oil (257 mg, 72%, 9:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.20 (9H, s), 3.48 (6H, s), 3.82 (3H, s), 3.86(3H, s), 4.99 (2H, s), 5.33 (2H, s), 6.18 (2H, s) 6.72–6.77 (2H, m), 6.80 (1H, d, <i>J</i> = 8.0 Hz), 7.12–7.17 (2H, m), 7.22–7.38 (8H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.2, 53.6, 55.8, 56.0, 60.9, 71.1, 106.1, 107.3, 111.2, 116.6, 123.6, 125.7, 126.4, 127.0, 127.1, 127.4, 127.8, 128.5, 128.6, 137.1, 137.7, 138.5, 141.0, 147.4, 148.5, 150.7, 152.8. FTIR: ν<sub>max</sub> 2956 (w), 2835 (w), 1583 (m), 1495 (m), 1244 (s), 1125 (s), 1026 (m), 1004 (m), 907 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>36</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub>Si: 609.2779. Found: 609.2772.</div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-(Methyl)-3-(trimethylsilyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>21</b>, Major) and 1-(Methyl)-3-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>17b</b>, Minor)</h3><div class="NLM_p last">Pyrazoles <b>17a</b> and <b>17b</b> (215 mg, 0.437 mmol) and 5-bromo-1,2,3-trimethoxybenzene (218 mg, 0.883 mmol) were subjected to general procedure D, affording an inseparable mixture of pyrazoles <b>21</b> and <b>17b</b> that was isolated as a yellow oil (137 mg, 60%, 4:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.21 (9H, s), 3.68 (9H, s), 3.83 (3H, s), 3.87 (3H, s), 5.01 (2H, s), 6.32 (2H, s) 6.68 (1H, d, <i>J</i> = 2.0 Hz), 6.77 (1H, d, <i>J</i> = 8.5, 2.0 Hz), 6.85 (1H, d, <i>J</i> = 8.5 Hz), 7.25–7.38 (5H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.2, 37.3, 56.0, 56.3, 61.0, 71.0, 104.7, 107.7, 111.5, 116.0, 122.6, 123.2, 127.0, 127.9, 128.6, 130.7, 136.8, 140.8, 147.6, 149.6, 149.8, 152.5, 153.4. FTIR: ν<sub>max</sub> 2934 (w), 1580 (m), 1493 (m), 1233 (s), 1125 (s), 1006 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>30</sub>H<sub>37</sub>N<sub>2</sub>O<sub>5</sub>Si: 533.2472. Found: 533.2497.</div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(Benzyl)-3-(trimethylsilyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>22</b>) and 1-(Benzyl)-3-(trimethylsilyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>18b</b>)</h3><div class="NLM_p last">Pyrazoles <b>18a</b> and <b>18b</b> (162 mg, 0.285 mmol) and 5-bromo-1,2,3-trimethoxybenzene (136 mg, 0.550 mmol) were subjected to general procedure D, affording an inseparable mixture of pyrazoles <b>22</b> and <b>18b</b> as a yellow oil (85 mg, 49%, 3:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.24 (9H, s), 3.66 (6H, s), 3.82 (3H, s), 3.86 (3H, s), 4.78 (2H, s), 5.22 (2H, s), 6.31 (2H, s) 6.56 (1H, d, <i>J</i> = 2.0 Hz), 6.62 (1H, d, <i>J</i> = 8.5, 2.0 Hz), 6.77 (1H, d, <i>J</i> = 8.5 Hz), 7.08 (2H, dd, <i>J</i> = 9.0, 7.0 Hz), 7.22–7.35 (8H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −0.1, 53.5, 56.1, 56.4, 61.1, 70.7, 107.7, 109.1, 111.5, 115.8, 122.1, 126.7, 127.2 (×2 C), 127.5, 128.0, 128.6 (x2 C), 130.6, 136.8, 138.2, 140.9, 147.7, 149.7, 150.3, 152.5, 154.0. FTIR: ν<sub>max</sub> 2955 (w), 2934 (w), 2834 (w), 1581 (m), 1494 (m), 1232 (s), 1124 (s), 1006 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>36</sub>H<sub>41</sub>N<sub>2</sub>O<sub>5</sub>Si: 609.2784. Found: 609.2785.</div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-(Methyl)-4-(3-phenylmethoxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>23a</b>) and 1-(Methyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>23b</b>)</h3><div class="NLM_p last">Pyrazoles <b>19</b> and <b>15b</b> (211 mg, 0.396 mmol, 3:1) and TBAF in THF (4 mL, 4 mmol) were subjected to general procedure E, affording a mixture of pyrazole <b>23a</b> and <b>23b</b> as a yellow oil (101 mg, 55%, 95:5). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.76 (6H, s), 3.83 (3H, s), 3.87 (3H, s), 3.89 (3H, s), 4.89 (2H, s), 6.48 (2H, s), 6.71 (1H, d, <i>J</i> = 2.0 Hz), 6.75–6.85 (2H, m), 7.20–7.32 (5H, m), 7.63 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.4, 56.1, 56.4, 61.1, 70.9, 106.4, 107.4, 112.0, 113.3, 120.0, 120.6, 125.8, 126.1, 127.1, 127.9, 128.6, 137.1, 137.2, 138.5, 139.4, 148.0, 148.2. FTIR: ν<sub>max</sub> 2935 (w), 2835 (w), 1583 (m), 1409 (m), 1236 (s), 1123 (s), 1002 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>: 461.2076. Found: 461.2090.</div></div><div id="sec5_7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-(Benzyl)-4-(3-phenylmethoxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>24</b>)</h3><div class="NLM_p last">Pyrazoles <b>20</b> and <b>16b</b> (244 mg, 0.401 mmol, 9:1) and TBAF in THF (4 mL, 4 mmol) were subjected to general procedure E, affording pyrazole <b>24</b> as a yellow oil (137 mg, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.59 (6H, s), 3.84 (3H, s), 3.87 (3H, s), 4.89 (2H, s), 5.22 (2H, s), 6.33 (2H, s), 6.76 (1H, d, <i>J</i> = 2.0 Hz), 6.79 (1H, d, <i>J</i> = 8.5 Hz), 6.85 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.04–7.08 (2H, m), 7.23–7.32 (8H, m), 7.74 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 53.6, 56.1 (x2 C), 61.1, 70.8, 107.5, 112.0, 113.1, 119.8, 120.8, 125.6, 125.8, 127.0, 127.1, 127.6, 127.8, 128.5, 128.6, 137.1, 137.6, 138.0, 138.4, 139.4, 148.0, 148.2, 153.5. FTIR: ν<sub>max</sub> 2999 (w), 2934 (w), 2836 (w), 1580 (m), 1517 (m), 1451 (m), 1220 (s), 1136 (s), 1106 (m), 1024 (m), 1001 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>33</sub>H<sub>33</sub>N<sub>2</sub>O<sub>5</sub>: 537.2384. Found: 537.2386.</div></div><div id="sec5_7_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-(Methyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>25</b>)</h3><div class="NLM_p last">Pyrazoles <b>21</b> and <b>17b</b> (137 mg, 0.257 mmol, 4:1) and TBAF in THF (2.6 mL, 2.6 mmol) were subjected to general procedure E, affording pyrazole <b>25</b> as an orange oil (66 mg, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.59 (3H, s), 3.62 (6H, s), 3.80 (3H, s), 3.93 (3H, s), 5.11 (2H, s), 6.36 (2H, s), 6.80 (1H, d, <i>J</i> = 2.0 Hz), 6.87 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.96 (1H, d, <i>J</i> = 8.0 Hz), 7.24–7.38 (5H, m), 7.62 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.1, 55.9, 56.2, 61.0, 71.2, 104.3, 112.0, 116.2, 120.8, 122.7, 123.6, 127.2, 128.1, 128.7 (x2 C), 136.4, 136.6, 137.0, 139.7, 148.1, 150.3, 153.1. FTIR: ν<sub>max</sub> 3002 (w), 2934 (w), 1584 (m), 1521 (m), 1418 (m), 1373 (m), 1253 (s), 1124 (s), 1021 (m), 1007 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>27</sub>H<sub>29</sub>N<sub>2</sub>O<sub>5</sub>: 461.2071. Found: 461.2070.</div></div><div id="sec5_7_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-(Benzyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-phenylmethoxy-4-methoxyphenyl)pyrazole (<b>26</b>)</h3><div class="NLM_p last">Pyrazoles <b>22</b> and <b>18b</b> (158 mg, 0.260 mmol, 4:1) and TBAF in THF (2.6 mL, 2.6 mmol) were subjected to general procedure E, affording pyrazole <b>26</b> as an orange oil (103 mg, 74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.61 (6H, s), 3.80 (3H, s), 3.91 (3H, s), 4.88 (2H, s), 5.13 (2H, s), 6.37 (2H, s), 6.67 (1H, d, <i>J</i> = 2.0 Hz), 6.79 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.90 (1H, d, <i>J</i> = 8.0 Hz), 6.98–7.03 (2H, m), 6.24–7.33 (8H, m), 7.79 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 53.3, 55.9, 56.2, 61.0, 70.8, 104.3, 111.9, 116.0, 121.2, 122.5, 123.8, 127.1, 127.3, 127.7, 128.1, 128.6, 128.7 (x2 C), 136.5, 136.6, 137.6, 137.7, 140.0, 148.1, 150.3, 153.2. FTIR: ν<sub>max</sub> 2935 (w), 2835 (w), 1583 (m), 1520 (m), 1454 (m), 1373 (m), 1245 (s), 1123 (s), 1002 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>33</sub>H<sub>33</sub>N<sub>2</sub>O<sub>5</sub>: 537.2384. Found: 537.2383.</div></div><div id="sec5_7_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-(Methyl)-4-(3-hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>27</b>)</h3><div class="NLM_p last">Pyrazoles <b>23a</b> and <b>23b</b> (100 mg, 0.217 mmol) and Pd/C (22 mg) were subjected to general procedure G, affording pyrazole <b>27</b> was isolated as a colorless solid (47 mg, 58%). Mp: 210 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.77 (3H, s), 3.79 (6H, s), 3.85 (3H, s), 3.92 (3H, s), 5.57 (1H, s), 6.50 (2H, s), 6.66 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 6.72 (1H, d, <i>J</i> = 8.5 Hz), 6.85 (1H, d, <i>J</i> = 2.0 Hz), 7.67 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.4, 56.0, 56.3, 61.1, 107.4, 110.8, 113.8, 119.1, 120.6, 125.9, 126.5, 137.4, 138.4, 139.5, 145.3, 145.6, 153.6. FTIR: ν<sub>max</sub> 3347 (br), 1582 (m), 1458 (m), 1406 (m), 1270 (m), 1232 (s), 1129 (s), 1028 (m), 997 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>: 371.1607. Found: 371.1611. HPLC: <i>t</i><sub>R</sub> = 11.31 min; purity 98.5%.</div></div><div id="sec5_7_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-(3-Hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>28</b>) and 1-(Benzyl)-4-(3-hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>29</b>)</h3><div class="NLM_p">Pyrazole <b>24</b> (126 mg, 0.235 mmol) and Pd/C (24 mg) were subjected to general procedure G, affording pyrazole <b>28</b> as a colorless solid (25 mg, 30%) and pyrazole <b>29</b> as a colorless solid (23 mg, 22%).</div><div class="NLM_p"><b>28</b>. Mp: 198–200 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.73 (6H, s), 3.87 (3H, s), 3.90 (3H, s), 6.71 (2H, s), 6.81 (2H, app. d, <i>J</i> = 1.0 Hz), 6.96 (1H, app. t, <i>J</i> = 1.0 Hz), 7.65 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.2 (x2 C), 61.1, 105.4, 105.6, 110.8, 115.2, 119.8, 120.7, 126.5, 127.1, 129.9, 138.1, 145.7, 145.8, 153.4. FTIR: ν<sub>max</sub> 3251 (m), 2966 (w), 2937 (w), 1587 (m), 1412 (m), 1274 (m), 1234 (s), 1121 (s), 1028 (m), 994 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>: 357.1445. Found: 357.1443. HPLC: <i>t</i><sub>R</sub> = 11.76 min; purity 98.2%.</div><div class="NLM_p last"><b>29</b>. Mp: 126 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.60 (6H, s), 3.84 (3H, s), 3.89 (3H, s), 5.22 (2H, s), 5.56 (1H, s), 6.33 (2H, s), 6.65–6.74 (2H, m), 6.87 (1H, d, <i>J</i> = 1.5 Hz), 7.06 (1H, d, <i>J</i> = 7.0 Hz), 7.19–7.33 (4H, m), 7.77 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 53.6, 56.1 (x2 C), 61.1, 107.6, 110.8, 113.6, 119.0, 120.8, 125.7, 126.5, 127.0, 127.6, 128.7, 138.0, 138.1, 138.5, 139.7, 145.3, 145.6, 153.4. FTIR: ν<sub>max</sub> 3423 (m), 2926 (m), 2835 (w), 1579 (m), 1500 (m), 1231 (m), 1216 (m), 1124 (s), 1028 (m), 1000 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1922. HPLC: <i>t</i><sub>R</sub> = 16.32 min; purity 95.7%.</div></div><div id="sec5_7_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-(3-Hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)pyrazole (<b>28</b>)</h3><div class="NLM_p last">Pyrazole <b>38</b> (79 mg, 0.18 mmol) and Pd/C (18 mg) were subjected to general procedure G, affording pyrazole <b>28</b> as a colorless solid (18 mg, 29%). See above for characterization.</div></div><div id="sec5_7_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-(Methyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>30</b>)</h3><div class="NLM_p last">Pyrazole <b>25</b> (177 mg, 0.384 mmol) and Pd/C (38 mg) were subjected to general procedure G, affording pyrazole <b>30</b> as a colorless solid (96 mg, 67%). Mp: 149–150 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.64 (6H, s), 3.74 (3H, s), 3.79 (3H, s), 3.92 (3H, s), 6.38 (1H, br), 6.41 (2H, s), 6.79 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.89–6.95 (2H, m), 7.68 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 37.2, 55.9, 56.1, 61.0, 104.4, 111.0, 116.5, 120.8, 122.4, 123.4, 128.8, 136.3, 137.0, 139.8, 146.1, 147.3, 153.1. FTIR: ν<sub>max</sub> 3269 (br), 2940 (w), 1583 (m), 1373 (m), 1272 (m), 1227 (m), 1173 (m), 1123 (s), 1007 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>: 371.1607. Found: 371.1605. HPLC: <i>t</i><sub>R</sub> = 13.06 min; purity 94.4%.</div></div><div id="sec5_7_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>31</b>) and 1-(Benzyl)-4-(3,4,5-trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>32</b>)</h3><div class="NLM_p">Pyrazole <b>26</b> (66 mg, 0.123 mmol) and Pd/C (15 mg) were subjected to general procedure G, affording pyrazole <b>31</b> as a colorless solid (12 mg, 27%) and pyrazole <b>32</b> as a tan solid (15 mg, 27%).</div><div class="NLM_p"><b>31</b>. Mp: 90–93 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.73 (6H, s), 3.86 (3H, s), 3.88 (3H, s), 6.51 (2H, s), 6.80 (1H, d, <i>J</i> = 8.5 Hz), 6.94 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.13 (1H, d, <i>J</i> = 2.0 Hz), 7.67 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.2, 61.1, 105.7, 110.9, 114.7, 119.6, 120.6, 124.2, 128.8, 135.9, 136.9, 142.6, 145.8, 147.1, 153.3. FTIR: ν<sub>max</sub> 3282 (br), 2934 (w), 2838 (w), 1584 (m), 1449 (m), 1411 (m), 1251 (m), 1231 (m), 1122 (s), 1019 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>: 357.1445. Found: 357.1440. HPLC: <i>t</i><sub>R</sub> = 12.08 min; purity 95.1%.</div><div class="NLM_p last"><b>32</b>. Mp: 167–168 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.65 (6H, s), 3.80 (3H, s), 3.93 (3H, s), 5.22 (2H, s), 5.66 (1H, s), 6.43 (2H, s), 6.72 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.83–6.88 (2H, m), 7.03–7.08 (2H, m), 7.23–7.29 (3H, m), 7.78 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.2, 56.3, 61.1, 105.9, 110.5, 115.0, 120.7, 121.0, 127.0, 128.1, 128.3, 129.0, 129.1, 136.5, 136.9, 145.5, 146.4, 148.5, 153.2 (one sp<sup>2</sup> carbon not observed). FTIR: ν<sub>max</sub> 2929 (br), 1584 (m), 1520 (m), 1374 (m), 1246 (m), 1120 (s), 1007 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1914. HPLC: <i>t</i><sub>R</sub> = 16.07 min; purity 98.6%.</div></div><div id="sec5_7_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-(3,4,5-Trimethoxyphenyl)-5-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>31</b>)</h3><div class="NLM_p last">A solution of pyrazole <b>40</b> (274 mg, 0.614 mmol) in methanol (6 mL) and AcOH (6 drops) was flowed through a H-Cube continuous flow hydrogenator (1 mL min<sup>–1</sup>) with a 10% Pd/C catalyst cartridge at 80 °C using controlled H<sub>2</sub> mode (80 bar) as a continuous loop. Once the reaction was complete by TLC analysis, the system was washed with methanol (10 mL). The reaction was subsequently neutralized with NaHCO<sub>3</sub>, then filtered, and the volatiles were removed in vacuo. Flash silica chromatography (gradient starting with 100% 40–60 petroleum ether and ending with 100% ethyl acetate in 40–60 petroleum ether) afforded pyrazole <b>31</b> as a colorless solid (144 mg, 66%). See above for characterization.</div></div><div id="sec5_7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-(Methyl)-3-(3,4,5-trimethoxyphenyl)pyrazole (<b>33</b>)</h3><div class="NLM_p last"><i>N</i>-Methylsydnone (150 mg, 1.50 mmol) and 3,4,5-trimethoxyphenylacetylene (576 mg, 3.00 mmol) were subjected to general procedure B, affording pyrazole <b>33</b> as an orange oil (236 mg, 63%, >98:2). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.83 (3H, s), 3.89 (9H, s), 6.45 (1H, d, <i>J</i> = 2.0 Hz), 6.99 (2H, s), 7.33 (1H, d, <i>J</i> = 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 39.0, 56.1, 60.9, 102.6, 102.7, 129.4, 131.5, 137.6, 151.4, 153.4. FTIR: ν<sub>max</sub> 2930 (w), 2827 (w), 1588 (m), 1507 (m), 1401 (m), 1232 (s), 1127 (s), 1008 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>13</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub>: 249.1234. Found: 249.1230.</div></div><div id="sec5_7_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-(Benzyl)-3-(3,4,5-trimethoxyphenyl)pyrazole (<b>34a</b>, Major) and 1-(Benzyl)-4-(3,4,5-trimethoxyphenyl)pyrazole (<b>34b</b>, Minor)</h3><div class="NLM_p last"><i>N</i>-Benzylsydnone (200 mg, 1.14 mmol) and 3,4,5-trimethoxyphenylacetylene (436 mg, 2.27 mmol) were subjected to general procedure B, affording an inseparable mixture of pyrazoles <b>34a</b> and <b>34b</b> as an orange oil (239 mg, 64%, 9:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.87 (3H, s), 3.93 (6H, s), 5.36 (2H, s), 6.53 (1H, d, <i>J</i> = 2.5 Hz), 7.05 (2H, s), 7.21–7.28 (2H, m), 7.29–7.40 (4H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.2, 56.3, 61.2, 103.0, 103.4, 106.5, 127.8, 128.1, 128.9, 129.5, 130.8, 136.7, 151.6, 153.6. FTIR: ν<sub>max</sub> 2934 (w), 1587 (m), 1500 (m), 1423 (m), 1228 (s), 1125 (s), 1000 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>: 325.1547. Found: 325.1550.</div></div><div id="sec5_7_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-(Methyl)-3-([3-<i>tert</i>-butyldimethyloxy]-4-methoxyphenyl)pyrazole (<b>35a</b>, Major) and 1-(Methyl)-4-([3-<i>tert</i>-butyldimethyloxy]-4-methoxyphenyl)pyrazole (<b>35b</b>, Minor)</h3><div class="NLM_p last"><i>N</i>-Methylsydnone (163 mg, 1.63 mmol) and (3-<i>tert</i>-butyldimethyloxy)-4-methoxyphenylacetylene (787 mg, 3.00 mmol) were subjected to general procedure B, affording an inseparable mixture of pyrazole <b>35a</b> and <b>35b</b> that was isolated as an orange oil (339 mg, 65%, 9:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.18 (6H, s), 1.01 (9H, s), 3.82 (3H, s), 3.93 (3H, s), 6.43 (1H, d, <i>J</i> = 2.5 Hz), 6.86 (1H, d, <i>J</i> = 8.5 Hz), 7.29 (1H, d, <i>J</i> = 2.0 Hz), 7.32–7.36 (2H, m); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −4.5, 18.6, 25.9, 39.1, 55.6, 102.5, 112.2, 118.6, 119.1, 126.9, 131.3, 145.2, 150.8, 151.6. FTIR: ν<sub>max</sub> 2952 (w), 2930 (w), 2857 (w), 1508 (m), 1472 (m), 1271 (s), 1229 (s), 1135 (m), 992 (m), 915 (s). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>17</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub>Si: 319.1836. Found: 319.1832.</div></div><div id="sec5_7_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-(Benzyl)-3-([3-<i>tert</i>-butyldimethyloxy]-4-methoxyphenyl)pyrazole (<b>36a</b>, Major) and 1-(Benzyl)-4-([3-<i>tert</i>-butyldimethyloxy]-4-methoxyphenyl)pyrazole (<b>36b</b>, Minor)</h3><div class="NLM_p last"><i>N</i>-Benzylsydnone (200 mg, 1.14 mmol) and (3-<i>tert</i>-butyldimethyloxy)-4-methoxyphenylacetylene (598 mg, 2.28 mmol) were subjected to general procedure B, affording an inseparable mixture of pyrazoles <b>36a</b> and <b>36b</b> as an orange oil (263 mg, 58%, >98:2). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.21 (6H, s), 1.05 (9H, s), 3.84 (3H, s), 5.35 (2H, s), 6.49 (1H, d, <i>J</i> = 2.5 Hz), 6.89 (1H, d, <i>J</i> = 8.5 Hz), 7.24–7.28 (2H, m), 7.31–7.38 (5H, m), 7.42 (1H, dd, <i>J</i> = 8.5, 2.0 Hz); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ −4.5, 18.6, 25.9, 55.6, 56.1, 103.0, 112.2, 118.7, 119.2, 126.9, 127.8, 128.0, 128.8, 130.5, 136.8, 145.2, 150.8, 151.4. FTIR: ν<sub>max</sub> 2952 (w), 2929 (w), 2857 (w), 1504 (m), 1472 (m), 1271 (s), 1229 (s), 1134 (m), 995 (m), 915 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>Si: 395.2149. Found: 395.2147.</div></div><div id="sec5_7_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-(Methyl)-3-(3,4,5-trimethoxyphenyl)-4-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>37</b>)</h3><div class="NLM_p last">Pyrazole <b>33</b> (543 mg, 2.19 mmol), NBS (389 mg, 2.19 mmol), 3-hydroxy-4-methoxyphenylboronic acid pinacol ester (822 mg, 3.29 mmol), XPhosPdG2 (172 mg, 0.219 mmol), and Na<sub>2</sub>CO<sub>3</sub> (812 mg, 7.67 mmol) were subjected to general procedure F, part i, affording pyrazole <b>37</b> as a tan solid (551 mg, 68%). The product could be further purified by recrystallization from pentane. Mp: 46–48 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.69 (6H, s), 3.72 (3H, s), 3.83 (3H, s), 3.95 (3H, s), 5.85 (1H, s), 6.74–6.77 (3H, m), 6.82 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.86 (1H, d, <i>J</i> = 8.0 Hz), 7.40 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 39.1, 55.9, 56.0, 61.0, 106.3, 111.9, 114.5, 120.8, 121.9, 125.4, 129.1, 130.2, 137.5, 144.7, 146.5, 148.3, 153.0. FTIR: ν<sub>max</sub> 3405 (br), 2935 (w), 2831 (w), 1587 (m), 1556 (m), 1508 (m), 1462 (m), 1413 (s), 1234 (s), 1119 (s), 1002 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>: 371.1601. Found: 371.1602. HPLC: <i>t</i><sub>R</sub> = 12.82 min; purity 95.2%.</div></div><div id="sec5_7_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-(Benzyl)-3-(3,4,5-trimethoxyphenyl)-4-(3-hydroxy-4-methoxyphenyl)pyrazole (<b>38</b>)</h3><div class="NLM_p last">Pyrazoles <b>34a</b> and <b>34b</b> (398 mg, 1.23 mmol, 9:1), NBS (218 mg, 1.23 mmol), 3-hydroxy-4-methoxyphenylboronic acid pinacol ester (461 mg, 1.85 mmol), XPhosPdG2 (97 mg, 0.123 mmol), and Na<sub>2</sub>CO<sub>3</sub> (456 mg, 4.31 mmol) were subjected to general procedure F, part i, affording pyrazole <b>38</b> as a colorless solid (323 mg, 59%). The product could be further purified by recrystallization from ethyl acetate/40–60 petroleum ether. Mp: 168–169 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.72 (6H, s), 3.72 (3H, s), 3.84 (3H, s), 5.36 (2H, s), 5.64 (1H, s), 6.74 (1H, d, <i>J</i> = 2.0 Hz), 6.79 (2H, s), 6.82 (1H, dd, <i>J</i> = 8.0, 2.0 Hz), 6.86 (1H, d, <i>J</i> = 8.0 Hz), 7.31–7.42 (5H, m), 7.38 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.0, 56.1, 56.3, 61.0, 105.5, 111.8, 114.5, 121.2, 122.0, 125.4, 128.1, 128.3, 129.0, 129.2 (×2 C), 136.4, 137.6, 144.7, 146.4, 148.3, 153.1. FTIR: ν<sub>max</sub> 2957 (w), 2933 (w), 1588 (m), 1558 (m), 1507 (m), 1418 (m), 1265 (m), 1240 (m), 1116 (s), 1004 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1913. HPLC: <i>t</i><sub>R</sub> = 16.29 min; purity 95.8%.</div></div><div id="sec5_7_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-(Methyl)-3-(3-hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)pyrazole (<b>39</b>)</h3><div class="NLM_p last">Pyrazoles <b>35a</b> and <b>35b</b> (125 mg, 0.392 mmol), NBS (70 mg, 0.392 mmol), potassium 3,4,5-trimethoxyphenyltrifluoroborate (159 mg, 0.580 mmol), XPhosPdG2 (31 mg, 0.039 mmol), Na<sub>2</sub>CO<sub>3</sub> (83 mg, 0.784 mmol), and K<sub>2</sub>CO<sub>3</sub> (163 mg, 1.18 mmol) were subjected to general procedure F, step ii, affording pyrazole <b>39</b> as a colorless solid (63 mg, 43%). The product could be further purified by recrystallization from ethyl acetate/40–60 petroleum ether. Mp: 171 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.72 (6H, s), 3.86 (3H, s), 3.88 (3H, s), 3.95 (3H, s), 5.62 (1H, s), 6.50 (2H, s), 6.79 (1H, d, <i>J</i> = 8.5 Hz), 7.00 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.15 (1H, d, <i>J</i> = 2.0 Hz), 7.44 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 39.1, 56.1, 56.2, 61.1, 105.9, 110.5, 114.9, 120.6 (×2 C), 127.0, 129.0, 130.0, 136.9, 145.5, 146.4, 148.5, 153.2. FTIR: ν<sub>max</sub> 3122 (br), 2965 (w), 2934 (w), 2838 (w), 1585 (m), 1462 (m), 1411 (s), 1338 (m), 1228 (s), 1127 (s), 1016 (m), 1000 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>: 371.1601. Found: 371.1598. HPLC: <i>t</i><sub>R</sub> = 13.49 min; purity 95.3%.</div></div><div id="sec5_7_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1-(Benzyl)-3-(3-hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)pyrazole (<b>40</b>)</h3><div class="NLM_p last">Pyrazoles <b>36a</b> and <b>36b</b> (252 mg, 0.639 mmol), NBS (114 mg, 0.639 mmol), potassium 3,4,5-trimethoxyphenyltrifluoroborate (263 mg, 0.959 mmol), XPhosPdG2 (50 mg, 0.064 mmol), Na<sub>2</sub>CO<sub>3</sub> (135 mg, 1.28 mmol), and K<sub>2</sub>CO<sub>3</sub> (265 mg, 1.92 mmol) were subjected to general procedure F, step ii, affording pyrazole <b>40</b> as a colorless solid (93 mg, 33%). The product could be further purified by recrystallization from ethyl acetate/40–60 petroleum ether. Mp: 56–58 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.71 (6H, s), 3.85 (3H, s), 3.89 (3H, s), 5.35 (2H, s), 5.54 (1H, s), 6.48 (2H, s), 6.80 (1H, d, <i>J</i> = 8.5 Hz), 7.02 (1H, dd, <i>J</i> = 8.5, 2.0 Hz), 7.19 (1H, d, <i>J</i> = 2.0 Hz), 7.30–7.40 (5H, m), 7.41 (1H, s); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 56.1, 56.2, 56.3, 61.1, 105.9, 110.5, 115.0, 120.7, 121.0, 128.1, 128.3, 129.0, 129.1, 136.5, 136.9, 145.5, 146.4, 148.5, 153.2 (two sp<sup>2</sup> carbons not observed). FTIR: ν<sub>max</sub> 2935 (w), 1583 (m), 1455 (m), 1406 (m), 1234 (s), 1122 (s), 1001 (m). HRMS (ESI-TOF) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calculated for C<sub>26</sub>H<sub>27</sub>N<sub>2</sub>O<sub>5</sub>: 447.1914. Found: 447.1914. HPLC: <i>t</i><sub>R</sub> = 16.34 min; purity 97.0%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Endothelial Cell Culture</h3><div class="NLM_p last">Human umbilical vein endothelial cells (HUVECs) from pooled donors (Promocell, C-12203) were cultured on gelatin-coated dishes in endothelial cell basal medium (EBM) (Promocell, C-22010) supplemented with endothelial cell growth supplement mix (Promocell, C-39215). The supplemented medium contained 2% fetal calf serum (FCS), 0.4% endothelial cell growth supplement (ECGS), 0.1 ng/mL recombinant human epidermal growth factor (hEGF), 1 ng/mL recombinant human basic fibroblast growth factor (hbFGF), 90 μg/mL heparin, and 1 μg/mL hydrocortisone. Further low endotoxin heat inactivated FCS was then added to the medium to increase the final concentration to 10% (v/v). Cells were then kept at 37 °C in a humidified incubator, were subcultured by trypsinization when confluent, and were used for up to 5 passages.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Immunofluorescence Staining of the Cell Cytoskeleton</h3><div class="NLM_p">Immunofluorescence staining was used to visualize changes in cell morphology and the cytoskeleton. HUVECs were plated on four- or eight-well fibronectin-coated Permanox chamber slides at 2.5 × 10<sup>4</sup> cells per well in 250 μL of EBM for eight-well slides and 5 × 10<sup>4</sup> cells per well in 500 μL for four-well slides. Microtubules and actin filaments were stained according to general staining protocols described previously.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">For activity studies, various concentrations of each drug were prepared in EBM via systematic dilutions from a 20 mM stock in DMSO. The cells were treated with drug or vehicle control for 30 min. The media were then discarded and the cells fixed with 3.7% formalin in PBS for 10–20 min and permeabilized in 0.1% Triton X-100 prior to staining the cytoskeleton.</div><div class="NLM_p last">For recovery studies, cells were treated with drug or vehicle control for 30 or 60 min at 37 °C The medium was then removed, and cells were washed four times with fresh medium containing serum. The cells were then placed in the incubator for 30 min; the washing procedure was then repeated and the cells incubated for a further 30 min.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Cell Proliferation Studies</h3><div class="NLM_p last">The effects of various drugs on cell proliferation were established, and GI<sub>50</sub> values were obtained. 96-multiwell plates were coated with 0.2% gelatin in PBS for at least 30 min prior to culture. Cells were plated at 5 × 10<sup>3</sup>/well in 100 μL of medium and left to adhere for 24 h. Different concentrations of drugs were then added in 50 μL of EBM. A minimum of eight wells were used for each drug concentration or vehicle control. The cells were incubated at 37 °C for 72 h before the media were removed and cells were fixed with 3.7% formalin for 10–20 min. The wells were then washed four times with PBS and stained with 1% crystal violet (Sigma, catalog number C3886) solution in 10% ethanol for 10–20 min at room temperature. The plates were then repeatedly rinsed with water, dried overnight, and then stained cells were lysed in 100 μL of 10% acetic acid. The absorbance at 590 nm was then recorded by a plate reader. The absorbance data were corrected against background (empty wells with lysis solution) and transformed into percentage growth inhibition for each drug concentration. Percentage growth inhibition values obtained from at least three independent experiments were plotted against the logarithm of drug concentration using GraphPad Prism software, and GI<sub>50</sub> values were established for each drug.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Endothelial Monolayer Permeability Assay</h3><div class="NLM_p last">Cell culture inserts (Falcon, 353492) with a PET track etched membrane with pore size of 3 μm (2.0 ± 0.2 × 10<sup>5</sup> pores/cm<sup>2</sup>) were coated with (5 μg/mL) fibronectin for a minimum of 30 min. Cells were then plated at 5.0 × 10<sup>4</sup> cells per insert in 200 μL of EBM. Each insert was placed in a well of a 24-multiwell companion plate, (Falcon, 353504), and an amount of 700 μL of EBM was added to the lower well. In each experiment an amount of 200 μL of EBM without cells was added to one insert coated with fibronectin. The cells were kept at 37 °C in a humidified incubator for 24 h before the media were changed in both the wells and inserts. The cells were then kept at 37 °C in a humidified incubator for a further 4 days. The cells were treated by the direct addition of 25 μL of drug solution into the inset and incubated at 37 °C for 30 min. The media were removed from the insets and replaced with 200 μL of EBM containing FITC-dextran (0.8 mg/mL) (Sigma, 46945). Inserts were then placed into the wells of a new 24-multiwell plate containing 700 μL of EBM and incubated at 37 °C in a humidified incubator for 30 min. Samples of media were taken from the lower well compartments, and fluorescence was quantified on a plate reader at excitation 488, emission 525. The raw emission reading from each well was transformed into % emission relative to the well without cells, which was normalized to 100% emission (equivalent to 100% permeability). The perturbation of the monolayer was proportional to the emission of FITC-dextran that passed through the inset into the well.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Analysis of pMLC Phosphorylation by Western Blotting</h3><div class="NLM_p last">HUVECs were cultured in gelatin-coated 12-multiwell plates at at 5 × 10<sup>4</sup> cells per well in 1 mL of EBM and kept at 37 °C in a humidified incubator for 7 days without media changes. Various concentrations of drugs were prepared in EBM via systematic dilutions from a 20 mM stock in DMSO except for Rho kinase inhibitor Y-27632 (Tocris), which was prepared as a 20 mM stock solution in dH<sub>2</sub>O and used at a final concentration of 5 μM. Following drug exposure, cell culture media were discarded and proteins were extracted in 1× NuPAGE LDS reducing sample buffer (LDS, ThermoFisher, catalog no. NP0008). The samples were then analyzed for MLC phosphorylation by Western blotting using an antibody to dually phosphorylated MLC (Cell Signalling, no. 3674) as described previously.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Blots were stripped and reprobed using an antibody to actin (Sigma, catalog no. A4700).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> In Vivo Analysis and Necrosis Scoring</h3><div class="NLM_p last">All animal care and experimental procedures were carried out in accordance with the UK Animals (Scientific Procedure) Act 1986, with local ethics committee approval and following published guidelines for the use of animals in cancer research.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Human colorectal adenocarcinoma SW1222 cells were injected sc (5 × 10<sup>6</sup> cells in 0.05 mL) into the rear dorsum of female severe combined immunodeficiency (SCID) mice (8–12 weeks old, 20–25 g). Three orthogonal diameters of subcutaneous tumors were measured using calipers, and tumors were treated when they reached approximately 8 mm in mean diameter. Vehicle (50% Na<sub>2</sub>CO<sub>3</sub>/NaCl, 10 mL/kg), CA4P (100 mg/kg, 0.227 mmol/kg, in 50% Na<sub>2</sub>CO<sub>3</sub>/NaCl, 10 mL/kg), or a solution of <b>31</b> (81 mg/kg, 0.227 mmol/kg, 50% Na<sub>2</sub>CO<sub>3</sub>/NaCl, 10 mL/kg) was given as a single dose. Subcutaneous tumors were formalin-fixed, paraffin-embedded, and hematoxylin and eosin (H&E) stained 24 h after treatment. The percentage of necrosis was measured from H&E sections and quantified according to a random points scoring (Chalkley) system.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Statistics</h3><div class="NLM_p last">Statistical analysis was carried out using GraphPad Prism 6 for Windows 8.1. The significance of differences between groups was assessed using a one-way ANOVA followed by a Tukey post-test, with <i>p</i> < 0.05 considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01128">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01128" class="ext-link">10.1021/acs.jmedchem.6b01128</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C NMR spectra for selected compounds and HPLC results of final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_001.pdf">jm6b01128_si_001.pdf (5.3 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_002.csv">jm6b01128_si_002.csv (2.85 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01128" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gillian M. Tozer</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#60074e140f1a051220130805060609050c044e01034e150b"><span class="__cf_email__" data-cfemail="ccabe2b8a3b6a9be8cbfa4a9aaaaa5a9a0a8e2adafe2b9a7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chryso Kanthou</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#22410c49434c564a4d5762514a4744444b474e460c43410c5749"><span class="__cf_email__" data-cfemail="a8cb86c3c9c6dcc0c7dde8dbc0cdcecec1cdc4cc86c9cb86ddc3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. A. Harrity</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Sheffield, Dainton Building, Brook Hill, Sheffield S3 7HF, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d1753151c0f0f1409043d0e15181b1b14181119531c1e530816"><span class="__cf_email__" data-cfemail="8fe5a1e7eefdfde6fbf6cffce7eae9e9e6eae3eba1eeeca1fae4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew W. Brown</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Sheffield, Dainton Building, Brook Hill, Sheffield S3 7HF, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Fisher</span> - <span class="hlFld-Affiliation affiliation">Department
of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.W.B. conducted all compound synthesis and in vitro evaluation. M.F. conducted in vivo work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3954-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to Cancer Research UK and Yorkshire Cancer Research for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> Abbreviations Used</h2><tr><td class="NLM_term">CA4</td><td class="NLM_def"><p class="first last">combretastatin A4</p></td></tr><tr><td class="NLM_term">CA4P</td><td class="NLM_def"><p class="first last">disodium combretastatin A-4 3-<i>O</i>-phosphate</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">FITC-dextran</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate-dextran</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cell</p></td></tr><tr><td class="NLM_term">MLC</td><td class="NLM_def"><p class="first last">myosin light chain</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamics</p></td></tr><tr><td class="NLM_term">pMLC</td><td class="NLM_def"><p class="first last">phosphorylated myosin light chain</p></td></tr><tr><td class="NLM_term">ROCK</td><td class="NLM_def"><p class="first last">Rho-associated protein kinase</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">trimethylsilyl</p></td></tr><tr><td class="NLM_term">VDA</td><td class="NLM_def"><p class="first last">vascular disrupting agent</p></td></tr><tr><td class="NLM_term">Y-27632</td><td class="NLM_def"><p class="first last"><i>trans</i>-4-[(1<i>R</i>)-1-aminoethyl]-<i>N</i>-4-pyridinylcyclohexanecarboxamide dihydrochloride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">What is the Evidence That Tumors Are Angiogenesis Dependent?</span> <span class="citation_source-journal">J. of the Natl. Cancer I.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1093/jnci/82.1.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1093%2Fjnci%2F82.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1688381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=4-7&author=J.+Folkman&title=What+is+the+Evidence+That+Tumors+Are+Angiogenesis+Dependent%3F&doi=10.1093%2Fjnci%2F82.1.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DWhat%2520is%2520the%2520Evidence%2520That%2520Tumors%2520Are%2520Angiogenesis%2520Dependent%253F%26jtitle%3DJ.%2520of%2520the%2520Natl.%2520Cancer%2520I.%26date%3D1990%26volume%3D82%26spage%3D4%26epage%3D7%26doi%3D10.1093%2Fjnci%2F82.1.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">Tumour Targeting by Microtubule-Depolymerising Vascular Disrupting Agents</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span><span class="refDoi"> DOI: 10.1517/14728222.11.11.1443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1517%2F14728222.11.11.1443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=18028009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1443-1457&author=C.+Kanthouauthor=G.+M.+Tozer&title=Tumour+Targeting+by+Microtubule-Depolymerising+Vascular+Disrupting+Agents&doi=10.1517%2F14728222.11.11.1443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour targeting by microtubule-depolymerising vascular disrupting agents</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1443-1457</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Low mol. wt. vascular disrupting agents of the microtubule depolymerising family cause marked and selective disruption of the established tumor blood vessel network, resulting in tumor cell necrosis.  The combretastatins are members of this family and these, together with several other related compds., have undergone extensive preclin. testing and are now in clin. trials for cancer.  Potentially, vascular disrupting agents can also interfere with angiogenesis and constitute a very promising group of novel cancer drugs.  In vitro anal. of their signalling activities points to the endothelial cytoskeleton as being their major target and a key player in the events that culminate in vascular collapse.  As more of these agents progress into the clin. setting, more research in this area is warranted in order to decipher exact mechanisms responsible for vascular disruption and to understand the reasons for drug selectivity for the tumor vasculature.  This information is essential in order to identify new targets within the tumor vasculature and to improve present therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyG45tAky0W7Vg90H21EOLACvtfcHk0lg42sseRhAAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE&md5=08c7e94cddef659fd730c74b86575c55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1443%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DTumour%2520Targeting%2520by%2520Microtubule-Depolymerising%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1443%26epage%3D1457%26doi%3D10.1517%2F14728222.11.11.1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Baluk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D. M.</span><span> </span><span class="NLM_article-title">Cellular Abnormalities of Blood Vessels as Targets in Cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.gde.2004.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.gde.2004.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=102-111&author=P.+Balukauthor=H.+Hashizumeauthor=D.+M.+McDonald&title=Cellular+Abnormalities+of+Blood+Vessels+as+Targets+in+Cancer&doi=10.1016%2Fj.gde.2004.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DBaluk%26aufirst%3DP.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DMcDonald%26aufirst%3DD.%2BM.%26atitle%3DCellular%2520Abnormalities%2520of%2520Blood%2520Vessels%2520as%2520Targets%2520in%2520Cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D102%26epage%3D111%26doi%3D10.1016%2Fj.gde.2004.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span> </span><span class="NLM_article-title">Disrupting Tumour Blood Vessels</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span><span class="refDoi"> DOI: 10.1038/nrc1628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fnrc1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=15928673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=423-435&author=G.+M.+Tozerauthor=C.+Kanthouauthor=B.+C.+Baguley&title=Disrupting+Tumour+Blood+Vessels&doi=10.1038%2Fnrc1628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting tumor blood vessels</span></div><div class="casAuthors">Tozer, Gillian M.; Kanthou, Chryso; Baguley, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-435</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. vascular-disrupting agents (VDAs) cause a pronounced shutdown in blood flow to solid tumors, resulting in extensive tumor-cell necrosis, while they leave the blood flow in normal tissues relatively intact.  The largest group of VDAs is the tubulin-binding combretastatins, several of which are now being tested in clin. trials.  DMXAA (5,6-dimethylxanthenone-4-acetic acid) - one of a structurally distinct group of drugs - is also being tested in clin. trials.  A full understanding of the action of these and other VDAs will provide insights into mechanisms that control tumor blood flow and will be the basis for the development of new therapeutic drugs for targeting the established tumor vasculature for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjdnxmo6H1JrVg90H21EOLACvtfcHk0liYVyIh233KLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D&md5=869e9f19ba4b9b82b166b39f089e003b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1628%26sid%3Dliteratum%253Aachs%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26atitle%3DDisrupting%2520Tumour%2520Blood%2520Vessels%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D423%26epage%3D435%26doi%3D10.1038%2Fnrc1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Boyland, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyland, M. E.</span><span> </span><span class="NLM_article-title">Studies in Tissue Metabolism: the Action of Colchicine and B Typhosus Extract</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1937</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1042/bj0310454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1042%2Fbj0310454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1937&pages=454-460&author=E.+Boylandauthor=M.+E.+Boyland&title=Studies+in+Tissue+Metabolism%3A+the+Action+of+Colchicine+and+B+Typhosus+Extract&doi=10.1042%2Fbj0310454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2Fbj0310454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0310454%26sid%3Dliteratum%253Aachs%26aulast%3DBoyland%26aufirst%3DE.%26aulast%3DBoyland%26aufirst%3DM.%2BE.%26atitle%3DStudies%2520in%2520Tissue%2520Metabolism%253A%2520the%2520Action%2520of%2520Colchicine%2520and%2520B%2520Typhosus%2520Extract%26jtitle%3DBiochem.%2520J.%26date%3D1937%26volume%3D31%26spage%3D454%26epage%3D460%26doi%3D10.1042%2Fbj0310454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ludford, R. J.</span><span> </span><span class="NLM_article-title">Factors Determining the Action of Colchicine on Tumour Growth</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1038/bjc.1948.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fbjc.1948.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=18863732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaG3cXksVCjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1948&pages=75-86&author=R.+J.+Ludford&title=Factors+Determining+the+Action+of+Colchicine+on+Tumour+Growth&doi=10.1038%2Fbjc.1948.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Factors determining the action of colchicine on tumor growth</span></div><div class="casAuthors">Ludford, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1948</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-86</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">cf. C.A. 40, 7398.7  Treating mice, bearing rapidly growing transplanted tumors, with colchicine (I) in doses just below lethal (a total of 0.13 mg.) caused regression of the tumors; 50 days after transplanting, the tumors of treated mice were approx. the same size as tumors in controls after 30 days.  Factors influencing the effect of I were: age (young adults tolerated larger doses, thus effecting the greatest regression of tumor growth), the genetic constitution of the mice which detd. the max. dose tolerated, and the sensitivity of the tumor capillaries to the action of I.  The cumulative toxic effect of I limited repeated application at short intervals.  Soft highly cellular, rapidly growing tumors responded best but this effect decreased after several large doses of I.  The degree of regression was dependent on the extent of the hemorrhage induced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuDC3D-AEArVg90H21EOLACvtfcHk0liYVyIh233KLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3cXksVCjsQ%253D%253D&md5=c6bcb3ccc41f4f50a5a74a5015925308</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1948.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1948.10%26sid%3Dliteratum%253Aachs%26aulast%3DLudford%26aufirst%3DR.%2BJ.%26atitle%3DFactors%2520Determining%2520the%2520Action%2520of%2520Colchicine%2520on%2520Tumour%2520Growth%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1948%26volume%3D2%26spage%3D75%26epage%3D86%26doi%3D10.1038%2Fbjc.1948.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Antineoplastic Agents, 122. Constituents of Combretum Caffrum</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1021/np50051a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50051a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=386-391&author=G.+R.+Pettitauthor=G.+M.+Craggauthor=S.+B.+Singh&title=Antineoplastic+Agents%2C+122.+Constituents+of+Combretum+Caffrum&doi=10.1021%2Fnp50051a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fnp50051a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50051a008%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DAntineoplastic%2520Agents%252C%2520122.%2520Constituents%2520of%2520Combretum%2520Caffrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1987%26volume%3D50%26spage%3D386%26epage%3D391%26doi%3D10.1021%2Fnp50051a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempcy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Interactions of Tubulin with Potent Natural and Synthetic Analogs of the Antimitotic Agent Combretastatin: A Structure-Activity Study</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=3412321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaL1MXmvV2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1988&pages=200-208&author=C.+M.+Linauthor=S.+B.+Singhauthor=P.+S.+Chuauthor=R.+O.+Dempcyauthor=J.+M.+Schmidtauthor=G.+R.+Pettitauthor=E.+Hamel&title=Interactions+of+Tubulin+with+Potent+Natural+and+Synthetic+Analogs+of+the+Antimitotic+Agent+Combretastatin%3A+A+Structure-Activity+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin:  a structure-activity study</span></div><div class="casAuthors">Lin, Chii M.; Singh, Sheo B.; Chu, Ping S.; Dempcy, Robert O.; Schmidt, Jean M.; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Available analogs (17 natural products and 22 synthetic agents) of combretastatin, an antineoplastic drug isolated from the bark of Combretum caffrum, were examd. for antimitotic and cytotoxic activity and for effects on tubulin polymn. and colchicine binding.  Nineteen compds. inhibited cell growth by 50% or more at concns. of 1 μM or less, and 14 inhibited tubulin polymn. by at least 50% at stoichiometric drug concns.  The most potent cytotoxic agents strongly inhibited both tubulin polymn. and the binding of colchicine to tubulin.  The most promising compd. is the (cis)-stilbene deriv. (cis)-1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene (I), which has been named combretastatin A-4.  This compd. inhibited cell growth by 50% at 7 nM, inhibited tubulin polymn. by 50% at 2.5 μM (1/4 molar equivalent), and competitively inhibited colchicine binding with an apparent Ki of 0.14 μM.  The structure-activity relationship of these compds. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZPVoqLHv4TLVg90H21EOLACvtfcHk0ljImDTvBlXiqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmvV2muw%253D%253D&md5=fa7b749542431a3bd0f593e93d11f028</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DChu%26aufirst%3DP.%2BS.%26aulast%3DDempcy%26aufirst%3DR.%2BO.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DInteractions%2520of%2520Tubulin%2520with%2520Potent%2520Natural%2520and%2520Synthetic%2520Analogs%2520of%2520the%2520Antimitotic%2520Agent%2520Combretastatin%253A%2520A%2520Structure-Activity%2520Study%26jtitle%3DMol.%2520Pharmacol.%26date%3D1988%26volume%3D34%26spage%3D200%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkins, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span> </span><span class="NLM_article-title">Antivascular Approaches to Solid Tumour Therapy: Evaluation of Tubulin Binding Agents</span> <span class="citation_source-journal">Br. J. Cancer. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S86</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=S86-S88&author=D.+J.+Chaplinauthor=G.+R.+Pettitauthor=C.+S.+Parkinsauthor=S.+A.+Hill&title=Antivascular+Approaches+to+Solid+Tumour+Therapy%3A+Evaluation+of+Tubulin+Binding+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DParkins%26aufirst%3DC.%2BS.%26aulast%3DHill%26aufirst%3DS.%2BA.%26atitle%3DAntivascular%2520Approaches%2520to%2520Solid%2520Tumour%2520Therapy%253A%2520Evaluation%2520of%2520Tubulin%2520Binding%2520Agents%26jtitle%3DBr.%2520J.%2520Cancer.%2520Suppl.%26date%3D1996%26volume%3D27%26spage%3DS86%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dark, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prise, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span> </span><span class="NLM_article-title">Combretastatin A-4, an Agent That Displays Potent and Selective Toxicity toward Tumor Vasculature</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=9157969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1829-1834&author=G.+G.+Darkauthor=S.+A.+Hillauthor=V.+E.+Priseauthor=G.+M.+Tozerauthor=G.+R.+Pettitauthor=D.+J.+Chaplin&title=Combretastatin+A-4%2C+an+Agent+That+Displays+Potent+and+Selective+Toxicity+toward+Tumor+Vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature</span></div><div class="casAuthors">Dark, Graham G.; Hill, Sally A.; Prise, Vivien E.; Tozer, Gillian M.; Pettit, George R.; Chaplin, Dai J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1834</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Selective induction of vascular damage within tumors represents an emerging approach to cancer treatment.  Histol. studies have shown that several tubulin-binding agents can induce vascular damage within tumors but only at doses approximating the max. tolerated dose, which has limited their clin. applicability.  In this study, we show that the combretastatin A-4 prodrug induces vascular shutdown within tumors at doses less than one-tenth of the max. tolerated dose.  In vitro studies indicate that a short drug exposure results in profound long-term antiproliferative/cytotoxic effects against proliferating endothelial cells but not cells that are quiescent prior to and during drug exposure.  Vascular shutdown, within exptl. and human breast cancer models in vivo following systemic drug administration, was demonstrated with a redn. in functional vascular vol. of 93% at 6 h following drug administration and persisted over the next 12 h, with corresponding histol. consistent with hemorrhagic necrosis resulting from vascular damage.  The actions against tumor vasculature and the broad therapeutic window demonstrate the clin. potential of these drugs and warrant further study to elucidate the mechanisms responsible for the antivascular effects of combretastatin A-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEdUvgSGIqp7Vg90H21EOLACvtfcHk0ljImDTvBlXiqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D&md5=889e82f6a746aef44c2a28b77135e61f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DPrise%26aufirst%3DV.%2BE.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DCombretastatin%2520A-4%252C%2520an%2520Agent%2520That%2520Displays%2520Potent%2520and%2520Selective%2520Toxicity%2520toward%2520Tumor%2520Vasculature%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D1829%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rener, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, N.</span><span> </span><span class="NLM_article-title">Antineoplastic Agents 322. Synthesis of Combretastatin A-4 Prodrugs</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=7786396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=299-309&author=G.+R.+Pettitauthor=C.+Templeauthor=V.+L.+Narayananauthor=R.+Varmaauthor=M.+J.+Simpsonauthor=M.+R.+Boydauthor=G.+A.+Renerauthor=N.+Bansal&title=Antineoplastic+Agents+322.+Synthesis+of+Combretastatin+A-4+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Temple, Carroll, Jr.; Narayanan, Ven L.; Varma, Ravi; Simpson, Michael J.; Boyd, Michael R.; Rener, Gregory A.; Bansal, Namita</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Combretastatin A-4 (I, R = H), the principal cancer cell growth-inhibitory constituent of the Zulu medicinal plant (Combretum caffrum, has been undergoing preclin. development.  However, the very limited water soly. of this phenol has complicated drug formation.  Hence, derivs. of the combretastatin A-4 3'-phenol group were prepd. for evaluation as possible water-sol. prodrugs.  As obsd. for combretastatin A-4, the sodium salt (I, R = Na), potassium salt (I, R = K), and hemisuccinic acid ester (I, R = COCH2CH2CO2H) derivs. were essentially insol. in water.  Indeed, these substances regenerated combretastatin A-4 upon reaction with water.  A series of other simple derivs., e.g. I [R = COCH(NH2)CH2CH2CO2H], proved unsatisfactory in terms of water soly. or stability, or both.  The most sol. derivs. evaluated included the ammonium [I, R = P(O)(OH)ONH4], and potassium [I, R = P(O)(OK)2] and sodium [I, R = P(O)(ONa)2] phosphate salts, where the latter two proved most stable and suitable.  Both the potassium and sodium phosphate derivs. of combretastatin A-4 were also found to exhibit the requisite biol. properties necessary for a useful prodrug.  The sodium phosphate salt was selected for drug formulation and further pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWV9UApN5crVg90H21EOLACvtfcHk0ljImDTvBlXiqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D&md5=0a16b2b4db491916a9a742c7af69669a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DVarma%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DRener%26aufirst%3DG.%2BA.%26aulast%3DBansal%26aufirst%3DN.%26atitle%3DAntineoplastic%2520Agents%2520322.%2520Synthesis%2520of%2520Combretastatin%2520A-4%2520Prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1995%26volume%3D10%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McGown, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. W.</span><span> </span><span class="NLM_article-title">Structural and Biochemical Comparison of the Anti-Mitotic Agents Colchicine, Combretastatin A4 and Amphethinile</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=249-254&author=A.+T.+McGownauthor=B.+W.+Fox&title=Structural+and+Biochemical+Comparison+of+the+Anti-Mitotic+Agents+Colchicine%2C+Combretastatin+A4+and+Amphethinile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26aulast%3DFox%26aufirst%3DB.%2BW.%26atitle%3DStructural%2520and%2520Biochemical%2520Comparison%2520of%2520the%2520Anti-Mitotic%2520Agents%2520Colchicine%252C%2520Combretastatin%2520A4%2520and%2520Amphethinile%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1989%26volume%3D3%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Antimitotic Natural Products Combretastatin A-4 and Combretastatin A-2: Studies on the Mechanism of Their Inhibition of the Binding of Colchicine to Tubulin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">6984</span><span class="NLM_x">–</span> <span class="NLM_lpage">6991</span><span class="refDoi"> DOI: 10.1021/bi00443a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00443a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2ru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=6984-6991&author=C.+M.+Linauthor=H.+H.+Hoauthor=G.+R.+Pettitauthor=E.+Hamel&title=Antimitotic+Natural+Products+Combretastatin+A-4+and+Combretastatin+A-2%3A+Studies+on+the+Mechanism+of+Their+Inhibition+of+the+Binding+of+Colchicine+to+Tubulin&doi=10.1021%2Fbi00443a031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic natural products combretastatin A-4 and combretastatin A-2:  studies on the mechanism of their inhibition of the binding of colchicine to tubulin</span></div><div class="casAuthors">Lin, Chii M.; Ho, Holly H.; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6984-91</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The mechanism of the binding of combretastatin A-4 (CS-A4) and combretastatin A-2 (CS-A2), isolated from Combretum caffrum, to tubulin was examd. indirectly by evaluating their effects on the binding of radiolabeled colchicine to the protein.  There was rapid binding of both compds. to tubulin even at 0° (binding was complete at the earliest times examd.), in contrast to the relatively slow and temp.-dependent binding of colchicine.  Although the binding of the C. caffrum compds. to tubulin was quite tight, permitting ready isolation of near-stoichiometric amts. of drug-tubulin complex even in the absence of free drug, both CS-A4 and CS-A2 dissocd. rapidly from tubulin in the presence of high concns. of radiolabeled colchicine.  Apparent rate consts. for drug dissocn. from tubulin at 37° were 3.2 × 10-3/s for CS-A4, 4.8 × 10-3/s for CS-A2, and 2.9 × 10-5/s for colchicine (half-lives of 3.6, 2.4, and 405 min, resp.).  Thus, the effectiveness of the C. caffrum compds. as antimitotic agents appears to derive primarily from the rapidity of their binding to tubulin.  A new model for the colchicine binding site on tubulin is proposed which envisages A-ring and C-ring subsites in homologous locations on the 2 tubulin subunits, with Ph rings binding as well as or better than the tropolone ring of colchicine in the C-ring subsite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBVM6YQr13WbVg90H21EOLACvtfcHk0lhYLlKPMl0KsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2ru78%253D&md5=4fc9bd899f65be38961729d7c51a6b16</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi00443a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00443a031%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHo%26aufirst%3DH.%2BH.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAntimitotic%2520Natural%2520Products%2520Combretastatin%2520A-4%2520and%2520Combretastatin%2520A-2%253A%2520Studies%2520on%2520the%2520Mechanism%2520of%2520Their%2520Inhibition%2520of%2520the%2520Binding%2520of%2520Colchicine%2520to%2520Tubulin%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D6984%26epage%3D6991%26doi%3D10.1021%2Fbi00443a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Monk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darus, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tewari, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkissoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aghajanian, C.</span><span> </span><span class="NLM_article-title">Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span><span class="refDoi"> DOI: 10.1200/JCO.2015.65.8153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1200%2FJCO.2015.65.8153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=27217446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2279-2286&author=B.+J.+Monkauthor=M.+W.+Sillauthor=J.+L.+Walkerauthor=C.+J.+Darusauthor=G.+Suttonauthor=K.+S.+Tewariauthor=L.+P.+Martinauthor=J.+M.+Schilderauthor=R.+L.+Colemanauthor=J.+Balkissoonauthor=C.+Aghajanian&title=Randomized+Phase+II+Evaluation+of+Bevacizumab+Versus+Bevacizumab+Plus+Fosbretabulin+in+Recurrent+Ovarian%2C+Tubal%2C+or+Peritoneal+Carcinoma%3A+An+NRG+Oncology%2FGynecologic+Oncology+Group+Study&doi=10.1200%2FJCO.2015.65.8153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: an NRG oncology/gynecologic oncology group study</span></div><div class="casAuthors">Monk, Bradley J.; Sill, Michael W.; Walker, Joan L.; Darus, Christopher J.; Sutton, Gregory; Tewari, Krishnansu S.; Martin, Lainie P.; Schilder, Jeanne M.; Coleman, Robert L.; Balkissoon, Jai; Aghajanian, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2279-2286</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose The vascular disrupting agent fosbretabulin tromethamine selectively targets pre-existing tumor vasculature, which causes vascular shutdown and leads to cancer cell death and necrosis.  Antiangiogenesis agents such as bevacizumab, a humanized antivascular endothelial growth factor monoclonal antibody, might prevent revascularization during and after treatment with a vascular disrupting agent.  Patients and Methods Patients with recurrent or persistent epithelial ovarian, tubal, or peritoneal carcinoma, measurable or detectable disease, and three or fewer prior regimens were randomly assigned to bevacizumab (15 mg/kg i.v. once every 3 wk) or the combination of bevacizumab (15 mg/kg) plus fosbretabulin (60 mg/m2) i.v. once every 3 wk until disease progression or toxicity.  Randomization was stratified by disease status (measurable v nonmeasurable), prior bevacizumab, and platinum-free interval.  The primary end point was progression-free survival (PFS).  The study was designed with 80% power for a one-sided alternative at a 10% level of significance to detect a redn. in the hazard by 37.5%.  Results The study enrolled 107 patients.  Median PFS was 4.8 mo for bevacizumab and 7.3 mo for bevacizumab plus fosbretabulin (hazard ratio, 0.69; 90% two-sided CI, 0.47 to 1.00; one-sided P =.05).  The proportion responding (overall response rate) to bevacizumab was 28.2% among 39 patients with measurable disease and 35.7% among 42 patients treated with the combination.  The relative probability of responding was 1.27 (90% CI, 0.74 to 2.17; one-sided P =.24).  Adverse events greater than grade 3 were more common in the combination regimen than in bevacizumab only for hypertension (35% v 20%).  There was one grade 3 thromboembolic event in the combination arm and one intestinal fistula in the bevacizumab only arm.  Conclusion On the basis of the PFS, overall response rate, and tolerability of these two antivascular therapies, further evaluation is warranted for this chemotherapy-free regimen.  Fosbretabulin in combination with bevacizumab increases the risk of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5a-7pBzglXbVg90H21EOLACvtfcHk0lhYLlKPMl0KsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGltL7O&md5=a062b3688fe997b13095ccc2695ff189</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.65.8153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.65.8153%26sid%3Dliteratum%253Aachs%26aulast%3DMonk%26aufirst%3DB.%2BJ.%26aulast%3DSill%26aufirst%3DM.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BL.%26aulast%3DDarus%26aufirst%3DC.%2BJ.%26aulast%3DSutton%26aufirst%3DG.%26aulast%3DTewari%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DL.%2BP.%26aulast%3DSchilder%26aufirst%3DJ.%2BM.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26aulast%3DBalkissoon%26aufirst%3DJ.%26aulast%3DAghajanian%26aufirst%3DC.%26atitle%3DRandomized%2520Phase%2520II%2520Evaluation%2520of%2520Bevacizumab%2520Versus%2520Bevacizumab%2520Plus%2520Fosbretabulin%2520in%2520Recurrent%2520Ovarian%252C%2520Tubal%252C%2520or%2520Peritoneal%2520Carcinoma%253A%2520An%2520NRG%2520Oncology%252FGynecologic%2520Oncology%2520Group%2520Study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D2279%26epage%3D2286%26doi%3D10.1200%2FJCO.2015.65.8153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborti, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Stilbene and Dihydrostilbene Derivatives as Potential Anticancer Agents That Inhibit Tubulin Polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1021/jm00112a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK3MXkvFWksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2579-2588&author=M.+Cushmanauthor=D.+Nagarathnamauthor=D.+Gopalauthor=A.+K.+Chakrabortiauthor=C.+M.+Linauthor=E.+Hamel&title=Synthesis+and+Evaluation+of+Stilbene+and+Dihydrostilbene+Derivatives+as+Potential+Anticancer+Agents+That+Inhibit+Tubulin+Polymerization&doi=10.1021%2Fjm00112a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization</span></div><div class="casAuthors">Cushman, Mark; Nagarathnam, Dhanapalan; Gopal, D.; Chakraborti, Asit K.; Lin, Chii M.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2579-88</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">cis- And trans-dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in five cancer cell cultures A-549 lung carcinoma, NCF-7 breast carcinoma, HT-δ colon adenocarcinoma, SKMEL-5 melanoma and MLM melanoma.  Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines, and active as inhibitors of tubulin polymn.  The most active compds. also inhibited the binding of colchicine to tubulin.  The most potent of the new compds., both as a tubulin polymn. inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (I) which was almost as potent as combrestatins A-4, the most active of the combrestatins, as a tubulin polymn. inhibitor.  I was a approx. 140 times more cytotoxic against HT-29:adenocarcinoma cells and about 10 times more cytotoxic against MCF-η breast carcinoma cells than combrestatin A-4, but it was about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against NLM melanoma cells than combrestatin A-4.  The relative potencies for the cis, dihydro, and trans compds., resp., as inhibitors of tubulin polymn. are in agreement with the relative potencies previously obsd. for combretastatin A-Δ, dihydrocombrestatin A-4, and trans-combrestatin A-4.  The relative potencies were also reflected as a result of the cytotoxicity assays.  Structure-activity relationships of this group of compds. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUMaB6teYTTrVg90H21EOLACvtfcHk0lhYLlKPMl0KsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvFWksLc%253D&md5=fe12d2c046d97aa417a1b7ece35d3414</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a036%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DGopal%26aufirst%3DD.%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Stilbene%2520and%2520Dihydrostilbene%2520Derivatives%2520as%2520Potential%2520Anticancer%2520Agents%2520That%2520Inhibit%2520Tubulin%2520Polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2579%26epage%3D2588%26doi%3D10.1021%2Fjm00112a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ohsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nihei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span> </span><span class="NLM_article-title">Syntheses and Antitumor Activity of Cis-Restricted Combretastatins: 5-Membered Heterocyclic Analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00579-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2FS0960-894X%2898%2900579-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=3153-3158&author=K.+Ohsumiauthor=T.+Hatanakaauthor=K.+Fujitaauthor=R.+Nakagawaauthor=Y.+Fukudaauthor=Y.+Niheiauthor=Y.+Sugaauthor=Y.+Morinagaauthor=Y.+Akiyamaauthor=T.+Tsuji&title=Syntheses+and+Antitumor+Activity+of+Cis-Restricted+Combretastatins%3A+5-Membered+Heterocyclic+Analogues&doi=10.1016%2FS0960-894X%2898%2900579-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900579-4%26sid%3Dliteratum%253Aachs%26aulast%3DOhsumi%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DR.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNihei%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DY.%26aulast%3DMorinaga%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520Antitumor%2520Activity%2520of%2520Cis-Restricted%2520Combretastatins%253A%25205-Membered%2520Heterocyclic%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D3153%26epage%3D3158%26doi%3D10.1016%2FS0960-894X%2898%2900579-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Convergent Synthesis and Biological Evaluation of 2-Amino-4-(3′,4′,5′-trimethoxyphenyl)-5-aryl Thiazoles as Microtubule Targeting Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5144</span><span class="NLM_x">–</span> <span class="NLM_lpage">5153</span><span class="refDoi"> DOI: 10.1021/jm200392p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200392p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVaksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5144-5153&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=A.+Brancaleauthor=A.+Ricciauthor=E.+Hamelauthor=R.+Bortolozziauthor=G.+Bassoauthor=G.+Viola&title=Convergent+Synthesis+and+Biological+Evaluation+of+2-Amino-4-%283%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2-trimethoxyphenyl%29-5-aryl+Thiazoles+as+Microtubule+Targeting+Agents&doi=10.1021%2Fjm200392p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent Synthesis and Biological Evaluation of 2-Amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl Thiazoles as Microtubule Targeting Agents</span></div><div class="casAuthors">Romagnoli, Romeo; Baraldi, Pier Giovanni; Brancale, Andrea; Ricci, Antonio; Hamel, Ernest; Bortolozzi, Roberta; Basso, Giuseppe; Viola, Giampietro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5144-5153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combretastatin A-4, a potent tubulin polymn. inhibitor, caused us to synthesize a novel series of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles with the goal of evaluating the effects of substituents on the Ph at the 5-position of the thiazole skeleton on biol. activities.  An ethoxy group at the para-position produced the most active compd. in the series, with IC50 values of 0.03-0.9 nM against five of seven cancer cell lines.  The most active compds. retained full activity in multidrug resistant cancer cells and acted through the colchicine site of tubulin.  Treated cells were arrested in the G2/M phase of the cell cycle, with cell death proceeding through an apoptotic pathway that was only partially caspase-dependent.  Preliminary results suggest that, in addn. to cell death by apoptosis, cells were also killed via mitotic catastrophe as an alternative cell death mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphsFMgTMUUn7Vg90H21EOLACvtfcHk0lg5c4C0xy4oAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVaksL0%253D&md5=9bd8f076b8c49a3894cda6c47d8cabb0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm200392p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200392p%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DConvergent%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%25202-Amino-4-%25283%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2-trimethoxyphenyl%2529-5-aryl%2520Thiazoles%2520as%2520Microtubule%2520Targeting%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5144%26epage%3D5153%26doi%3D10.1021%2Fjm200392p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz-Lopez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez Cara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrion, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4248</span><span class="NLM_x">–</span> <span class="NLM_lpage">4258</span><span class="refDoi"> DOI: 10.1021/jm100245q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100245q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4248-4258&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=O.+Cruz-Lopezauthor=C.+Lopez+Caraauthor=M.+D.+Carrionauthor=A.+Brancaleauthor=E.+Hamelauthor=L.+Chenauthor=R.+Bortolozziauthor=G.+Bassoauthor=G.+Viola&title=Synthesis+and+Antitumor+Activity+of+1%2C5-Disubstituted+1%2C2%2C4-Triazoles+as+Cis-Restricted+Combretastatin+Analogues&doi=10.1021%2Fjm100245q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100245q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100245q%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCruz-Lopez%26aufirst%3DO.%26aulast%3DLopez%2BCara%26aufirst%3DC.%26aulast%3DCarrion%26aufirst%3DM.%2BD.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%25201%252C5-Disubstituted%25201%252C2%252C4-Triazoles%2520as%2520Cis-Restricted%2520Combretastatin%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4248%26epage%3D4258%26doi%3D10.1021%2Fjm100245q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallac, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span> </span><span class="NLM_article-title">Evaluation of Tumor Ischemia in Response to an Indole-Based Vascular Disrupting Agent Using BLI and (19)F MRI</span> <span class="citation_source-journal">Am. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=25973335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSqtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=143-153&author=H.+Zhouauthor=R.+R.+Hallacauthor=R.+Lopezauthor=R.+Denneyauthor=M.+T.+MacDonoughauthor=L.+Liauthor=L.+Liuauthor=E.+E.+Gravesauthor=M.+L.+Trawickauthor=K.+G.+Pinneyauthor=R.+P.+Mason&title=Evaluation+of+Tumor+Ischemia+in+Response+to+an+Indole-Based+Vascular+Disrupting+Agent+Using+BLI+and+%2819%29F+MRI"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and 19F MRI</span></div><div class="casAuthors">Zhou, Heling; Hallac, Rami R.; Lopez, Ramona; Denney, Rebecca; MacDonough, Matthew T.; Li, Li; Liu, Li; Graves, Edward E.; Trawick, Mary Lynn; Pinney, Kevin G.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-153</span>CODEN:
                <span class="NLM_cas:coden">AJNMAU</span>;
        ISSN:<span class="NLM_cas:issn">2160-8407</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Vascular disrupting agents (VDAs) have been proposed as an effective broad spectrum approach to cancer therapy, by inducing ischemia leading to hypoxia and cell death.  A novel VDA (OXi8007) was recently reported to show rapid acute selective shutdown of tumor vasculature based on color-Doppler ultrasound.  We have now expanded investigations to noninvasively assess perfusion and hypoxiation of orthotopic human MDA-MB-231/luc breast tumor xenografts following the administration of OXi8007 based on dynamic bioluminescence imaging (BLI) and magnetic resonance imaging (MRI).  BLI showed significantly lower signal four hours after the administration of OXi8007, which was very similar to the response to combretastatin A-4P (CA4P), but the effect lasted considerably longer, with the BLI signal remaining depressed at 72 h.  Meanwhile, control tumors exhibited minimal change.  Oximetry used 19F MRI of the reporter mol. hexafluorobenzene and FREDOM (Fluorocarbon Relaxometry using Echo Planar Imaging for Dynamic Oxygen Mapping) to assess pO2 distributions during air and oxygen breathing. pO2 decreased significantly upon the administration of OXi8007 during oxygen breathing (from 122 ± 64 to 34 ± 20 Torr), with further decrease upon switching the gas to air (pO2 = 17 ± 9 Torr). pO2 maps indicated intra-tumor heterogeneity in response to OXi8007, though ultimately all tumor regions became hypoxic.  Both BLI and FREDOM showed the efficacy of OXi8007.  The pO2 changes measured by FREDOM may be crucial for future study of combined therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8JSG6Slq47Vg90H21EOLACvtfcHk0ljpY7ifOr3XfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSqtL7L&md5=17055d7f2cc929636d5ccf0c0ac7d221</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHallac%26aufirst%3DR.%2BR.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DDenney%26aufirst%3DR.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DE.%2BE.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DEvaluation%2520of%2520Tumor%2520Ischemia%2520in%2520Response%2520to%2520an%2520Indole-Based%2520Vascular%2520Disrupting%2520Agent%2520Using%2520BLI%2520and%2520%252819%2529F%2520MRI%26jtitle%3DAm.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D5%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zaninetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aprile, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span> </span><span class="NLM_article-title">A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Anti-Tubulin Agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cmdc.201200561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fcmdc.201200561" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=633-643&author=R.+Zaninettiauthor=S.+V.+Corteseauthor=S.+Aprileauthor=A.+Massarottiauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=G.+Grosaauthor=A.+A.+Genazzaniauthor=T.+Pirali&title=A+Concise+Synthesis+of+Pyrazole+Analogues+of+Combretastatin+A1+as+Potent+Anti-Tubulin+Agents&doi=10.1002%2Fcmdc.201200561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200561%26sid%3Dliteratum%253Aachs%26aulast%3DZaninetti%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DS.%2BV.%26aulast%3DAprile%26aufirst%3DS.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DGrosa%26aufirst%3DG.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DPirali%26aufirst%3DT.%26atitle%3DA%2520Concise%2520Synthesis%2520of%2520Pyrazole%2520Analogues%2520of%2520Combretastatin%2520A1%2520as%2520Potent%2520Anti-Tubulin%2520Agents%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D633%26epage%3D643%26doi%3D10.1002%2Fcmdc.201200561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hadimani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strecker, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirali, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span> </span><span class="NLM_article-title">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1678</span><span class="refDoi"> DOI: 10.1021/np400374w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400374w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1668-1678&author=M.+B.+Hadimaniauthor=M.+T.+MacDonoughauthor=A.+Ghatakauthor=T.+E.+Streckerauthor=R.+Lopezauthor=M.+Sriramauthor=B.+L.+Nguyenauthor=J.+J.+Hallauthor=R.+J.+Kesslerauthor=A.+R.+Shiraliauthor=L.+Liuauthor=C.+M.+Garnerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+a+2-Aryl-3-aroyl+Indole+Salt+%28OXi8007%29+Resembling+Combretastatin+A-4+with+Application+as+a+Vascular+Disrupting+Agent&doi=10.1021%2Fnp400374w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span></div><div class="casAuthors">Hadimani, Mallinath B.; MacDonough, Matthew T.; Ghatak, Anjan; Strecker, Tracy E.; Lopez, Ramona; Sriram, Madhavi; Nguyen, Benson L.; Hall, John J.; Kessler, Raymond J.; Shirali, Anupama R.; Liu, Li; Garner, Charles M.; Pettit, George R.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1678</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 are potent inhibitors of tubulin assembly, and they have inspired the design and synthesis of a large no. of small-mol., potential anticancer agents.  The indole-based mol. scaffold is prominent among these SAR modifications, leading to a rapidly increasing no. of agents.  The water-sol. phosphate prodrug I [R = P(O)(O-Na+)2] (OXi8007) (II) of 2-aryl-3-aroylindole-based phenol I (R = H) (OXi8006) (III) was prepd. by chem. synthesis and found to be strongly cytotoxic against selected human cancer cell lines (GI50 = 36 nM against DU-145 cells, for example).  The free phenol, III (OXi8006), was a strong inhibitor (IC50 = 1.1 μM) of tubulin assembly.  The corresponding phosphate prodrug II (OXi8007) also demonstrated pronounced interference with tumor vasculature in a preliminary in vivo study utilizing a SCID mouse model bearing an orthotopic PC-3 (prostate) tumor as imaged by color Doppler ultrasound.  The combination of these results provides evidence that the indole-based phosphate prodrug II (OXi8007) functions as a vascular disrupting agent that may prove useful for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPuuWz4Lp4LVg90H21EOLACvtfcHk0ljpY7ifOr3XfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN&md5=d17de0d4667b5565c5715a956549c456</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fnp400374w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400374w%26sid%3Dliteratum%253Aachs%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DKessler%26aufirst%3DR.%2BJ.%26aulast%3DShirali%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520a%25202-Aryl-3-aroyl%2520Indole%2520Salt%2520%2528OXi8007%2529%2520Resembling%2520Combretastatin%2520A-4%2520with%2520Application%2520as%2520a%2520Vascular%2520Disrupting%2520Agent%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26spage%3D1668%26epage%3D1678%26doi%3D10.1021%2Fnp400374w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Combretastatin A4: Present and Future Directions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3044</span><span class="refDoi"> DOI: 10.1021/jm0512903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3033-3044&author=G.+C.+Tronauthor=T.+Piraliauthor=G.+Sorbaauthor=F.+Pagliaiauthor=S.+Busaccaauthor=A.+A.+Genazzani&title=Medicinal+Chemistry+of+Combretastatin+A4%3A+Present+and+Future+Directions&doi=10.1021%2Fjm0512903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of combretastatin A4: Present and future directions</span></div><div class="casAuthors">Tron, Gian Cesare; Pirali, Tracey; Sorba, Giovanni; Pagliai, Francesca; Busacca, Sara; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3033-3044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs.  A review on the medicinal chem. of combretastatin A4 (CA-4), a compd. with antitumor properties.  The mechanism of action of CA-4, including its ability to inhibit tubulin polymn., is discussed, along with selected analogs of CA-4 modified on the arom. rings A and B, substituted Ph rings, heterocycling rings, non-substituted arom. rings, modifications on the double bond, and analogs where the olefinic group is replaced by a ring.  Some issues related to the pharmacol. of CA-4 and future directions in research are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNHvpiUH4mbVg90H21EOLACvtfcHk0lgzqobHbIvo8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyjuro%253D&md5=be023d8f1f059f952308bb06196459da</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0512903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512903%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DPagliai%26aufirst%3DF.%26aulast%3DBusacca%26aufirst%3DS.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Combretastatin%2520A4%253A%2520Present%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3033%26epage%3D3044%26doi%3D10.1021%2Fjm0512903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Siebert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gensicka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholewinski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzierzbicka, K.</span><span> </span><span class="NLM_article-title">Synthesis of Combretastatin A-4 Analogs and their Biological Activities</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.2174/1871520616666160204111832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.2174%2F1871520616666160204111832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=942-960&author=A.+Siebertauthor=M.+Gensickaauthor=G.+Cholewinskiauthor=K.+Dzierzbicka&title=Synthesis+of+Combretastatin+A-4+Analogs+and+their+Biological+Activities&doi=10.2174%2F1871520616666160204111832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160204111832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160204111832%26sid%3Dliteratum%253Aachs%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DGensicka%26aufirst%3DM.%26aulast%3DCholewinski%26aufirst%3DG.%26aulast%3DDzierzbicka%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Combretastatin%2520A-4%2520Analogs%2520and%2520their%2520Biological%2520Activities%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D942%26epage%3D960%26doi%3D10.2174%2F1871520616666160204111832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span><span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-Based+Approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0lgzqobHbIvo8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure-Activity Relationships and Molecular Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.1021/jm050809s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050809s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=947-954&author=G.+De+Martinoauthor=M.+C.+Edlerauthor=G.+La+Reginaauthor=A.+Colucciaauthor=M.+C.+Barberaauthor=D.+Barrowauthor=R.+I.+Nicholsonauthor=G.+Chiosisauthor=A.+Brancaleauthor=E.+Hamelauthor=M.+Articoauthor=R.+Silvestri&title=New+Arylthioindoles%3A+Potent+Inhibitors+of+Tubulin+Polymerization.+2.+Structure-Activity+Relationships+and+Molecular+Modeling+Studies&doi=10.1021%2Fjm050809s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure-Activity Relationships and Molecular Modeling Studies</span></div><div class="casAuthors">De Martino, Gabriella; Edler, Michael C.; La Regina, Giuseppe; Coluccia, Antonio; Barbera, Maria Chiara; Barrow, Denise; Nicholson, Robert I.; Chiosis, Gabriela; Brancale, Andrea; Hamel, Ernest; Artico, Marino; Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">947-954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylthioindoles (ATIs) that possess a 3-methoxyphenylthio or a 3,5-dimethoxyphenylthio moiety at position 2 of the indole ring were effective tubulin assembly inhibitors, but weak inhibitors of MCF-7 cell growth.  ATIs bearing a 3-(3,4,5-trimethoxyphenyl)thio moiety were potent tubulin polymn. inhibitors, with IC50s in the 2.0 (35) to 4.5 (37) μM range.  They also inhibited MCF-7 cell growth at nanomolar concns.  The 3,4,5-trimethoxy substituted ATIs showed potencies comparable to those of the ref. compds. colchicine and combretastatin A-4 in both tubulin assembly and cell growth inhibition assays.  Dynamics simulation studies correlate well with the obsd. exptl. data.  Furthermore, from careful anal. of the biol. and in silico data, we can now hypothesize a basic pharmacophore for this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-C6vrzb-eFLVg90H21EOLACvtfcHk0lgzqobHbIvo8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ktw%253D%253D&md5=a3dc1f35656374edab6b6546972337a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm050809s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050809s%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26aulast%3DBarrow%26aufirst%3DD.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DNew%2520Arylthioindoles%253A%2520Potent%2520Inhibitors%2520of%2520Tubulin%2520Polymerization.%25202.%2520Structure-Activity%2520Relationships%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D947%26epage%3D954%26doi%3D10.1021%2Fjm050809s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sanghai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohapatra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priyadarshani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashyap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satapathy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddharth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchhait, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharatam, P. V.</span><span> </span><span class="NLM_article-title">Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span><span class="refDoi"> DOI: 10.1039/c3md00357d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1039%2Fc3md00357d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=766-782&author=N.+Sanghaiauthor=V.+Jainauthor=R.+Preetauthor=S.+Kandekarauthor=S.+Dasauthor=N.+Trivediauthor=P.+Mohapatraauthor=G.+Priyadarshaniauthor=M.+Kashyapauthor=D.+Dasauthor=S.+R.+Satapathyauthor=S.+Siddharthauthor=S.+K.+Guchhaitauthor=C.+N.+Kunduauthor=P.+V.+Bharatam&title=Combretastatin+A-4+inspired+novel+2-aryl-3-arylamino-imidazo-pyridines%2Fpyrazines+as+tubulin+polymerization+inhibitors%2C+antimitotic+and+anticancer+agents&doi=10.1039%2Fc3md00357d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fc3md00357d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00357d%26sid%3Dliteratum%253Aachs%26aulast%3DSanghai%26aufirst%3DN.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DPreet%26aufirst%3DR.%26aulast%3DKandekar%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DMohapatra%26aufirst%3DP.%26aulast%3DPriyadarshani%26aufirst%3DG.%26aulast%3DKashyap%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSatapathy%26aufirst%3DS.%2BR.%26aulast%3DSiddharth%26aufirst%3DS.%26aulast%3DGuchhait%26aufirst%3DS.%2BK.%26aulast%3DKundu%26aufirst%3DC.%2BN.%26aulast%3DBharatam%26aufirst%3DP.%2BV.%26atitle%3DCombretastatin%2520A-4%2520inspired%2520novel%25202-aryl-3-arylamino-imidazo-pyridines%252Fpyrazines%2520as%2520tubulin%2520polymerization%2520inhibitors%252C%2520antimitotic%2520and%2520anticancer%2520agents%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D766%26epage%3D782%26doi%3D10.1039%2Fc3md00357d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1<i>H-</i>Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128710</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1371%2Fjournal.pone.0128710" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128710&author=Q.+Xuauthor=H.+Qiauthor=M.+Sunauthor=D.+Zuoauthor=X.+Jiangauthor=Z.+Wenauthor=Z.+Wangauthor=Y.+Wuauthor=W.+Zhang&title=Synthesis+and+Biological+Evaluation+of+3-Alkyl-1%2C5-Diaryl-1H-Pyrazoles+as+Rigid+Analogues+of+Combretastatin+A-4+with+Potent+Antiproliferative+Activity&doi=10.1371%2Fjournal.pone.0128710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128710%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DZuo%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25203-Alkyl-1%252C5-Diaryl-1H-Pyrazoles%2520as%2520Rigid%2520Analogues%2520of%2520Combretastatin%2520A-4%2520with%2520Potent%2520Antiproliferative%2520Activity%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128710%26doi%3D10.1371%2Fjournal.pone.0128710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Burja, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Čimbora-Zovko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomić, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelušić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kočevar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmak, M.</span><span> </span><span class="NLM_article-title">Pyrazolone-Fused Combretastatins and Their Precursors: Synthesis, Cytotoxicity, Antitubulin Activity and Molecular Modeling Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.bmc.2010.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=20338766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2375-2387&author=B.+Burjaauthor=T.+%C4%8Cimbora-Zovkoauthor=S.+Tomi%C4%87author=T.+Jelu%C5%A1i%C4%87author=M.+Ko%C4%8Devarauthor=S.+Polancauthor=M.+Osmak&title=Pyrazolone-Fused+Combretastatins+and+Their+Precursors%3A+Synthesis%2C+Cytotoxicity%2C+Antitubulin+Activity+and+Molecular+Modeling+Studies&doi=10.1016%2Fj.bmc.2010.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies</span></div><div class="casAuthors">Burja, Bojan; Cimbora-Zovko, Tamara; Tomic, Sanja; Jelusic, Tihana; Kocevar, Marijan; Polanc, Slovenko; Osmak, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2375-2387</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pyrazolone-fused combretastatins and precursors were synthesized and their cytotoxicity as well as antitubulin potential was evaluated.  The hydrazide 9f and the pyrazolone-fused combretastatins 12a, 12b and 12c were highly cytotoxic against various tumor cell lines including cisplatin resistant cells.  The same compds. were also the best inhibitors of tubulin polymn.  Mol. modeling results showed that they bind the colchicine binding site at the tubulin heterodimer.  The hydrazide 9f arrested HeLa cells in the G2/M phase of the cell cycle and strongly affected cell shape and microtubule network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm219DOix7w7Vg90H21EOLACvtfcHk0liDSQNhlcBg3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejs7c%253D&md5=e1f34ada02e5c3fbb979c0365ee7b575</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DBurja%26aufirst%3DB.%26aulast%3D%25C4%258Cimbora-Zovko%26aufirst%3DT.%26aulast%3DTomi%25C4%2587%26aufirst%3DS.%26aulast%3DJelu%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DKo%25C4%258Devar%26aufirst%3DM.%26aulast%3DPolanc%26aufirst%3DS.%26aulast%3DOsmak%26aufirst%3DM.%26atitle%3DPyrazolone-Fused%2520Combretastatins%2520and%2520Their%2520Precursors%253A%2520Synthesis%252C%2520Cytotoxicity%252C%2520Antitubulin%2520Activity%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2375%26epage%3D2387%26doi%3D10.1016%2Fj.bmc.2010.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span> </span><span class="NLM_article-title">Search for MDR Modulators: Design, Syntheses and Evaluations of <i>N</i>-substituted Acridones for Interactions with <i>p</i>-glycoprotein and Mg<sup>2+</sup></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2427</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.bmc.2009.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2423-2427&author=P.+Singhauthor=J.+Kaurauthor=P.+Kaurauthor=S.+Kaur&title=Search+for+MDR+Modulators%3A+Design%2C+Syntheses+and+Evaluations+of+N-substituted+Acridones+for+Interactions+with+p-glycoprotein+and+Mg2%2B&doi=10.1016%2Fj.bmc.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DKaur%26aufirst%3DS.%26atitle%3DSearch%2520for%2520MDR%2520Modulators%253A%2520Design%252C%2520Syntheses%2520and%2520Evaluations%2520of%2520N-substituted%2520Acridones%2520for%2520Interactions%2520with%2520p-glycoprotein%2520and%2520Mg2%252B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2423%26epage%3D2427%26doi%3D10.1016%2Fj.bmc.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lamberth, C.</span><span> </span><span class="NLM_article-title">Pyrazole Chemistry in Crop Protection</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span><span class="refDoi"> DOI: 10.3987/REV-07-613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.3987%2FREV-07-613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1467-1502&author=C.+Lamberth&title=Pyrazole+Chemistry+in+Crop+Protection&doi=10.3987%2FREV-07-613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole chemistry in crop protection</span></div><div class="casAuthors">Lamberth, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1467-1502</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">A review.  An overview is given of the significance of pyrazole derivs. in crop protection chem.  The main herbicidally, fungicidally and insecticidally active pyrazole classes are presented, together with their synthetic routes, their modes-of-action and their biol. efficacies.  Indazoles and other bicyclic pyrazole derivs. are also covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8_VLb2dv2rVg90H21EOLACvtfcHk0lgoFQZ-1JHKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFWjtr0%253D&md5=783057731513897b2bf8e7d53d41ee5b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3987%2FREV-07-613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FREV-07-613%26sid%3Dliteratum%253Aachs%26aulast%3DLamberth%26aufirst%3DC.%26atitle%3DPyrazole%2520Chemistry%2520in%2520Crop%2520Protection%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D71%26spage%3D1467%26epage%3D1502%26doi%3D10.3987%2FREV-07-613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Recent Developments in the Chemistry of Sydnones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1016/j.tet.2009.10.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.tet.2009.10.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=553-568&author=D.+L.+Browneauthor=J.+P.+A.+Harrity&title=Recent+Developments+in+the+Chemistry+of+Sydnones&doi=10.1016%2Fj.tet.2009.10.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the chemistry of sydnones</span></div><div class="casAuthors">Browne, Duncan L.; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent times, sydnones have gained significant interest through the discovery of their useful biol. properties (i.e., antibacterial, antineoplastic and antiinflammatory agents), which have driven the development of new functionalization methods.  In addn., sydnones act as useful and novel precursors for pyrazoles (via cycloaddn. with alkynes).  This report provides an overview of the recently developed chem. of sydnones with particular emphasis on useful reactions for the synthesis of these biol. interesting mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMqIRaChOnurVg90H21EOLACvtfcHk0lgoFQZ-1JHKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnu7zM&md5=f2602f4ebebc43ef241de753d08d43e7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.10.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.10.085%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Chemistry%2520of%2520Sydnones%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D553%26epage%3D568%26doi%3D10.1016%2Fj.tet.2009.10.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Decuypere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Specklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabillet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plougastel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodych, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">Copper(I)-Catalyzed Cycloaddition of 4-Bromosydnones and Alkynes for the Regioselective Synthesis of 1,4,5-Trisubstituted Pyrazoles</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1021/ol503482a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503482a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=362-365&author=E.+Decuypereauthor=S.+Specklinauthor=S.+Gabilletauthor=D.+Audisioauthor=H.+Liuauthor=L.+Plougastelauthor=S.+Kolodychauthor=F.+Taran&title=Copper%28I%29-Catalyzed+Cycloaddition+of+4-Bromosydnones+and+Alkynes+for+the+Regioselective+Synthesis+of+1%2C4%2C5-Trisubstituted+Pyrazoles&doi=10.1021%2Fol503482a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Cycloaddition of 4-Bromosydnones and Alkynes for the Regioselective Synthesis of 1,4,5-Trisubstituted Pyrazoles</span></div><div class="casAuthors">Decuypere, Elodie; Specklin, Simon; Gabillet, Sandra; Audisio, Davide; Liu, Hui; Plougastel, Lucie; Kolodych, Sergii; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">362-365</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Copper-catalyzed cycloaddn. of alkynes with 4-bromosydnones provides a convenient, mild, and regioselective method for the synthesis of a wide range of bromopyrazoles.  The broad functional group tolerance of the cycloaddn. reaction and further palladium-catalyzed cross-coupling reactions allowed the prepn. of polyfunctionalized 1,4,5-pyrazoles e. g., I, that are otherwise difficult to obtain by conventional methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq90U7CvRb7KLVg90H21EOLACvtfcHk0liIYMlvGGJIxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLvO&md5=0c74338f868b720243fd891437981300</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol503482a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503482a%26sid%3Dliteratum%253Aachs%26aulast%3DDecuypere%26aufirst%3DE.%26aulast%3DSpecklin%26aufirst%3DS.%26aulast%3DGabillet%26aufirst%3DS.%26aulast%3DAudisio%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DPlougastel%26aufirst%3DL.%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DCopper%2528I%2529-Catalyzed%2520Cycloaddition%2520of%25204-Bromosydnones%2520and%2520Alkynes%2520for%2520the%2520Regioselective%2520Synthesis%2520of%25201%252C4%252C5-Trisubstituted%2520Pyrazoles%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D362%26epage%3D365%26doi%3D10.1021%2Fol503482a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kolodych, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasolofonjatovo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumontet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevers, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Créminon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">Discovery of Chemoselective and Biocompatible Reactions Using a High-Throughput Immunoassay Screening</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">12056</span><span class="NLM_x">–</span> <span class="NLM_lpage">12060</span><span class="refDoi"> DOI: 10.1002/anie.201305645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fanie.201305645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WmtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12056-12060&author=S.+Kolodychauthor=E.+Rasolofonjatovoauthor=M.+Chaumontetauthor=M.-C.+Neversauthor=C.+Cr%C3%A9minonauthor=F.+Taran&title=Discovery+of+Chemoselective+and+Biocompatible+Reactions+Using+a+High-Throughput+Immunoassay+Screening&doi=10.1002%2Fanie.201305645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Chemoselective and Biocompatible Reactions Using a High-Throughput Immunoassay Screening</span></div><div class="casAuthors">Kolodych, Sergii; Rasolofonjatovo, Evelia; Chaumontet, Manon; Nevers, Marie-Claire; Creminon, Christophe; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12056-12060</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A method for high-throughput screening for identification and optimization of potential "click" reactions, particularly dipolar cycloaddns., using an immunoassay is described.  Reactive groups attached to either homovanillic amide or histamine groups were reacted on nanomolar scale with a variety of metal catalysts; treatment with surface-linked anti(homovanillamide) monoclonal antibodies and antihistamine monoclonal antibodies in soln. led to a color change only when cycloadducts (contg. both homovanillamide and histamine tags) were formed and immobilized on the surface.  Reactions that generated product were then optimized using the same assay format; four of the reactions were then performed using nontagged substrates.  A rhodium-catalyzed cycloaddns. of pyridiniumacetates to nitriles to form imidazolopyridinecarboxylates, an iridium-catalyzed cycloaddn. of benzyl azide with bromoalkynes to form bromo-1,2,3-triazoles, a palladium-catalyzed and copper-mediated oxidative Heck reaction of a phenylsydnone with alkenes to yield alkenylsydnones, and a copper-catalyzed cycloaddn. of arylsydnones with alkynes to form arylpyrazoles were discovered using this method.  In particular, copper-catalyzed cycloaddn. of arylsydnones with alkynes to form arylpyrazoles was found to be applicable to a variety of biol. relevant substrates, was performed successfully in human blood plasma, and was used to label bovine serum albumin with a fluorescent tag.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1VcQhA-O_9rVg90H21EOLACvtfcHk0liIYMlvGGJIxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WmtbvF&md5=fd99fb5fdf15e10d8b9078ce2dc90491</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305645%26sid%3Dliteratum%253Aachs%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DChaumontet%26aufirst%3DM.%26aulast%3DNevers%26aufirst%3DM.-C.%26aulast%3DCr%25C3%25A9minon%26aufirst%3DC.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Chemoselective%2520and%2520Biocompatible%2520Reactions%2520Using%2520a%2520High-Throughput%2520Immunoassay%2520Screening%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12056%26epage%3D12060%26doi%3D10.1002%2Fanie.201305645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Specklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decuypere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plougastel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">One-Pot Synthesis of 1,4-Disubstituted Pyrazoles from Arylglycines via Copper-Catalyzed Sydnone–Alkyne Cycloaddition Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7777</span><span class="refDoi"> DOI: 10.1021/jo501420r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo501420r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=7772-7777&author=S.+Specklinauthor=E.+Decuypereauthor=L.+Plougastelauthor=S.+Alianiauthor=F.+Taran&title=One-Pot+Synthesis+of+1%2C4-Disubstituted+Pyrazoles+from+Arylglycines+via+Copper-Catalyzed+Sydnone%E2%80%93Alkyne+Cycloaddition+Reaction&doi=10.1021%2Fjo501420r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of 1,4-Disubstituted Pyrazoles from Arylglycines via Copper-Catalyzed Sydnone-Alkyne Cycloaddition Reaction</span></div><div class="casAuthors">Specklin, Simon; Decuypere, Elodie; Plougastel, Lucie; Aliani, Soifia; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7772-7777</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A robust method for constructing 1,4-pyrazoles e. g., I, from arylglycines was developed using the copper-catalyzed sydnone-alkyne cycloaddn. reaction.  The procedure offers a straightforward and general route to the pyrazole heterocycle through a three-step one-pot procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM8RhZ6lPO57Vg90H21EOLACvtfcHk0liIYMlvGGJIxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbfE&md5=d1dffdf698762842c8f6c4e61714ca20</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo501420r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo501420r%26sid%3Dliteratum%253Aachs%26aulast%3DSpecklin%26aufirst%3DS.%26aulast%3DDecuypere%26aufirst%3DE.%26aulast%3DPlougastel%26aufirst%3DL.%26aulast%3DAliani%26aufirst%3DS.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DOne-Pot%2520Synthesis%2520of%25201%252C4-Disubstituted%2520Pyrazoles%2520from%2520Arylglycines%2520via%2520Copper-Catalyzed%2520Sydnone%25E2%2580%2593Alkyne%2520Cycloaddition%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D7772%26epage%3D7777%26doi%3D10.1021%2Fjo501420r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helm, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">A Sydnone Cycloaddition Route to Pyrazole Boronic Esters</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8656</span><span class="NLM_x">–</span> <span class="NLM_lpage">8658</span><span class="refDoi"> DOI: 10.1002/anie.200703767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fanie.200703767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2rsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=8656-8658&author=D.+L.+Browneauthor=M.+D.+Helmauthor=A.+Plantauthor=J.+P.+A.+Harrity&title=A+Sydnone+Cycloaddition+Route+to+Pyrazole+Boronic+Esters&doi=10.1002%2Fanie.200703767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A sydnone cycloaddition route to pyrazole boronic esters</span></div><div class="casAuthors">Browne, Duncan L.; Helm, Matthew D.; Plant, Andrew; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8656-8658</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Regioselective 1,3-cycloaddn. of N-methylsydnone with alkynylboronates gave 4-pyrazolylboronic acids.  Cycloaddn. of pinacol alkynylboronate R1C≡CB(OCMe2)2 with 3-R1-5-oxy-1,2,3-oxadiazole (N-R1-sydnone) in xylene at reflux gave 1-R1-3-R2-4-B(OCMe2)-1H-pyrazoles (3a-12a; R1 = Ph, 4-MeOC6H4, 4-NO2C6H4; R2 = Ph, Bu, Me3Si, H) together with their regioisomeric 1-R1-4-R2-3-B(OCMe2)-1H-pyrazoles (3b-12b, same R1, R2) with 54-83% yields and 2:1 to 100% a/b regioselectivity.  Functionalization of the products by Suzuki coupling and N-deprotection processes highlight the potential synthetic utility of these species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHAPl57nDUD7Vg90H21EOLACvtfcHk0liIYMlvGGJIxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2rsrfJ&md5=939484bae67c840afd1dfc6f66a2dac8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.200703767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200703767%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DPlant%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DA%2520Sydnone%2520Cycloaddition%2520Route%2520to%2520Pyrazole%2520Boronic%2520Esters%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D8656%26epage%3D8658%26doi%3D10.1002%2Fanie.200703767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Bengoa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Investigation of the Scope and Regiochemistry of Alkynylboronate Cycloadditions with Sydnones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7769</span><span class="refDoi"> DOI: 10.1021/ja902460n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902460n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVGms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=7762-7769&author=D.+L.+Browneauthor=J.+F.+Vivatauthor=A.+Plantauthor=E.+Gomez-Bengoaauthor=J.+P.+A.+Harrity&title=Investigation+of+the+Scope+and+Regiochemistry+of+Alkynylboronate+Cycloadditions+with+Sydnones&doi=10.1021%2Fja902460n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the scope and regiochemistry of alkynylboronate cycloadditions with sydnones</span></div><div class="casAuthors">Browne, Duncan L.; Vivat, Jerome F.; Plant, Andrew; Gomez-Bengoa, Enrique; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7762-7769</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Di-, tri-, and tetrasubstituted 3- and 4-pyrazolylboronates were prepd. by a convenient and highly regioselective procedure comprising cycloaddn. of alkynylboronates to sydnones.  Addn. of 3-R1-4-R2-5-oxy-1,2,3-oxadiazolium with 2-alkynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolanes R3C≡CB(OCMe2)2 in 1,2-dichlorobenzene at 180° gave 1-R1-3-R3-4-X-5-R2-1H-pyrazoles (20a-30a; X = 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl; R1 = Ph, Me, 4-NO2C6H4; R2 = Ph, Me, iPr; R3 = Ph, Me3Si); the corresponding regioisomers, 1-R1-4-R3-3-X-5-R2-1H-pyrazoles, were formed in less than 2% amts.  However, regioselectivity (a:b) of the reaction of 3-Ph-5-oxy-1,2,3-oxadiazolium with R4C≡CB(OCMe2)2 giving 1-R1-3-R4-4-X- and 1-R1-4-R4-3-X-1H-pyrazoles (8a-13a, 8b-13b, resp., R1 = Ph, Me, PhCH2, R4 = H, Bu, Me3Si) was lower (1:7, 5:2 and 2:1, resp.).  The origins of an obsd. regiochem. divergence in the reactions of terminal alkynylboronates with their more substituted analogs have been studied by DFT methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5i5kaEKPo_rVg90H21EOLACvtfcHk0lgHt7qqBYipDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVGms7s%253D&md5=1cde7f18d95179d9e57cf1aa6faac1ee</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja902460n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902460n%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DVivat%26aufirst%3DJ.%2BF.%26aulast%3DPlant%26aufirst%3DA.%26aulast%3DGomez-Bengoa%26aufirst%3DE.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520Scope%2520and%2520Regiochemistry%2520of%2520Alkynylboronate%2520Cycloadditions%2520with%2520Sydnones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D7762%26epage%3D7769%26doi%3D10.1021%2Fja902460n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Comas-Barceló, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Bengoa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Cu-Promoted Sydnone Cycloadditions of Alkynes: Scope and Mechanism Studies</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3257</span><span class="NLM_x">–</span> <span class="NLM_lpage">3263</span><span class="refDoi"> DOI: 10.1002/chem.201406118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fchem.201406118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=25557473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3257-3263&author=J.+Comas-Barcel%C3%B3author=R.+S.+Fosterauthor=B.+Fiserauthor=E.+Gomez-Bengoaauthor=J.+P.+A.+Harrity&title=Cu-Promoted+Sydnone+Cycloadditions+of+Alkynes%3A+Scope+and+Mechanism+Studies&doi=10.1002%2Fchem.201406118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cu-Promoted Sydnone Cycloadditions of Alkynes: Scope and Mechanism Studies</span></div><div class="casAuthors">Comas-Barcelo, Julia; Foster, Robert S.; Fiser, Bela; Gomez-Bengoa, Enrique; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3257-3263</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cu salts have been found to promote the cycloaddn. reaction of sydnones and terminal alkynes, providing significant redn. in reaction times.  Specifically, the use of Cu(OTf)2 is found to provide 1,3-disubstituted pyrazoles, whereas simply switching the promoter system to Cu(OAc)2 allows the corresponding 1,4-isomers to be produced.  The mechanism of the Cu-effect in each case has been investigated by exptl. and theor. studies, and they suggest that Cu(OTf)2 functions by Lewis acid activation of the sydnone, whereas Cu(OAc)2 promotes formation of reactive CuI acetylides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-FXg3iQuJbVg90H21EOLACvtfcHk0lgHt7qqBYipDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFU%253D&md5=c23cce1544edb1e34dad67d8e5b5ced3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fchem.201406118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201406118%26sid%3Dliteratum%253Aachs%26aulast%3DComas-Barcel%25C3%25B3%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DR.%2BS.%26aulast%3DFiser%26aufirst%3DB.%26aulast%3DGomez-Bengoa%26aufirst%3DE.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DCu-Promoted%2520Sydnone%2520Cycloadditions%2520of%2520Alkynes%253A%2520Scope%2520and%2520Mechanism%2520Studies%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D3257%26epage%3D3263%26doi%3D10.1002%2Fchem.201406118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Brown, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Direct Arylation of Sydnones with Aryl Chlorides toward Highly Substituted Pyrazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2472</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=2467-2472&author=A.+W.+Brownauthor=J.+P.+A.+Harrity&title=Direct+Arylation+of+Sydnones+with+Aryl+Chlorides+toward+Highly+Substituted+Pyrazoles&doi=10.1021%2Facs.joc.5b00143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BW.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DDirect%2520Arylation%2520of%2520Sydnones%2520with%2520Aryl%2520Chlorides%2520toward%2520Highly%2520Substituted%2520Pyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D2467%26epage%3D2472%26doi%3D10.1021%2Facs.joc.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Lunt, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Aldasoro, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span> </span><span class="NLM_article-title">Vascular Effects Dominate Solid Tumor Response to Treatment with Combretastatin A-4-phosphate</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1979</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span><span class="refDoi"> DOI: 10.1002/ijc.25848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fijc.25848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=21154772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKlsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=1979-1989&author=S.-J.+Luntauthor=S.+Akermanauthor=S.+A.+Hillauthor=M.+Fisherauthor=V.+J.+Wrightauthor=C.+C.+Reyes-Aldasoroauthor=G.+M.+Tozerauthor=C.+Kanthou&title=Vascular+Effects+Dominate+Solid+Tumor+Response+to+Treatment+with+Combretastatin+A-4-phosphate&doi=10.1002%2Fijc.25848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate</span></div><div class="casAuthors">Lunt, Sarah Jane; Akerman, Simon; Hill, Sally A.; Fisher, Matthew; Wright, Victoria J.; Reyes-Aldasoro, Constantino C.; Tozer, Gillian M.; Kanthou, Chryso</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1979-1989</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular-targeted therapeutics are increasingly used in the clinic.  However, less is known about the direct response of tumor cells to these agents.  We have developed a combretastatin-A-4-phosphate (CA4P) resistant variant of SW1222 human colorectal carcinoma cells to examine the relative importance of vascular vs. tumor cell targeting in the ultimate treatment response.  SW1222Res cells were generated through exposure of wild-type cells (SW1222WT) to increasing CA4P concns. in vitro.  Increased resistance was confirmed through analyses of cell viability, apoptosis and multidrug-resistance (MDR) protein expression.  In vivo, comparative studies examd. tumor cell necrosis, apoptosis, vessel morphol. and functional vascular end-points following treatment with CA4P (single 100 mg/kg dose).  Tumor response to repeated CA4P dosing (50 mg/kg/day, 5 days/wk for 2 wk) was examd. through growth measurement, and ultimate tumor cell survival was studied by ex vivo clonogenic assay.  In vitro, SW1222Res cells showed reduced CA4P sensitivity, enhanced MDR protein expression and a reduced apoptotic index.  In vivo, CA4P induced significantly lower apoptotic cell death in SW1222Res vs. SW1222WT tumors indicating maintenance of resistance characteristics.  However, CA4P-induced tumor necrosis was equiv. in both lines.  Similarly, rapid CA4P-mediated vessel disruption and blood flow shut-down were obsd. in both lines.  Cell surviving fraction was comparable in the two tumor types following single dose CA4P and SW1222Res tumors were at least as sensitive as SW1222WT tumors to repeated dosing.  Despite tumor cell resistance to CA4P, SW1222Res response in vivo was not impaired, strongly supporting the view that vascular damage dominates the therapeutic response to this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXfeiOzwb1brVg90H21EOLACvtfcHk0ljXurrWZ_L1BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKlsrvI&md5=155f50bc021c9117845b47f4b63268b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.25848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25848%26sid%3Dliteratum%253Aachs%26aulast%3DLunt%26aufirst%3DS.-J.%26aulast%3DAkerman%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DV.%2BJ.%26aulast%3DReyes-Aldasoro%26aufirst%3DC.%2BC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26atitle%3DVascular%2520Effects%2520Dominate%2520Solid%2520Tumor%2520Response%2520to%2520Treatment%2520with%2520Combretastatin%2520A-4-phosphate%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D129%26spage%3D1979%26epage%3D1989%26doi%3D10.1002%2Fijc.25848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">The Tumor Vascular Targeting Agent Combretastatin A-4-Phosphate Induces Reorganization of the Actin Cytoskeleton and Early Membrane Blebbing in Human Endothelial Cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2060</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span><span class="refDoi"> DOI: 10.1182/blood.V99.6.2060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1182%2Fblood.V99.6.2060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=2060-2069&author=C.+Kanthouauthor=G.+M.+Tozer&title=The+Tumor+Vascular+Targeting+Agent+Combretastatin+A-4-Phosphate+Induces+Reorganization+of+the+Actin+Cytoskeleton+and+Early+Membrane+Blebbing+in+Human+Endothelial+Cells&doi=10.1182%2Fblood.V99.6.2060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood.V99.6.2060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V99.6.2060%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Tumor%2520Vascular%2520Targeting%2520Agent%2520Combretastatin%2520A-4-Phosphate%2520Induces%2520Reorganization%2520of%2520the%2520Actin%2520Cytoskeleton%2520and%2520Early%2520Membrane%2520Blebbing%2520in%2520Human%2520Endothelial%2520Cells%26jtitle%3DBlood%26date%3D2002%26volume%3D99%26spage%3D2060%26epage%3D2069%26doi%3D10.1182%2Fblood.V99.6.2060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Strecker, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odutola, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidmore, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton-Sevcik, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadimani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span> </span><span class="NLM_article-title">The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1016/j.canlet.2015.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.canlet.2015.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=26325604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVent77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2015&pages=229-241&author=T.+E.+Streckerauthor=S.+O.+Odutolaauthor=R.+Lopezauthor=M.+S.+Cooperauthor=J.+K.+Tidmoreauthor=A.+K.+Charlton-Sevcikauthor=L.+Liauthor=M.+T.+Macdonoughauthor=M.+B.+Hadimaniauthor=A.+Ghatakauthor=L.+Liuauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=K.+G.+Pinneyauthor=M.+L.+Trawick&title=The+vascular+disrupting+activity+of+OXi8006+in+endothelial+cells+and+its+phosphate+prodrug+OXi8007+in+breast+tumor+xenografts&doi=10.1016%2Fj.canlet.2015.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts</span></div><div class="casAuthors">Strecker, Tracy E.; Odutola, Samuel O.; Lopez, Ramona; Cooper, Morgan S.; Tidmore, Justin K.; Charlton-Sevcik, Amanda K.; Li, Li; MacDonough, Matthew T.; Hadimani, Mallinath B.; Ghatak, Anjan; Liu, Li; Chaplin, David J.; Mason, Ralph P.; Pinney, Kevin G.; Trawick, Mary Lynn</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">229-241</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study describes the vascular disrupting ability and the mechanism of action of the indole-based tubulin-binding compd., OXi8006, and its water-sol. phosphate prodrug OXi8007.  Treatment of rapidly proliferating human umbilical vein endothelial cells (HUVECs), used as a model for the tumor vasculature, with OXi8006 or OXi8007, caused potent microtubule disruption followed by extensive reorganization of the cytoskeletal network.  The mechanism of action involved an increase in focal adhesion formation assocd. with an increase in phosphorylation of both non-muscle myosin light chain and focal adhesion kinase.  These effects were dramatically diminished by an inhibitor of RhoA kinase, a downstream effector of RhoA.  Cell cycle blockade at G2/M and cytotoxicity toward rapidly proliferating HUVECs were also obsd.  Capillary-like networks of HUVECs were disrupted by the action of both OXi8006 and OXi8007.  The prodrug OXi8007 exhibited potent and rapid dose-dependent antivascular activity assessed by dynamic bioluminescence imaging (BLI) in an MDA-MB-231-luc breast cancer xenograft mouse model.  By 6 h post treatment, over 93% of the BLI signal was abolished with only a slight recovery at 24 h.  These findings were confirmed by histol.  The results from this study demonstrate that OXi8007 is a potent vascular disrupting agent acting through an anti-microtubule mechanism involving RhoA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDurrLSPKWdLVg90H21EOLACvtfcHk0ljXurrWZ_L1BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVent77J&md5=043667a926725754e893c022e807a159</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DOdutola%26aufirst%3DS.%2BO.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BS.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DCharlton-Sevcik%26aufirst%3DA.%2BK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMacdonough%26aufirst%3DM.%2BT.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26atitle%3DThe%2520vascular%2520disrupting%2520activity%2520of%2520OXi8006%2520in%2520endothelial%2520cells%2520and%2520its%2520phosphate%2520prodrug%2520OXi8007%2520in%2520breast%2520tumor%2520xenografts%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D369%26spage%3D229%26epage%3D241%26doi%3D10.1016%2Fj.canlet.2015.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Chalkley, H. W.</span><span> </span><span class="NLM_article-title">Method for the Quantitative Morphologic Analysis of Tissues</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1943</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1093/jnci/4.1.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1093%2Fjnci%2F4.1.47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1943&pages=47-53&author=H.+W.+Chalkley&title=Method+for+the+Quantitative+Morphologic+Analysis+of+Tissues&doi=10.1093%2Fjnci%2F4.1.47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F4.1.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F4.1.47%26sid%3Dliteratum%253Aachs%26aulast%3DChalkley%26aufirst%3DH.%2BW.%26atitle%3DMethod%2520for%2520the%2520Quantitative%2520Morphologic%2520Analysis%2520of%2520Tissues%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1943%26volume%3D4%26spage%3D47%26epage%3D53%26doi%3D10.1093%2Fjnci%2F4.1.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Williams, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Aldasoro, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">An <i>in vivo</i> Role for Rho Kinase Activation in the Tumour Vascular Disrupting Activity of Combretastatin A-4 3-O-phosphate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">4902</span><span class="NLM_x">–</span> <span class="NLM_lpage">4913</span><span class="refDoi"> DOI: 10.1111/bph.12817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1111%2Fbph.12817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=24930520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=4902-4913&author=L.+J.+Williamsauthor=D.+Mukherjeeauthor=M.+Fisherauthor=C.+C.+Reyes-Aldasoroauthor=S.+Akermanauthor=C.+Kanthouauthor=G.+M.+Tozer&title=An+in+vivo+Role+for+Rho+Kinase+Activation+in+the+Tumour+Vascular+Disrupting+Activity+of+Combretastatin+A-4+3-O-phosphate&doi=10.1111%2Fbph.12817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate</span></div><div class="casAuthors">Williams, L. J.; Mukherjee, D.; Fisher, M.; Reyes-Aldasoro, C. C.; Akerman, S.; Kanthou, C.; Tozer, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4902-4913</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Combretastatin A-4 3-O-phosphate (CA4P) is in clin. trial as a tumor vascular disrupting agent (VDA) but the cause of blood flow disruption is unclear.  We tested the hypothesis that activation of Rho/Rho kinase (ROCK) is fundamental to the effects of this drug in vivo.  Mouse models of human colorectal carcinoma (SW1222 and LS174T) were used.  Effects of the ROCK inhibitor, Y27632, alone or in combination with CA4P, on ROCK activity, vascular function, necrosis and immune cell infiltration in solid tumors were detd.  Mean arterial BP (MABP) was measured to monitor systemic interactions and the vasodilator, hydralazine, was used to control for the hypotensive effects of Y27632.  Y27632 caused a rapid drop in blood flow in SW1222 tumors, with recovery by around 3 h, which was paralleled by MABP changes.  Y27632 pretreatment reduced CA4P-induced ROCK activation and partially blocked CA4P-induced tumor vascular effects, in both tumor types.  Y27632 also partially inhibited CA4P-induced tumor necrosis and was assocd. with reduced immune cell infiltration in SW1222 tumors.  Hydralazine caused a similar hypotensive effect as Y27632 but had no protective effect against CA4P treatment.  These results demonstrate that ROCK activity is crit. for full manifestation of the vascular activity of CA4P in vivo, providing the evidence for pharmacol. intervention to enhance the anti-tumor efficacy of CA4P and related VDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3sOB9jdFIrVg90H21EOLACvtfcHk0lhtM98xawzMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsLbF&md5=044a7f085749c5ca6d8f3eac8438375d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fbph.12817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12817%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DL.%2BJ.%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DReyes-Aldasoro%26aufirst%3DC.%2BC.%26aulast%3DAkerman%26aufirst%3DS.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DAn%2520in%2520vivo%2520Role%2520for%2520Rho%2520Kinase%2520Activation%2520in%2520the%2520Tumour%2520Vascular%2520Disrupting%2520Activity%2520of%2520Combretastatin%2520A-4%25203-O-phosphate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D4902%26epage%3D4913%26doi%3D10.1111%2Fbph.12817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Guidelines for the Welfare and Use of Animals in Cancer Research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1577</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+Welfare+and+Use+of+Animals+in+Cancer+Research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2ebIVp6ER1GN6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520Welfare%2520and%2520Use%2520of%2520Animals%2520in%2520Cancer%2520Research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Karine Porte, Margaux Riomet, Carlotta Figliola, Davide Audisio, <span class="NLM_string-name hlFld-ContribAuthor">Frédéric Taran</span>. </span><span class="cited-content_cbyCitation_article-title">Click and Bio-Orthogonal Reactions with Mesoionic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (12)
                                     , 6718-6743. <a href="https://doi.org/10.1021/acs.chemrev.0c00806" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00806%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DClick%252Band%252BBio-Orthogonal%252BReactions%252Bwith%252BMesoionic%252BCompounds%26aulast%3DPorte%26aufirst%3DKarine%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D30072020%26date%3D25112020%26volume%3D121%26issue%3D12%26spage%3D6718%26epage%3D6743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jakob Bouton, Serge Van Calenbergh, <span class="NLM_string-name hlFld-ContribAuthor">Jan Hullaert</span>. </span><span class="cited-content_cbyCitation_article-title">Sydnone Ribosides as a Platform for the Synthesis of Pyrazole C-Nucleosides: A Unified Synthesis of Formycin B and Pyrazofurin. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (23)
                                     , 9287-9291. <a href="https://doi.org/10.1021/acs.orglett.0c03523" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03523%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSydnone%252BRibosides%252Bas%252Ba%252BPlatform%252Bfor%252Bthe%252BSynthesis%252Bof%252BPyrazole%252BC-Nucleosides%25253A%252BA%252BUnified%252BSynthesis%252Bof%252BFormycin%252BB%252Band%252BPyrazofurin%26aulast%3DBouton%26aufirst%3DJakob%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22102020%26date%3D19112020%26volume%3D22%26issue%3D23%26spage%3D9287%26epage%3D9291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marina
N. Semenova, Dmitry V. Demchuk, Dmitry V. Tsyganov, Natalia B. Chernysheva, Alexander V. Samet, Eugenia A. Silyanova, Victor P. Kislyi, Anna S. Maksimenko, Alexander E. Varakutin, Leonid D. Konyushkin, Mikhail M. Raihstat, Alex S. Kiselyov, <span class="NLM_string-name hlFld-ContribAuthor">Victor V. Semenov</span>. </span><span class="cited-content_cbyCitation_article-title">Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (12)
                                     , 700-721. <a href="https://doi.org/10.1021/acscombsci.8b00113" title="DOI URL">https://doi.org/10.1021/acscombsci.8b00113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.8b00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.8b00113%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DSea%252BUrchin%252BEmbryo%252BModel%252BAs%252Ba%252BReliable%252Bin%252BVivo%252BPhenotypic%252BScreen%252Bto%252BCharacterize%252BSelective%252BAntimitotic%252BMolecules.%252BComparative%252Bevaluation%252Bof%252BCombretapyrazoles%25252C%252B-isoxazoles%25252C%252B-1%25252C2%25252C3-triazoles%25252C%252Band%252B-pyrroles%252Bas%252BTubulin-Binding%252BAgents%26aulast%3DSemenova%26aufirst%3DMarina%2BN.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03082018%26date%3D01112018%26date%3D29112018%26date%3D19112018%26volume%3D20%26issue%3D12%26spage%3D700%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guirong You, Kai Wang, Xiaodan Wang, Guodong Wang, Jian Sun, Guiyun Duan, <span class="NLM_string-name hlFld-ContribAuthor">Chengcai Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Mediated Nickel(II)-Catalyzed C–N Cross-Coupling in Water: Green and Regioselective Access for the Synthesis of Pyrazole-Containing Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (13)
                                     , 4005-4009. <a href="https://doi.org/10.1021/acs.orglett.8b01395" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01395%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Mediated%252BNickel%252528II%252529-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252Bin%252BWater%25253A%252BGreen%252Band%252BRegioselective%252BAccess%252Bfor%252Bthe%252BSynthesis%252Bof%252BPyrazole-Containing%252BCompounds%26aulast%3DYou%26aufirst%3DGuirong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18052018%26date%3D26062018%26volume%3D20%26issue%3D13%26spage%3D4005%26epage%3D4009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinzhe  Shi</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Jean‐François  Soulé</span>, <span class="hlFld-ContribAuthor ">Henri  Doucet</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Direct Diarylation of 2‐Benzyl‐1,2,3‐triazole: a Simple Access to 4‐Aryl‐ or 4,5‐Diaryl‐2‐benzyl‐1,2,3‐triazoles and Phenanthro[9,10‐
              d
              ][1,2,3]triazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (17)
                                     , 2375-2382. <a href="https://doi.org/10.1002/ejoc.202100324" title="DOI URL">https://doi.org/10.1002/ejoc.202100324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100324%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BDirect%252BDiarylation%252Bof%252B2%2525E2%252580%252590Benzyl%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590triazole%25253A%252Ba%252BSimple%252BAccess%252Bto%252B4%2525E2%252580%252590Aryl%2525E2%252580%252590%252Bor%252B4%25252C5%2525E2%252580%252590Diaryl%2525E2%252580%2525902%2525E2%252580%252590benzyl%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590triazoles%252Band%252BPhenanthro%25255B9%25252C10%2525E2%252580%252590%252Bd%252B%25255D%25255B1%25252C2%25252C3%25255Dtriazoles%26aulast%3DShi%26aufirst%3DXinzhe%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D17%26spage%3D2375%26epage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinzhe  Shi</span>, <span class="hlFld-ContribAuthor ">E. Daiann  Sosa Carrizo</span>, <span class="hlFld-ContribAuthor ">Marie  Cordier</span>, <span class="hlFld-ContribAuthor ">Julien  Roger</span>, <span class="hlFld-ContribAuthor ">Nadine  Pirio</span>, <span class="hlFld-ContribAuthor ">Jean‐Cyrille  Hierso</span>, <span class="hlFld-ContribAuthor ">Paul  Fleurat‐Lessard</span>, <span class="hlFld-ContribAuthor ">Jean‐François  Soulé</span>, <span class="hlFld-ContribAuthor ">Henri  Doucet</span>. </span><span class="cited-content_cbyCitation_article-title">C−H Bond Arylation of Pyrazoles at the β‐Position: General Conditions and Computational Elucidation for a High Regioselectivity. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (17)
                                     , 5546-5554. <a href="https://doi.org/10.1002/chem.202100031" title="DOI URL">https://doi.org/10.1002/chem.202100031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100031%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DC%2525E2%252588%252592H%252BBond%252BArylation%252Bof%252BPyrazoles%252Bat%252Bthe%252B%2525CE%2525B2%2525E2%252580%252590Position%25253A%252BGeneral%252BConditions%252Band%252BComputational%252BElucidation%252Bfor%252Ba%252BHigh%252BRegioselectivity%26aulast%3DShi%26aufirst%3DXinzhe%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D17%26spage%3D5546%26epage%3D5554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Fraser</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00039-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00039-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00039-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00039-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C3-Oxadiazoles%26aulast%3DFraser%26aufirst%3DWilliam%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3Dvol.%25206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingli  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Lulu  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhiming  Wang</span>, <span class="hlFld-ContribAuthor ">Pinhua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light Photoredox Catalyzed C−N Coupling of Quinoxaline‐2(1
              H
              )‐ones with Azoles without External Photosensitizer. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (20)
                                     , 5261-5268. <a href="https://doi.org/10.1002/cctc.202000459" title="DOI URL">https://doi.org/10.1002/cctc.202000459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.202000459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.202000459%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DVisible%2525E2%252580%252590Light%252BPhotoredox%252BCatalyzed%252BC%2525E2%252588%252592N%252BCoupling%252Bof%252BQuinoxaline%2525E2%252580%2525902%2525281%252BH%252B%252529%2525E2%252580%252590ones%252Bwith%252BAzoles%252Bwithout%252BExternal%252BPhotosensitizer%26aulast%3DSun%26aufirst%3DMingli%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D20%26spage%3D5261%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garima  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Abhijeet  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Arylpyrazoles: Heterocyclic Scaffold of Immense Therapeutic Application. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>24 </em>
                                    (14)
                                     , 1555-1581. <a href="https://doi.org/10.2174/1570179417999200628035645" title="DOI URL">https://doi.org/10.2174/1570179417999200628035645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179417999200628035645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179417999200628035645%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DArylpyrazoles%25253A%252BHeterocyclic%252BScaffold%252Bof%252BImmense%252BTherapeutic%252BApplication%26aulast%3DTripathi%26aufirst%3DGarima%26date%3D2020%26volume%3D24%26issue%3D14%26spage%3D1555%26epage%3D1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie G.  Barnes</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Parker</span>, <span class="hlFld-ContribAuthor ">Amjed A.  Ahmed Mal Ullah</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Ragazzon</span>, <span class="hlFld-ContribAuthor ">John A.  Hadfield</span>. </span><span class="cited-content_cbyCitation_article-title">A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (19)
                                     , 115684. <a href="https://doi.org/10.1016/j.bmc.2020.115684" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115684%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252B2-step%252Bsynthesis%252Bof%252BCombretastatin%252BA-4%252Band%252Bderivatives%252Bas%252Bpotent%252Btubulin%252Bassembly%252Binhibitors%26aulast%3DBarnes%26aufirst%3DNatalie%2BG.%26date%3D2020%26volume%3D28%26issue%3D19%26spage%3D115684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulina  Pecyna</span>, <span class="hlFld-ContribAuthor ">Joanna  Wargula</span>, <span class="hlFld-ContribAuthor ">Marek  Murias</span>, <span class="hlFld-ContribAuthor ">Malgorzata  Kucinska</span>. </span><span class="cited-content_cbyCitation_article-title">More Than Resveratrol: New Insights into Stilbene-Based Compounds. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1111. <a href="https://doi.org/10.3390/biom10081111" title="DOI URL">https://doi.org/10.3390/biom10081111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10081111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10081111%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMore%252BThan%252BResveratrol%25253A%252BNew%252BInsights%252Binto%252BStilbene-Based%252BCompounds%26aulast%3DPecyna%26aufirst%3DPaulina%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uroš  Grošelj</span>, <span class="hlFld-ContribAuthor ">Jurij  Svete</span>, . </span><span class="cited-content_cbyCitation_article-title">[3 + 2] Cycloadditions of Azomethine Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 529-930. <a href="https://doi.org/10.1002/0471264180.or103.02" title="DOI URL">https://doi.org/10.1002/0471264180.or103.02</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or103.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or103.02%26sid%3Dliteratum%253Aachs%26atitle%3D%25255B3%252B%25252B%252B2%25255D%252BCycloadditions%252Bof%252BAzomethine%252BImines%26aulast%3DGro%25C5%25A1elj%26aufirst%3DUro%25C5%25A1%26date%3D2020%26date%3D2020%26spage%3D529%26epage%3D930%26pub%3DWiley%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Il’ya A.  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Sergey K.  Moiseev</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the chemistry of sydnones and sydnone imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 49-164. <a href="https://doi.org/10.1016/bs.aihch.2019.11.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.11.003%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bchemistry%252Bof%252Bsydnones%252Band%252Bsydnone%252Bimines%26aulast%3DCherepanov%26aufirst%3DIl%25E2%2580%2599ya%2BA.%26date%3D2020%26spage%3D49%26epage%3D164%26pub%3DElsevier%26date%3D2020%26volume%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Egor S.  Zhilin</span>, <span class="hlFld-ContribAuthor ">Dmitry M.  Bystrov</span>, <span class="hlFld-ContribAuthor ">Ivan V.  Ananyev</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>, <span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (63)
                                     , 14284-14289. <a href="https://doi.org/10.1002/chem.201903526" title="DOI URL">https://doi.org/10.1002/chem.201903526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903526%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DStraightforward%252BAccess%252Bto%252Bthe%252BNitric%252BOxide%252BDonor%252BAzasydnone%252BScaffold%252Bby%252BCascade%252BReactions%252Bof%252BAmines%26aulast%3DZhilin%26aufirst%3DEgor%2BS.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D63%26spage%3D14284%26epage%3D14289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Paola  Oliva</span>, <span class="hlFld-ContribAuthor ">Maria Kimatrai  Salvador</span>, <span class="hlFld-ContribAuthor ">Maria Encarnacion  Camacho</span>, <span class="hlFld-ContribAuthor ">Chiara  Padroni</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Salvatore  Ferla</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Roberto  Ronca</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Grillo</span>, <span class="hlFld-ContribAuthor ">Roberta  Bortolozzi</span>, <span class="hlFld-ContribAuthor ">Fatlum  Rruga</span>, <span class="hlFld-ContribAuthor ">Elena  Mariotto</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111577. <a href="https://doi.org/10.1016/j.ejmech.2019.111577" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111577%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bvicinal%252Bdiaryl-substituted%252B1H-Pyrazole%252Banalogues%252Bof%252Bcombretastatin%252BA-4%252Bas%252Bhighly%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DRomagnoli%26aufirst%3DRomeo%26date%3D2019%26volume%3D181%26spage%3D111577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tashrique A.  Khandaker</span>, <span class="hlFld-ContribAuthor ">Jessica D.  Hess</span>, <span class="hlFld-ContribAuthor ">Renato  Aguilera</span>, <span class="hlFld-ContribAuthor ">Graciela  Andrei</span>, <span class="hlFld-ContribAuthor ">Robert  Snoeck</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Padmanava  Pradhan</span>, <span class="hlFld-ContribAuthor ">Mahesh K.  Lakshman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluations of “1,4‐Triazolyl Combretacoumarins” and Desmethoxy Analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (33)
                                     , 5610-5623. <a href="https://doi.org/10.1002/ejoc.201900569" title="DOI URL">https://doi.org/10.1002/ejoc.201900569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900569%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluations%252Bof%252B%2525E2%252580%25259C1%25252C4%2525E2%252580%252590Triazolyl%252BCombretacoumarins%2525E2%252580%25259D%252Band%252BDesmethoxy%252BAnalogs%26aulast%3DKhandaker%26aufirst%3DTashrique%2BA.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D33%26spage%3D5610%26epage%3D5623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-Hong  Hsiao</span>, <span class="hlFld-ContribAuthor ">Ching-Chun  Tseng</span>, <span class="hlFld-ContribAuthor ">Jia-Jun  Xie</span>, <span class="hlFld-ContribAuthor ">Shuo-En  Tsai</span>, <span class="hlFld-ContribAuthor ">Naoto  Uramaru</span>, <span class="hlFld-ContribAuthor ">Ching-Ya  Lin</span>, <span class="hlFld-ContribAuthor ">Ching-Yuh  Chern</span>, <span class="hlFld-ContribAuthor ">Fung Fuh  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective synthesis of functionalized pyrazoles from 5-amino-1H-pyrazole-4-carbaldehydes with sodium nitrite: 5-Amino-4-nitrosopyrazoles and pyrazole-4-carbaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (33)
                                     , 4561-4569. <a href="https://doi.org/10.1016/j.tet.2019.06.048" title="DOI URL">https://doi.org/10.1016/j.tet.2019.06.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.06.048%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSelective%252Bsynthesis%252Bof%252Bfunctionalized%252Bpyrazoles%252Bfrom%252B5-amino-1H-pyrazole-4-carbaldehydes%252Bwith%252Bsodium%252Bnitrite%25253A%252B5-Amino-4-nitrosopyrazoles%252Band%252Bpyrazole-4-carbaldehydes%26aulast%3DHsiao%26aufirst%3DRong-Hong%26date%3D2019%26volume%3D75%26issue%3D33%26spage%3D4561%26epage%3D4569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitry V.  Tsyganov</span>, <span class="hlFld-ContribAuthor ">Marina N.  Semenova</span>, <span class="hlFld-ContribAuthor ">Leonid D.  Konyushkin</span>, <span class="hlFld-ContribAuthor ">Vladimir I.  Ushkarov</span>, <span class="hlFld-ContribAuthor ">Mikhail M.  Raihstat</span>, <span class="hlFld-ContribAuthor ">Victor V.  Semenov</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient synthesis of cis-restricted combretastatin analogues with pyrazole and isoxazole cores. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2019,</strong> <em>29 </em>
                                    (2)
                                     , 163-165. <a href="https://doi.org/10.1016/j.mencom.2019.03.015" title="DOI URL">https://doi.org/10.1016/j.mencom.2019.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2019.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DA%252Bconvenient%252Bsynthesis%252Bof%252Bcis-restricted%252Bcombretastatin%252Banalogues%252Bwith%252Bpyrazole%252Band%252Bisoxazole%252Bcores%26aulast%3DTsyganov%26aufirst%3DDmitry%2BV.%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D163%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Ramajayam</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of vicinal diaryl scaffold: A mini review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 1-17. <a href="https://doi.org/10.1016/j.ejmech.2018.10.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bof%252Bvicinal%252Bdiaryl%252Bscaffold%25253A%252BA%252Bmini%252Breview%26aulast%3DRamajayam%26aufirst%3DR.%26date%3D2019%26volume%3D162%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Brown</span>, <span class="hlFld-ContribAuthor ">Toby  Holmes</span>, <span class="hlFld-ContribAuthor ">Matthew  Fisher</span>, <span class="hlFld-ContribAuthor ">Gillian M.  Tozer</span>, <span class="hlFld-ContribAuthor ">Joseph P. A.  Harrity</span>, <span class="hlFld-ContribAuthor ">Chryso  Kanthou</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (24)
                                     , 2618-2626. <a href="https://doi.org/10.1002/cmdc.201800567" title="DOI URL">https://doi.org/10.1002/cmdc.201800567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800567%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DEvaluation%252Bof%252BSydnone-Based%252BAnalogues%252Bof%252BCombretastatin%252BA-4%252BPhosphate%252B%252528CA4P%252529%252Bas%252BVascular%252BDisrupting%252BAgents%252Bfor%252BUse%252Bin%252BCancer%252BTherapy%26aulast%3DBrown%26aufirst%3DAndrew%2BW.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D24%26spage%3D2618%26epage%3D2626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Taneja</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Peddinti</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free direct
              C
              -arylation of 1,3-dicarbonyl compounds and ethyl cyanoacetate: a platform to access diverse arrays of
              meta
              -functionalized phenols. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (81)
                                     , 11423-11426. <a href="https://doi.org/10.1039/C8CC06235H" title="DOI URL">https://doi.org/10.1039/C8CC06235H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC06235H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC06235H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DMetal-free%252Bdirect%252BC%252B-arylation%252Bof%252B1%25252C3-dicarbonyl%252Bcompounds%252Band%252Bethyl%252Bcyanoacetate%25253A%252Ba%252Bplatform%252Bto%252Baccess%252Bdiverse%252Barrays%252Bof%252Bmeta%252B-functionalized%252Bphenols%26aulast%3DTaneja%26aufirst%3DNeha%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D81%26spage%3D11423%26epage%3D11426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinhuai  Lai</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Ruixue  Wang</span>, <span class="hlFld-ContribAuthor ">Weirong  Lai</span>, <span class="hlFld-ContribAuthor ">Liangze  Tang</span>, <span class="hlFld-ContribAuthor ">Yiran  Tao</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Ruirui  Zhang</span>, <span class="hlFld-ContribAuthor ">Luyi  Huang</span>, <span class="hlFld-ContribAuthor ">Haotian  Xiang</span>, <span class="hlFld-ContribAuthor ">Shaoxue  Zeng</span>, <span class="hlFld-ContribAuthor ">Lantu  Gou</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Yuqin  Yao</span>, <span class="hlFld-ContribAuthor ">Jinliang  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 162-179. <a href="https://doi.org/10.1016/j.ejmech.2018.05.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Btubulin%252Binhibitor%252B7a3%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%26aulast%3DLai%26aufirst%3DQinhuai%26date%3D2018%26volume%3D156%26spage%3D162%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tyll  Freese</span>, <span class="hlFld-ContribAuthor ">Ana-Luiza  Lücke</span>, <span class="hlFld-ContribAuthor ">Jan C.  Namyslo</span>, <span class="hlFld-ContribAuthor ">Martin  Nieger</span>, <span class="hlFld-ContribAuthor ">Andreas  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocycle Syntheses with Anionic N-Heterocyclic Carbenes: Ring Transformations of Sydnone Imine Anions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (14)
                                     , 1646-1654. <a href="https://doi.org/10.1002/ejoc.201800028" title="DOI URL">https://doi.org/10.1002/ejoc.201800028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHeterocycle%252BSyntheses%252Bwith%252BAnionic%252BN-Heterocyclic%252BCarbenes%25253A%252BRing%252BTransformations%252Bof%252BSydnone%252BImine%252BAnions%26aulast%3DFreese%26aufirst%3DTyll%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D14%26spage%3D1646%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in the Chemistry of Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 55-107. <a href="https://doi.org/10.1016/bs.aihch.2018.02.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bin%252Bthe%252BChemistry%252Bof%252BPyrazoles%26aulast%3DBrown%26aufirst%3DAndrew%2BW.%26date%3D2018%26spage%3D55%26epage%3D107%26pub%3DElsevier%26date%3D2018%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farida  Tripodi</span>, <span class="hlFld-ContribAuthor ">Federico  Dapiaggi</span>, <span class="hlFld-ContribAuthor ">Fulvia  Orsini</span>, <span class="hlFld-ContribAuthor ">Roberto  Pagliarin</span>, <span class="hlFld-ContribAuthor ">Guido  Sello</span>, <span class="hlFld-ContribAuthor ">Paola  Coccetti</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 843-852. <a href="https://doi.org/10.1039/C8MD00147B" title="DOI URL">https://doi.org/10.1039/C8MD00147B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00147B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00147B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B3-amino-2-azetidinone%252Bderivatives%252Bas%252Banti-colorectal%252Bcancer%252Bagents%26aulast%3DTripodi%26aufirst%3DFarida%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D5%26spage%3D843%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Hladíková</span>, <span class="hlFld-ContribAuthor ">Jiří  Váňa</span>, <span class="hlFld-ContribAuthor ">Jiří  Hanusek</span>. </span><span class="cited-content_cbyCitation_article-title">[3 + 2]-Cycloaddition reaction of sydnones with alkynes. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 1317-1348. <a href="https://doi.org/10.3762/bjoc.14.113" title="DOI URL">https://doi.org/10.3762/bjoc.14.113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.113%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%25255B3%252B%25252B%252B2%25255D-Cycloaddition%252Breaction%252Bof%252Bsydnones%252Bwith%252Balkynes%26aulast%3DHlad%25C3%25ADkov%25C3%25A1%26aufirst%3DVeronika%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D1317%26epage%3D1348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Ru  Liang</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Ming-Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6623-6634. <a href="https://doi.org/10.1016/j.bmc.2017.10.045" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bhydantoin%252Bbridged%252Banalogues%252Bof%252Bcombretastatin%252BA-4%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DZhang%26aufirst%3DMao%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6623%26epage%3D6634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qile  Xu</span>, <span class="hlFld-ContribAuthor ">Kai  Bao</span>, <span class="hlFld-ContribAuthor ">Maolin  Sun</span>, <span class="hlFld-ContribAuthor ">Jingwen  Xu</span>, <span class="hlFld-ContribAuthor ">Yueting  Wang</span>, <span class="hlFld-ContribAuthor ">Haiqiu  Tian</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Qi  Guan</span>, <span class="hlFld-ContribAuthor ">Yingliang  Wu</span>, <span class="hlFld-ContribAuthor ">Weige  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-10860-7" title="DOI URL">https://doi.org/10.1038/s41598-017-10860-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-10860-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-10860-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationship%252Bof%252B3%25252C6-diaryl-7H-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B3%25252C4-b%25255D%25255B1%25252C3%25252C4%25255Dthiadiazines%252Bas%252Bnovel%252Btubulin%252Binhibitors%26aulast%3DXu%26aufirst%3DQile%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Ling  Fu</span>, <span class="hlFld-ContribAuthor ">Ying-Chao  Liu</span>, <span class="hlFld-ContribAuthor ">Jun-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Bing-Kai  Han</span>, <span class="hlFld-ContribAuthor ">Xiao-Rui  Li</span>, <span class="hlFld-ContribAuthor ">Chuang  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Song</span>, <span class="hlFld-ContribAuthor ">Bing  Zhao</span>, <span class="hlFld-ContribAuthor ">Ruo-Wang  Mao</span>, <span class="hlFld-ContribAuthor ">Ruo-Han  Zhao</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-12912-4" title="DOI URL">https://doi.org/10.1038/s41598-017-12912-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-12912-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-12912-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStructure-Activity%252BRelationship%252BStudies%252Bof%252B%2525CE%2525B2-Lactam-azide%252BAnalogues%252Bas%252BOrally%252BActive%252BAntitumor%252BAgents%252BTargeting%252Bthe%252BTubulin%252BColchicine%252BSite%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anver Basha  Shaik</span>, <span class="hlFld-ContribAuthor ">Garikapati Koteswara  Rao</span>, <span class="hlFld-ContribAuthor ">G. Bharath  Kumar</span>, <span class="hlFld-ContribAuthor ">Nibeditha  Patel</span>, <span class="hlFld-ContribAuthor ">Vangala Santhosh  Reddy</span>, <span class="hlFld-ContribAuthor ">Irfan  Khan</span>, <span class="hlFld-ContribAuthor ">Sunitha Rani  Routhu</span>, <span class="hlFld-ContribAuthor ">C. Ganesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Immadi  Veena</span>, <span class="hlFld-ContribAuthor ">Kunta  Chandra Shekar</span>, <span class="hlFld-ContribAuthor ">Madan  Barkume</span>, <span class="hlFld-ContribAuthor ">Shailesh  Jadhav</span>, <span class="hlFld-ContribAuthor ">Aarti  Juvekar</span>, <span class="hlFld-ContribAuthor ">Jyoti  Kode</span>, <span class="hlFld-ContribAuthor ">Manika  Pal-Bhadra</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 305-324. <a href="https://doi.org/10.1016/j.ejmech.2017.07.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazolochalcones%252Bas%252Bpotential%252Bmodulators%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bpathway%252Band%252Binducers%252Bof%252Bapoptosis%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DShaik%26aufirst%3DAnver%2BBasha%26date%3D2017%26volume%3D139%26spage%3D305%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Pervaram</span>, <span class="hlFld-ContribAuthor ">D.  Ashok</span>, <span class="hlFld-ContribAuthor ">B. A.  Rao</span>, <span class="hlFld-ContribAuthor ">M.  Sarasija</span>, <span class="hlFld-ContribAuthor ">C. V. R.  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new 1,2,3-triazole-pyrazole hybrids as antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2017,</strong> <em>87 </em>
                                    (10)
                                     , 2454-2461. <a href="https://doi.org/10.1134/S1070363217100280" title="DOI URL">https://doi.org/10.1134/S1070363217100280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363217100280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363217100280%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252B1%25252C2%25252C3-triazole-pyrazole%252Bhybrids%252Bas%252Bantimicrobial%252Bagents%26aulast%3DPervaram%26aufirst%3DS.%26date%3D2017%26date%3D2017%26volume%3D87%26issue%3D10%26spage%3D2454%26epage%3D2461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.W.  Brown</span>, <span class="hlFld-ContribAuthor ">J.P.A.  Harrity</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding available pyrazole substitution patterns by sydnone cycloaddition reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (22)
                                     , 3160-3172. <a href="https://doi.org/10.1016/j.tet.2017.04.049" title="DOI URL">https://doi.org/10.1016/j.tet.2017.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DExpanding%252Bavailable%252Bpyrazole%252Bsubstitution%252Bpatterns%252Bby%252Bsydnone%252Bcycloaddition%252Breactions%26aulast%3DBrown%26aufirst%3DA.W.%26date%3D2017%26volume%3D73%26issue%3D22%26spage%3D3160%26epage%3D3172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Brown</span>, <span class="hlFld-ContribAuthor ">Júlia  Comas-Barceló</span>, <span class="hlFld-ContribAuthor ">Joseph P. A.  Harrity</span>. </span><span class="cited-content_cbyCitation_article-title">A Mild and Regiospecific Synthesis of Pyrazoleboranes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (22)
                                     , 5228-5231. <a href="https://doi.org/10.1002/chem.201701019" title="DOI URL">https://doi.org/10.1002/chem.201701019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201701019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201701019%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BMild%252Band%252BRegiospecific%252BSynthesis%252Bof%252BPyrazoleboranes%26aulast%3DBrown%26aufirst%3DAndrew%2BW.%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D22%26spage%3D5228%26epage%3D5231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay A.  Zefirov</span>, <span class="hlFld-ContribAuthor ">Olga N.  Zefirova</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocycles as classical and nonclassical ring B isosters in combretastatin A-4. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (3)
                                     , 273-280. <a href="https://doi.org/10.1007/s10593-017-2049-1" title="DOI URL">https://doi.org/10.1007/s10593-017-2049-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2049-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DHeterocycles%252Bas%252Bclassical%252Band%252Bnonclassical%252Bring%252BB%252Bisosters%252Bin%252Bcombretastatin%252BA-4%26aulast%3DZefirov%26aufirst%3DNikolay%2BA.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D3%26spage%3D273%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Wang</span>, <span class="hlFld-ContribAuthor ">Lailiang  Qu</span>, <span class="hlFld-ContribAuthor ">Shengnan  Xu</span>, <span class="hlFld-ContribAuthor ">Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Ruoqian  Xie</span>, <span class="hlFld-ContribAuthor ">Mengxing  Huang</span>, <span class="hlFld-ContribAuthor ">Yanbing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, antibacterial and insecticidal activities of novel N-phenylpyrazole fraxinellone hybrid compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (19)
                                     , 11796-11802. <a href="https://doi.org/10.1039/C6RA28064A" title="DOI URL">https://doi.org/10.1039/C6RA28064A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA28064A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA28064A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bantibacterial%252Band%252Binsecticidal%252Bactivities%252Bof%252Bnovel%252BN-phenylpyrazole%252Bfraxinellone%252Bhybrid%252Bcompounds%26aulast%3DGuo%26aufirst%3DYong%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D19%26spage%3D11796%26epage%3D11802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elodie  Decuypère</span>, <span class="hlFld-ContribAuthor ">Lucie  Plougastel</span>, <span class="hlFld-ContribAuthor ">Davide  Audisio</span>, <span class="hlFld-ContribAuthor ">Frédéric  Taran</span>. </span><span class="cited-content_cbyCitation_article-title">Sydnone–alkyne cycloaddition: applications in synthesis and bioconjugation. </span><span class="cited-content_cbyCitation_journal-name">Chem. Commun.</span><span> <strong>2017,</strong> <em>53 </em>
                                    (84)
                                     , 11515-11527. <a href="https://doi.org/10.1039/C7CC06405E" title="DOI URL">https://doi.org/10.1039/C7CC06405E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC06405E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC06405E%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Commun.%26atitle%3DSydnone%2525E2%252580%252593alkyne%252Bcycloaddition%25253A%252Bapplications%252Bin%252Bsynthesis%252Band%252Bbioconjugation%26aulast%3DDecuyp%25C3%25A8re%26aufirst%3DElodie%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D84%26spage%3D11515%26epage%3D11527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zaki S.  Seddigi</span>, <span class="hlFld-ContribAuthor ">M. Shaheer  Malik</span>, <span class="hlFld-ContribAuthor ">A Prasanth  Saraswati</span>, <span class="hlFld-ContribAuthor ">Saleh A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ahmed O.  Babalghith</span>, <span class="hlFld-ContribAuthor ">Hawazen A.  Lamfon</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1592-1603. <a href="https://doi.org/10.1039/C7MD00227K" title="DOI URL">https://doi.org/10.1039/C7MD00227K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00227K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00227K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bcombretastatin%252Bbased%252Bderivatives%252Band%252Bprodrugs%252Bas%252Bantimitotic%252Bagents%26aulast%3DSeddigi%26aufirst%3DZaki%2BS.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D8%26spage%3D1592%26epage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Tubulin-binding VDAs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Sydnone Cycloaddition Strategy to Pyrazole-Based Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Strategy for the Synthesis of 1,5-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrazole <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrazole <b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Strategy for the Synthesis of 4,5-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 4,5-Disubstituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Strategy for the Synthesis of 3,4-Disubstituted Pyrazoles</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 3,4-Disubstituted Analogs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0020.jpeg" id="rightTab-GRAPHIC-d7e665-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Most active pyrazole analogs from initial screen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Drug effects on HUVEC cytoskeletal structures. Cells were treated with a single dose of either vehicle (A, B), 250 nM CA4P (C, D), 1 μM colchicine (E, F), 250 nM drug <b>5</b> (G, H), or 250 nM drug <b>31</b> (I, J). Drug treatments were for 30 min with CA4P, drug <b>5</b>, and drug <b>31</b> and 90 min with colchicine. Cells were fixed and stained with an antibody to β-tubulin (A, C, E, G, I) and F-actin (B, D, F, H, J) and nuclei stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Recovery of cytoskeletal structures after drug removal. HUVECs were treated with a single dose of 250 nM CA4P (A, B), 1 μM colchicine (C–F), 250 nM drug <b>5</b> (G, H), or 250 nM drug <b>31</b> (I–L). Drug treatments were for 30 min. Cells were then washed with serum containing medium and allowed to recover for 60 min (A–D, G–J) or 120 min (E, F, K, L). Cells were fixed and stained with an antibody to β-tubulin (A, C, E, G, I, K) and F-actin (B, D, F, H, J, L) and nuclei stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Drug-induced induction of phosphorylation of Rho kinase target MLC. HUVECs were treated with increasing concentrations of CA4P or drug <b>31</b> for 15 min after which proteins were extracted and analyzed for phosphorylation of ROCK target MLC (pMLC) by Western blotting using an antibody specific to the phosphorylated form of the protein (A). Immunoblots were reprobed with an antibody to actin to confirm equal loading. In part B, pMLC band intensities were analyzed by ImageJ and results expressed as fold-change over control cells treated with vehicle alone. Each column represents the mean of 3–4 independent cell culture experiments ± SEM. ∗ represents <i>P</i> < 0.05 for the significance of differences between drug treatment groups and controls (one-way ANOVA followed by a Tukey post-test). In C, HUVECs were incubated with Rho kinase inhibitor Y-27632 (5 μM) for 5 min and then treated with 500 nM drug <b>31</b> for 15 min. Proteins were extracted and analyzed for pMLC as in part A.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Drug-induced changes in endothelial monolayer permeability comparing CA4P and <b>31</b>. Confluent monolayers of cells grown on microporous filter inserts were treated with vehicle control, CA4P (50 nM, 30 min), or compound <b>31</b> (50 nM, 30 min). Drugs were removed and replaced with FITC-dextran for a further 30 min. The passage of FITC-dextran through the monolayer was quantified and expressed as a percentage of FITC that passed through a filter without cells. Results are a mean of three independent experiments ± SEM. ∗∗ represents <i>P</i> < 0.01 and ∗∗∗ represents <i>P</i> < 0.001 for the significance of differences between groups (one-way ANOVA followed by a Tukey post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/medium/jm-2016-011288_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo study of drug-induced effects on tumor cell necrosis comparing CA4P and <b>31</b>. Each point represents the combined data from a single tumor. Five sections (cut at different tumor depths) were analyzed per tumor using a ×20 objective on a Nikon Eclipse TS100 microscope. The total section was analyzed and % necrosis calculated in each field from the relative number of points in a Chalkley eyepiece graticule coincident with necrotic versus viable tumor tissue. Bars represent the mean ± SEM of the combined data for each tumor. ∗ represents <i>P</i> < 0.05 for the significance of differences between groups (one-way ANOVA followed by a Tukey post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b01128/20161021/images/large/jm-2016-011288_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01128&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">What is the Evidence That Tumors Are Angiogenesis Dependent?</span> <span class="citation_source-journal">J. of the Natl. Cancer I.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1093/jnci/82.1.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1093%2Fjnci%2F82.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1688381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=4-7&author=J.+Folkman&title=What+is+the+Evidence+That+Tumors+Are+Angiogenesis+Dependent%3F&doi=10.1093%2Fjnci%2F82.1.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DWhat%2520is%2520the%2520Evidence%2520That%2520Tumors%2520Are%2520Angiogenesis%2520Dependent%253F%26jtitle%3DJ.%2520of%2520the%2520Natl.%2520Cancer%2520I.%26date%3D1990%26volume%3D82%26spage%3D4%26epage%3D7%26doi%3D10.1093%2Fjnci%2F82.1.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">Tumour Targeting by Microtubule-Depolymerising Vascular Disrupting Agents</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span><span class="refDoi"> DOI: 10.1517/14728222.11.11.1443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1517%2F14728222.11.11.1443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=18028009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1443-1457&author=C.+Kanthouauthor=G.+M.+Tozer&title=Tumour+Targeting+by+Microtubule-Depolymerising+Vascular+Disrupting+Agents&doi=10.1517%2F14728222.11.11.1443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour targeting by microtubule-depolymerising vascular disrupting agents</span></div><div class="casAuthors">Kanthou, Chryso; Tozer, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1443-1457</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Low mol. wt. vascular disrupting agents of the microtubule depolymerising family cause marked and selective disruption of the established tumor blood vessel network, resulting in tumor cell necrosis.  The combretastatins are members of this family and these, together with several other related compds., have undergone extensive preclin. testing and are now in clin. trials for cancer.  Potentially, vascular disrupting agents can also interfere with angiogenesis and constitute a very promising group of novel cancer drugs.  In vitro anal. of their signalling activities points to the endothelial cytoskeleton as being their major target and a key player in the events that culminate in vascular collapse.  As more of these agents progress into the clin. setting, more research in this area is warranted in order to decipher exact mechanisms responsible for vascular disruption and to understand the reasons for drug selectivity for the tumor vasculature.  This information is essential in order to identify new targets within the tumor vasculature and to improve present therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyG45tAky0W7Vg90H21EOLACvtfcHk0lifMr70og0mSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbnE&md5=08c7e94cddef659fd730c74b86575c55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1443%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DTumour%2520Targeting%2520by%2520Microtubule-Depolymerising%2520Vascular%2520Disrupting%2520Agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1443%26epage%3D1457%26doi%3D10.1517%2F14728222.11.11.1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Baluk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D. M.</span><span> </span><span class="NLM_article-title">Cellular Abnormalities of Blood Vessels as Targets in Cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.gde.2004.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.gde.2004.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=102-111&author=P.+Balukauthor=H.+Hashizumeauthor=D.+M.+McDonald&title=Cellular+Abnormalities+of+Blood+Vessels+as+Targets+in+Cancer&doi=10.1016%2Fj.gde.2004.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2004.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2004.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DBaluk%26aufirst%3DP.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DMcDonald%26aufirst%3DD.%2BM.%26atitle%3DCellular%2520Abnormalities%2520of%2520Blood%2520Vessels%2520as%2520Targets%2520in%2520Cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2005%26volume%3D15%26spage%3D102%26epage%3D111%26doi%3D10.1016%2Fj.gde.2004.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span> </span><span class="NLM_article-title">Disrupting Tumour Blood Vessels</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span><span class="refDoi"> DOI: 10.1038/nrc1628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fnrc1628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=15928673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=423-435&author=G.+M.+Tozerauthor=C.+Kanthouauthor=B.+C.+Baguley&title=Disrupting+Tumour+Blood+Vessels&doi=10.1038%2Fnrc1628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting tumor blood vessels</span></div><div class="casAuthors">Tozer, Gillian M.; Kanthou, Chryso; Baguley, Bruce C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-435</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low-mol.-wt. vascular-disrupting agents (VDAs) cause a pronounced shutdown in blood flow to solid tumors, resulting in extensive tumor-cell necrosis, while they leave the blood flow in normal tissues relatively intact.  The largest group of VDAs is the tubulin-binding combretastatins, several of which are now being tested in clin. trials.  DMXAA (5,6-dimethylxanthenone-4-acetic acid) - one of a structurally distinct group of drugs - is also being tested in clin. trials.  A full understanding of the action of these and other VDAs will provide insights into mechanisms that control tumor blood flow and will be the basis for the development of new therapeutic drugs for targeting the established tumor vasculature for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjdnxmo6H1JrVg90H21EOLACvtfcHk0lhe_YRFKjfJ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gmsr0%253D&md5=869e9f19ba4b9b82b166b39f089e003b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1628%26sid%3Dliteratum%253Aachs%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26atitle%3DDisrupting%2520Tumour%2520Blood%2520Vessels%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D423%26epage%3D435%26doi%3D10.1038%2Fnrc1628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Boyland, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyland, M. E.</span><span> </span><span class="NLM_article-title">Studies in Tissue Metabolism: the Action of Colchicine and B Typhosus Extract</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1937</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1042/bj0310454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1042%2Fbj0310454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1937&pages=454-460&author=E.+Boylandauthor=M.+E.+Boyland&title=Studies+in+Tissue+Metabolism%3A+the+Action+of+Colchicine+and+B+Typhosus+Extract&doi=10.1042%2Fbj0310454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1042%2Fbj0310454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj0310454%26sid%3Dliteratum%253Aachs%26aulast%3DBoyland%26aufirst%3DE.%26aulast%3DBoyland%26aufirst%3DM.%2BE.%26atitle%3DStudies%2520in%2520Tissue%2520Metabolism%253A%2520the%2520Action%2520of%2520Colchicine%2520and%2520B%2520Typhosus%2520Extract%26jtitle%3DBiochem.%2520J.%26date%3D1937%26volume%3D31%26spage%3D454%26epage%3D460%26doi%3D10.1042%2Fbj0310454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ludford, R. J.</span><span> </span><span class="NLM_article-title">Factors Determining the Action of Colchicine on Tumour Growth</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1038/bjc.1948.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fbjc.1948.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=18863732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaG3cXksVCjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1948&pages=75-86&author=R.+J.+Ludford&title=Factors+Determining+the+Action+of+Colchicine+on+Tumour+Growth&doi=10.1038%2Fbjc.1948.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Factors determining the action of colchicine on tumor growth</span></div><div class="casAuthors">Ludford, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1948</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-86</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">cf. C.A. 40, 7398.7  Treating mice, bearing rapidly growing transplanted tumors, with colchicine (I) in doses just below lethal (a total of 0.13 mg.) caused regression of the tumors; 50 days after transplanting, the tumors of treated mice were approx. the same size as tumors in controls after 30 days.  Factors influencing the effect of I were: age (young adults tolerated larger doses, thus effecting the greatest regression of tumor growth), the genetic constitution of the mice which detd. the max. dose tolerated, and the sensitivity of the tumor capillaries to the action of I.  The cumulative toxic effect of I limited repeated application at short intervals.  Soft highly cellular, rapidly growing tumors responded best but this effect decreased after several large doses of I.  The degree of regression was dependent on the extent of the hemorrhage induced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuDC3D-AEArVg90H21EOLACvtfcHk0lhe_YRFKjfJ8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3cXksVCjsQ%253D%253D&md5=c6bcb3ccc41f4f50a5a74a5015925308</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1948.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1948.10%26sid%3Dliteratum%253Aachs%26aulast%3DLudford%26aufirst%3DR.%2BJ.%26atitle%3DFactors%2520Determining%2520the%2520Action%2520of%2520Colchicine%2520on%2520Tumour%2520Growth%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1948%26volume%3D2%26spage%3D75%26epage%3D86%26doi%3D10.1038%2Fbjc.1948.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Antineoplastic Agents, 122. Constituents of Combretum Caffrum</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1021/np50051a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50051a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1987&pages=386-391&author=G.+R.+Pettitauthor=G.+M.+Craggauthor=S.+B.+Singh&title=Antineoplastic+Agents%2C+122.+Constituents+of+Combretum+Caffrum&doi=10.1021%2Fnp50051a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fnp50051a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50051a008%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DAntineoplastic%2520Agents%252C%2520122.%2520Constituents%2520of%2520Combretum%2520Caffrum%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1987%26volume%3D50%26spage%3D386%26epage%3D391%26doi%3D10.1021%2Fnp50051a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempcy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Interactions of Tubulin with Potent Natural and Synthetic Analogs of the Antimitotic Agent Combretastatin: A Structure-Activity Study</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=3412321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaL1MXmvV2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1988&pages=200-208&author=C.+M.+Linauthor=S.+B.+Singhauthor=P.+S.+Chuauthor=R.+O.+Dempcyauthor=J.+M.+Schmidtauthor=G.+R.+Pettitauthor=E.+Hamel&title=Interactions+of+Tubulin+with+Potent+Natural+and+Synthetic+Analogs+of+the+Antimitotic+Agent+Combretastatin%3A+A+Structure-Activity+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin:  a structure-activity study</span></div><div class="casAuthors">Lin, Chii M.; Singh, Sheo B.; Chu, Ping S.; Dempcy, Robert O.; Schmidt, Jean M.; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Available analogs (17 natural products and 22 synthetic agents) of combretastatin, an antineoplastic drug isolated from the bark of Combretum caffrum, were examd. for antimitotic and cytotoxic activity and for effects on tubulin polymn. and colchicine binding.  Nineteen compds. inhibited cell growth by 50% or more at concns. of 1 μM or less, and 14 inhibited tubulin polymn. by at least 50% at stoichiometric drug concns.  The most potent cytotoxic agents strongly inhibited both tubulin polymn. and the binding of colchicine to tubulin.  The most promising compd. is the (cis)-stilbene deriv. (cis)-1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene (I), which has been named combretastatin A-4.  This compd. inhibited cell growth by 50% at 7 nM, inhibited tubulin polymn. by 50% at 2.5 μM (1/4 molar equivalent), and competitively inhibited colchicine binding with an apparent Ki of 0.14 μM.  The structure-activity relationship of these compds. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZPVoqLHv4TLVg90H21EOLACvtfcHk0lj0ETlNhAtT3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmvV2muw%253D%253D&md5=fa7b749542431a3bd0f593e93d11f028</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DChu%26aufirst%3DP.%2BS.%26aulast%3DDempcy%26aufirst%3DR.%2BO.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DInteractions%2520of%2520Tubulin%2520with%2520Potent%2520Natural%2520and%2520Synthetic%2520Analogs%2520of%2520the%2520Antimitotic%2520Agent%2520Combretastatin%253A%2520A%2520Structure-Activity%2520Study%26jtitle%3DMol.%2520Pharmacol.%26date%3D1988%26volume%3D34%26spage%3D200%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkins, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span> </span><span class="NLM_article-title">Antivascular Approaches to Solid Tumour Therapy: Evaluation of Tubulin Binding Agents</span> <span class="citation_source-journal">Br. J. Cancer. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S86</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=S86-S88&author=D.+J.+Chaplinauthor=G.+R.+Pettitauthor=C.+S.+Parkinsauthor=S.+A.+Hill&title=Antivascular+Approaches+to+Solid+Tumour+Therapy%3A+Evaluation+of+Tubulin+Binding+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DParkins%26aufirst%3DC.%2BS.%26aulast%3DHill%26aufirst%3DS.%2BA.%26atitle%3DAntivascular%2520Approaches%2520to%2520Solid%2520Tumour%2520Therapy%253A%2520Evaluation%2520of%2520Tubulin%2520Binding%2520Agents%26jtitle%3DBr.%2520J.%2520Cancer.%2520Suppl.%26date%3D1996%26volume%3D27%26spage%3DS86%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dark, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prise, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span> </span><span class="NLM_article-title">Combretastatin A-4, an Agent That Displays Potent and Selective Toxicity toward Tumor Vasculature</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=9157969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1829-1834&author=G.+G.+Darkauthor=S.+A.+Hillauthor=V.+E.+Priseauthor=G.+M.+Tozerauthor=G.+R.+Pettitauthor=D.+J.+Chaplin&title=Combretastatin+A-4%2C+an+Agent+That+Displays+Potent+and+Selective+Toxicity+toward+Tumor+Vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature</span></div><div class="casAuthors">Dark, Graham G.; Hill, Sally A.; Prise, Vivien E.; Tozer, Gillian M.; Pettit, George R.; Chaplin, Dai J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1829-1834</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Selective induction of vascular damage within tumors represents an emerging approach to cancer treatment.  Histol. studies have shown that several tubulin-binding agents can induce vascular damage within tumors but only at doses approximating the max. tolerated dose, which has limited their clin. applicability.  In this study, we show that the combretastatin A-4 prodrug induces vascular shutdown within tumors at doses less than one-tenth of the max. tolerated dose.  In vitro studies indicate that a short drug exposure results in profound long-term antiproliferative/cytotoxic effects against proliferating endothelial cells but not cells that are quiescent prior to and during drug exposure.  Vascular shutdown, within exptl. and human breast cancer models in vivo following systemic drug administration, was demonstrated with a redn. in functional vascular vol. of 93% at 6 h following drug administration and persisted over the next 12 h, with corresponding histol. consistent with hemorrhagic necrosis resulting from vascular damage.  The actions against tumor vasculature and the broad therapeutic window demonstrate the clin. potential of these drugs and warrant further study to elucidate the mechanisms responsible for the antivascular effects of combretastatin A-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEdUvgSGIqp7Vg90H21EOLACvtfcHk0lj0ETlNhAtT3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlGnsbk%253D&md5=889e82f6a746aef44c2a28b77135e61f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDark%26aufirst%3DG.%2BG.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DPrise%26aufirst%3DV.%2BE.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26atitle%3DCombretastatin%2520A-4%252C%2520an%2520Agent%2520That%2520Displays%2520Potent%2520and%2520Selective%2520Toxicity%2520toward%2520Tumor%2520Vasculature%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D1829%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rener, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, N.</span><span> </span><span class="NLM_article-title">Antineoplastic Agents 322. Synthesis of Combretastatin A-4 Prodrugs</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=7786396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=299-309&author=G.+R.+Pettitauthor=C.+Templeauthor=V.+L.+Narayananauthor=R.+Varmaauthor=M.+J.+Simpsonauthor=M.+R.+Boydauthor=G.+A.+Renerauthor=N.+Bansal&title=Antineoplastic+Agents+322.+Synthesis+of+Combretastatin+A-4+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs</span></div><div class="casAuthors">Pettit, George R.; Temple, Carroll, Jr.; Narayanan, Ven L.; Varma, Ravi; Simpson, Michael J.; Boyd, Michael R.; Rener, Gregory A.; Bansal, Namita</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drug Design</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-309</span>CODEN:
                <span class="NLM_cas:coden">ACDDEA</span>;
        ISSN:<span class="NLM_cas:issn">0266-9536</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Combretastatin A-4 (I, R = H), the principal cancer cell growth-inhibitory constituent of the Zulu medicinal plant (Combretum caffrum, has been undergoing preclin. development.  However, the very limited water soly. of this phenol has complicated drug formation.  Hence, derivs. of the combretastatin A-4 3'-phenol group were prepd. for evaluation as possible water-sol. prodrugs.  As obsd. for combretastatin A-4, the sodium salt (I, R = Na), potassium salt (I, R = K), and hemisuccinic acid ester (I, R = COCH2CH2CO2H) derivs. were essentially insol. in water.  Indeed, these substances regenerated combretastatin A-4 upon reaction with water.  A series of other simple derivs., e.g. I [R = COCH(NH2)CH2CH2CO2H], proved unsatisfactory in terms of water soly. or stability, or both.  The most sol. derivs. evaluated included the ammonium [I, R = P(O)(OH)ONH4], and potassium [I, R = P(O)(OK)2] and sodium [I, R = P(O)(ONa)2] phosphate salts, where the latter two proved most stable and suitable.  Both the potassium and sodium phosphate derivs. of combretastatin A-4 were also found to exhibit the requisite biol. properties necessary for a useful prodrug.  The sodium phosphate salt was selected for drug formulation and further pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWV9UApN5crVg90H21EOLACvtfcHk0lj0ETlNhAtT3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Wktbs%253D&md5=0a16b2b4db491916a9a742c7af69669a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DVarma%26aufirst%3DR.%26aulast%3DSimpson%26aufirst%3DM.%2BJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26aulast%3DRener%26aufirst%3DG.%2BA.%26aulast%3DBansal%26aufirst%3DN.%26atitle%3DAntineoplastic%2520Agents%2520322.%2520Synthesis%2520of%2520Combretastatin%2520A-4%2520Prodrugs%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1995%26volume%3D10%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McGown, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, B. W.</span><span> </span><span class="NLM_article-title">Structural and Biochemical Comparison of the Anti-Mitotic Agents Colchicine, Combretastatin A4 and Amphethinile</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=249-254&author=A.+T.+McGownauthor=B.+W.+Fox&title=Structural+and+Biochemical+Comparison+of+the+Anti-Mitotic+Agents+Colchicine%2C+Combretastatin+A4+and+Amphethinile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGown%26aufirst%3DA.%2BT.%26aulast%3DFox%26aufirst%3DB.%2BW.%26atitle%3DStructural%2520and%2520Biochemical%2520Comparison%2520of%2520the%2520Anti-Mitotic%2520Agents%2520Colchicine%252C%2520Combretastatin%2520A4%2520and%2520Amphethinile%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D1989%26volume%3D3%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Antimitotic Natural Products Combretastatin A-4 and Combretastatin A-2: Studies on the Mechanism of Their Inhibition of the Binding of Colchicine to Tubulin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">6984</span><span class="NLM_x">–</span> <span class="NLM_lpage">6991</span><span class="refDoi"> DOI: 10.1021/bi00443a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00443a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2ru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=6984-6991&author=C.+M.+Linauthor=H.+H.+Hoauthor=G.+R.+Pettitauthor=E.+Hamel&title=Antimitotic+Natural+Products+Combretastatin+A-4+and+Combretastatin+A-2%3A+Studies+on+the+Mechanism+of+Their+Inhibition+of+the+Binding+of+Colchicine+to+Tubulin&doi=10.1021%2Fbi00443a031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic natural products combretastatin A-4 and combretastatin A-2:  studies on the mechanism of their inhibition of the binding of colchicine to tubulin</span></div><div class="casAuthors">Lin, Chii M.; Ho, Holly H.; Pettit, George R.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6984-91</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The mechanism of the binding of combretastatin A-4 (CS-A4) and combretastatin A-2 (CS-A2), isolated from Combretum caffrum, to tubulin was examd. indirectly by evaluating their effects on the binding of radiolabeled colchicine to the protein.  There was rapid binding of both compds. to tubulin even at 0° (binding was complete at the earliest times examd.), in contrast to the relatively slow and temp.-dependent binding of colchicine.  Although the binding of the C. caffrum compds. to tubulin was quite tight, permitting ready isolation of near-stoichiometric amts. of drug-tubulin complex even in the absence of free drug, both CS-A4 and CS-A2 dissocd. rapidly from tubulin in the presence of high concns. of radiolabeled colchicine.  Apparent rate consts. for drug dissocn. from tubulin at 37° were 3.2 × 10-3/s for CS-A4, 4.8 × 10-3/s for CS-A2, and 2.9 × 10-5/s for colchicine (half-lives of 3.6, 2.4, and 405 min, resp.).  Thus, the effectiveness of the C. caffrum compds. as antimitotic agents appears to derive primarily from the rapidity of their binding to tubulin.  A new model for the colchicine binding site on tubulin is proposed which envisages A-ring and C-ring subsites in homologous locations on the 2 tubulin subunits, with Ph rings binding as well as or better than the tropolone ring of colchicine in the C-ring subsite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBVM6YQr13WbVg90H21EOLACvtfcHk0limWtXUHz8r-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2ru78%253D&md5=4fc9bd899f65be38961729d7c51a6b16</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi00443a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00443a031%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHo%26aufirst%3DH.%2BH.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DAntimitotic%2520Natural%2520Products%2520Combretastatin%2520A-4%2520and%2520Combretastatin%2520A-2%253A%2520Studies%2520on%2520the%2520Mechanism%2520of%2520Their%2520Inhibition%2520of%2520the%2520Binding%2520of%2520Colchicine%2520to%2520Tubulin%26jtitle%3DBiochemistry%26date%3D1989%26volume%3D28%26spage%3D6984%26epage%3D6991%26doi%3D10.1021%2Fbi00443a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Monk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darus, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tewari, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkissoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aghajanian, C.</span><span> </span><span class="NLM_article-title">Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span><span class="refDoi"> DOI: 10.1200/JCO.2015.65.8153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1200%2FJCO.2015.65.8153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=27217446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGltL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2279-2286&author=B.+J.+Monkauthor=M.+W.+Sillauthor=J.+L.+Walkerauthor=C.+J.+Darusauthor=G.+Suttonauthor=K.+S.+Tewariauthor=L.+P.+Martinauthor=J.+M.+Schilderauthor=R.+L.+Colemanauthor=J.+Balkissoonauthor=C.+Aghajanian&title=Randomized+Phase+II+Evaluation+of+Bevacizumab+Versus+Bevacizumab+Plus+Fosbretabulin+in+Recurrent+Ovarian%2C+Tubal%2C+or+Peritoneal+Carcinoma%3A+An+NRG+Oncology%2FGynecologic+Oncology+Group+Study&doi=10.1200%2FJCO.2015.65.8153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: an NRG oncology/gynecologic oncology group study</span></div><div class="casAuthors">Monk, Bradley J.; Sill, Michael W.; Walker, Joan L.; Darus, Christopher J.; Sutton, Gregory; Tewari, Krishnansu S.; Martin, Lainie P.; Schilder, Jeanne M.; Coleman, Robert L.; Balkissoon, Jai; Aghajanian, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2279-2286</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose The vascular disrupting agent fosbretabulin tromethamine selectively targets pre-existing tumor vasculature, which causes vascular shutdown and leads to cancer cell death and necrosis.  Antiangiogenesis agents such as bevacizumab, a humanized antivascular endothelial growth factor monoclonal antibody, might prevent revascularization during and after treatment with a vascular disrupting agent.  Patients and Methods Patients with recurrent or persistent epithelial ovarian, tubal, or peritoneal carcinoma, measurable or detectable disease, and three or fewer prior regimens were randomly assigned to bevacizumab (15 mg/kg i.v. once every 3 wk) or the combination of bevacizumab (15 mg/kg) plus fosbretabulin (60 mg/m2) i.v. once every 3 wk until disease progression or toxicity.  Randomization was stratified by disease status (measurable v nonmeasurable), prior bevacizumab, and platinum-free interval.  The primary end point was progression-free survival (PFS).  The study was designed with 80% power for a one-sided alternative at a 10% level of significance to detect a redn. in the hazard by 37.5%.  Results The study enrolled 107 patients.  Median PFS was 4.8 mo for bevacizumab and 7.3 mo for bevacizumab plus fosbretabulin (hazard ratio, 0.69; 90% two-sided CI, 0.47 to 1.00; one-sided P =.05).  The proportion responding (overall response rate) to bevacizumab was 28.2% among 39 patients with measurable disease and 35.7% among 42 patients treated with the combination.  The relative probability of responding was 1.27 (90% CI, 0.74 to 2.17; one-sided P =.24).  Adverse events greater than grade 3 were more common in the combination regimen than in bevacizumab only for hypertension (35% v 20%).  There was one grade 3 thromboembolic event in the combination arm and one intestinal fistula in the bevacizumab only arm.  Conclusion On the basis of the PFS, overall response rate, and tolerability of these two antivascular therapies, further evaluation is warranted for this chemotherapy-free regimen.  Fosbretabulin in combination with bevacizumab increases the risk of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5a-7pBzglXbVg90H21EOLACvtfcHk0limWtXUHz8r-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGltL7O&md5=a062b3688fe997b13095ccc2695ff189</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.65.8153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.65.8153%26sid%3Dliteratum%253Aachs%26aulast%3DMonk%26aufirst%3DB.%2BJ.%26aulast%3DSill%26aufirst%3DM.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BL.%26aulast%3DDarus%26aufirst%3DC.%2BJ.%26aulast%3DSutton%26aufirst%3DG.%26aulast%3DTewari%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DL.%2BP.%26aulast%3DSchilder%26aufirst%3DJ.%2BM.%26aulast%3DColeman%26aufirst%3DR.%2BL.%26aulast%3DBalkissoon%26aufirst%3DJ.%26aulast%3DAghajanian%26aufirst%3DC.%26atitle%3DRandomized%2520Phase%2520II%2520Evaluation%2520of%2520Bevacizumab%2520Versus%2520Bevacizumab%2520Plus%2520Fosbretabulin%2520in%2520Recurrent%2520Ovarian%252C%2520Tubal%252C%2520or%2520Peritoneal%2520Carcinoma%253A%2520An%2520NRG%2520Oncology%252FGynecologic%2520Oncology%2520Group%2520Study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D2279%26epage%3D2286%26doi%3D10.1200%2FJCO.2015.65.8153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborti, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Stilbene and Dihydrostilbene Derivatives as Potential Anticancer Agents That Inhibit Tubulin Polymerization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1021/jm00112a036</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a036" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADyaK3MXkvFWksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2579-2588&author=M.+Cushmanauthor=D.+Nagarathnamauthor=D.+Gopalauthor=A.+K.+Chakrabortiauthor=C.+M.+Linauthor=E.+Hamel&title=Synthesis+and+Evaluation+of+Stilbene+and+Dihydrostilbene+Derivatives+as+Potential+Anticancer+Agents+That+Inhibit+Tubulin+Polymerization&doi=10.1021%2Fjm00112a036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization</span></div><div class="casAuthors">Cushman, Mark; Nagarathnam, Dhanapalan; Gopal, D.; Chakraborti, Asit K.; Lin, Chii M.; Hamel, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2579-88</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">cis- And trans-dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in five cancer cell cultures A-549 lung carcinoma, NCF-7 breast carcinoma, HT-δ colon adenocarcinoma, SKMEL-5 melanoma and MLM melanoma.  Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines, and active as inhibitors of tubulin polymn.  The most active compds. also inhibited the binding of colchicine to tubulin.  The most potent of the new compds., both as a tubulin polymn. inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (I) which was almost as potent as combrestatins A-4, the most active of the combrestatins, as a tubulin polymn. inhibitor.  I was a approx. 140 times more cytotoxic against HT-29:adenocarcinoma cells and about 10 times more cytotoxic against MCF-η breast carcinoma cells than combrestatin A-4, but it was about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against NLM melanoma cells than combrestatin A-4.  The relative potencies for the cis, dihydro, and trans compds., resp., as inhibitors of tubulin polymn. are in agreement with the relative potencies previously obsd. for combretastatin A-Δ, dihydrocombrestatin A-4, and trans-combrestatin A-4.  The relative potencies were also reflected as a result of the cytotoxicity assays.  Structure-activity relationships of this group of compds. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUMaB6teYTTrVg90H21EOLACvtfcHk0lgcSAEhAEq2vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvFWksLc%253D&md5=fe12d2c046d97aa417a1b7ece35d3414</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a036%26sid%3Dliteratum%253Aachs%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DGopal%26aufirst%3DD.%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Stilbene%2520and%2520Dihydrostilbene%2520Derivatives%2520as%2520Potential%2520Anticancer%2520Agents%2520That%2520Inhibit%2520Tubulin%2520Polymerization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2579%26epage%3D2588%26doi%3D10.1021%2Fjm00112a036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ohsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nihei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span> </span><span class="NLM_article-title">Syntheses and Antitumor Activity of Cis-Restricted Combretastatins: 5-Membered Heterocyclic Analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span><span class="refDoi"> DOI: 10.1016/S0960-894X(98)00579-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2FS0960-894X%2898%2900579-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=3153-3158&author=K.+Ohsumiauthor=T.+Hatanakaauthor=K.+Fujitaauthor=R.+Nakagawaauthor=Y.+Fukudaauthor=Y.+Niheiauthor=Y.+Sugaauthor=Y.+Morinagaauthor=Y.+Akiyamaauthor=T.+Tsuji&title=Syntheses+and+Antitumor+Activity+of+Cis-Restricted+Combretastatins%3A+5-Membered+Heterocyclic+Analogues&doi=10.1016%2FS0960-894X%2898%2900579-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2898%2900579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252898%252900579-4%26sid%3Dliteratum%253Aachs%26aulast%3DOhsumi%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DR.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNihei%26aufirst%3DY.%26aulast%3DSuga%26aufirst%3DY.%26aulast%3DMorinaga%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520Antitumor%2520Activity%2520of%2520Cis-Restricted%2520Combretastatins%253A%25205-Membered%2520Heterocyclic%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D3153%26epage%3D3158%26doi%3D10.1016%2FS0960-894X%2898%2900579-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Convergent Synthesis and Biological Evaluation of 2-Amino-4-(3′,4′,5′-trimethoxyphenyl)-5-aryl Thiazoles as Microtubule Targeting Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5144</span><span class="NLM_x">–</span> <span class="NLM_lpage">5153</span><span class="refDoi"> DOI: 10.1021/jm200392p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200392p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVaksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5144-5153&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=A.+Brancaleauthor=A.+Ricciauthor=E.+Hamelauthor=R.+Bortolozziauthor=G.+Bassoauthor=G.+Viola&title=Convergent+Synthesis+and+Biological+Evaluation+of+2-Amino-4-%283%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2-trimethoxyphenyl%29-5-aryl+Thiazoles+as+Microtubule+Targeting+Agents&doi=10.1021%2Fjm200392p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Convergent Synthesis and Biological Evaluation of 2-Amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl Thiazoles as Microtubule Targeting Agents</span></div><div class="casAuthors">Romagnoli, Romeo; Baraldi, Pier Giovanni; Brancale, Andrea; Ricci, Antonio; Hamel, Ernest; Bortolozzi, Roberta; Basso, Giuseppe; Viola, Giampietro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5144-5153</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combretastatin A-4, a potent tubulin polymn. inhibitor, caused us to synthesize a novel series of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles with the goal of evaluating the effects of substituents on the Ph at the 5-position of the thiazole skeleton on biol. activities.  An ethoxy group at the para-position produced the most active compd. in the series, with IC50 values of 0.03-0.9 nM against five of seven cancer cell lines.  The most active compds. retained full activity in multidrug resistant cancer cells and acted through the colchicine site of tubulin.  Treated cells were arrested in the G2/M phase of the cell cycle, with cell death proceeding through an apoptotic pathway that was only partially caspase-dependent.  Preliminary results suggest that, in addn. to cell death by apoptosis, cells were also killed via mitotic catastrophe as an alternative cell death mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphsFMgTMUUn7Vg90H21EOLACvtfcHk0lgcSAEhAEq2vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVaksL0%253D&md5=9bd8f076b8c49a3894cda6c47d8cabb0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm200392p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200392p%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DConvergent%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%25202-Amino-4-%25283%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2-trimethoxyphenyl%2529-5-aryl%2520Thiazoles%2520as%2520Microtubule%2520Targeting%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5144%26epage%3D5153%26doi%3D10.1021%2Fjm200392p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Romagnoli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz-Lopez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez Cara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrion, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolozzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span> </span><span class="NLM_article-title">Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4248</span><span class="NLM_x">–</span> <span class="NLM_lpage">4258</span><span class="refDoi"> DOI: 10.1021/jm100245q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100245q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4248-4258&author=R.+Romagnoliauthor=P.+G.+Baraldiauthor=O.+Cruz-Lopezauthor=C.+Lopez+Caraauthor=M.+D.+Carrionauthor=A.+Brancaleauthor=E.+Hamelauthor=L.+Chenauthor=R.+Bortolozziauthor=G.+Bassoauthor=G.+Viola&title=Synthesis+and+Antitumor+Activity+of+1%2C5-Disubstituted+1%2C2%2C4-Triazoles+as+Cis-Restricted+Combretastatin+Analogues&doi=10.1021%2Fjm100245q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100245q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100245q%26sid%3Dliteratum%253Aachs%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCruz-Lopez%26aufirst%3DO.%26aulast%3DLopez%2BCara%26aufirst%3DC.%26aulast%3DCarrion%26aufirst%3DM.%2BD.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Antitumor%2520Activity%2520of%25201%252C5-Disubstituted%25201%252C2%252C4-Triazoles%2520as%2520Cis-Restricted%2520Combretastatin%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4248%26epage%3D4258%26doi%3D10.1021%2Fjm100245q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallac, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span> </span><span class="NLM_article-title">Evaluation of Tumor Ischemia in Response to an Indole-Based Vascular Disrupting Agent Using BLI and (19)F MRI</span> <span class="citation_source-journal">Am. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=25973335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFSqtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=143-153&author=H.+Zhouauthor=R.+R.+Hallacauthor=R.+Lopezauthor=R.+Denneyauthor=M.+T.+MacDonoughauthor=L.+Liauthor=L.+Liuauthor=E.+E.+Gravesauthor=M.+L.+Trawickauthor=K.+G.+Pinneyauthor=R.+P.+Mason&title=Evaluation+of+Tumor+Ischemia+in+Response+to+an+Indole-Based+Vascular+Disrupting+Agent+Using+BLI+and+%2819%29F+MRI"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and 19F MRI</span></div><div class="casAuthors">Zhou, Heling; Hallac, Rami R.; Lopez, Ramona; Denney, Rebecca; MacDonough, Matthew T.; Li, Li; Liu, Li; Graves, Edward E.; Trawick, Mary Lynn; Pinney, Kevin G.; Mason, Ralph P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-153</span>CODEN:
                <span class="NLM_cas:coden">AJNMAU</span>;
        ISSN:<span class="NLM_cas:issn">2160-8407</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Vascular disrupting agents (VDAs) have been proposed as an effective broad spectrum approach to cancer therapy, by inducing ischemia leading to hypoxia and cell death.  A novel VDA (OXi8007) was recently reported to show rapid acute selective shutdown of tumor vasculature based on color-Doppler ultrasound.  We have now expanded investigations to noninvasively assess perfusion and hypoxiation of orthotopic human MDA-MB-231/luc breast tumor xenografts following the administration of OXi8007 based on dynamic bioluminescence imaging (BLI) and magnetic resonance imaging (MRI).  BLI showed significantly lower signal four hours after the administration of OXi8007, which was very similar to the response to combretastatin A-4P (CA4P), but the effect lasted considerably longer, with the BLI signal remaining depressed at 72 h.  Meanwhile, control tumors exhibited minimal change.  Oximetry used 19F MRI of the reporter mol. hexafluorobenzene and FREDOM (Fluorocarbon Relaxometry using Echo Planar Imaging for Dynamic Oxygen Mapping) to assess pO2 distributions during air and oxygen breathing. pO2 decreased significantly upon the administration of OXi8007 during oxygen breathing (from 122 ± 64 to 34 ± 20 Torr), with further decrease upon switching the gas to air (pO2 = 17 ± 9 Torr). pO2 maps indicated intra-tumor heterogeneity in response to OXi8007, though ultimately all tumor regions became hypoxic.  Both BLI and FREDOM showed the efficacy of OXi8007.  The pO2 changes measured by FREDOM may be crucial for future study of combined therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8JSG6Slq47Vg90H21EOLACvtfcHk0ljC-MIRG-vaYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFSqtL7L&md5=17055d7f2cc929636d5ccf0c0ac7d221</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHallac%26aufirst%3DR.%2BR.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DDenney%26aufirst%3DR.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGraves%26aufirst%3DE.%2BE.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DMason%26aufirst%3DR.%2BP.%26atitle%3DEvaluation%2520of%2520Tumor%2520Ischemia%2520in%2520Response%2520to%2520an%2520Indole-Based%2520Vascular%2520Disrupting%2520Agent%2520Using%2520BLI%2520and%2520%252819%2529F%2520MRI%26jtitle%3DAm.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D5%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zaninetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aprile, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massarotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canonico, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span> </span><span class="NLM_article-title">A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Anti-Tubulin Agents</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1002/cmdc.201200561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fcmdc.201200561" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=633-643&author=R.+Zaninettiauthor=S.+V.+Corteseauthor=S.+Aprileauthor=A.+Massarottiauthor=P.+L.+Canonicoauthor=G.+Sorbaauthor=G.+Grosaauthor=A.+A.+Genazzaniauthor=T.+Pirali&title=A+Concise+Synthesis+of+Pyrazole+Analogues+of+Combretastatin+A1+as+Potent+Anti-Tubulin+Agents&doi=10.1002%2Fcmdc.201200561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200561%26sid%3Dliteratum%253Aachs%26aulast%3DZaninetti%26aufirst%3DR.%26aulast%3DCortese%26aufirst%3DS.%2BV.%26aulast%3DAprile%26aufirst%3DS.%26aulast%3DMassarotti%26aufirst%3DA.%26aulast%3DCanonico%26aufirst%3DP.%2BL.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DGrosa%26aufirst%3DG.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DPirali%26aufirst%3DT.%26atitle%3DA%2520Concise%2520Synthesis%2520of%2520Pyrazole%2520Analogues%2520of%2520Combretastatin%2520A1%2520as%2520Potent%2520Anti-Tubulin%2520Agents%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D633%26epage%3D643%26doi%3D10.1002%2Fcmdc.201200561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hadimani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strecker, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirali, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span> </span><span class="NLM_article-title">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1678</span><span class="refDoi"> DOI: 10.1021/np400374w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400374w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=1668-1678&author=M.+B.+Hadimaniauthor=M.+T.+MacDonoughauthor=A.+Ghatakauthor=T.+E.+Streckerauthor=R.+Lopezauthor=M.+Sriramauthor=B.+L.+Nguyenauthor=J.+J.+Hallauthor=R.+J.+Kesslerauthor=A.+R.+Shiraliauthor=L.+Liuauthor=C.+M.+Garnerauthor=G.+R.+Pettitauthor=E.+Hamelauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=M.+L.+Trawickauthor=K.+G.+Pinney&title=Synthesis+of+a+2-Aryl-3-aroyl+Indole+Salt+%28OXi8007%29+Resembling+Combretastatin+A-4+with+Application+as+a+Vascular+Disrupting+Agent&doi=10.1021%2Fnp400374w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent</span></div><div class="casAuthors">Hadimani, Mallinath B.; MacDonough, Matthew T.; Ghatak, Anjan; Strecker, Tracy E.; Lopez, Ramona; Sriram, Madhavi; Nguyen, Benson L.; Hall, John J.; Kessler, Raymond J.; Shirali, Anupama R.; Liu, Li; Garner, Charles M.; Pettit, George R.; Hamel, Ernest; Chaplin, David J.; Mason, Ralph P.; Trawick, Mary Lynn; Pinney, Kevin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1668-1678</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The natural products colchicine and combretastatin A-4 are potent inhibitors of tubulin assembly, and they have inspired the design and synthesis of a large no. of small-mol., potential anticancer agents.  The indole-based mol. scaffold is prominent among these SAR modifications, leading to a rapidly increasing no. of agents.  The water-sol. phosphate prodrug I [R = P(O)(O-Na+)2] (OXi8007) (II) of 2-aryl-3-aroylindole-based phenol I (R = H) (OXi8006) (III) was prepd. by chem. synthesis and found to be strongly cytotoxic against selected human cancer cell lines (GI50 = 36 nM against DU-145 cells, for example).  The free phenol, III (OXi8006), was a strong inhibitor (IC50 = 1.1 μM) of tubulin assembly.  The corresponding phosphate prodrug II (OXi8007) also demonstrated pronounced interference with tumor vasculature in a preliminary in vivo study utilizing a SCID mouse model bearing an orthotopic PC-3 (prostate) tumor as imaged by color Doppler ultrasound.  The combination of these results provides evidence that the indole-based phosphate prodrug II (OXi8007) functions as a vascular disrupting agent that may prove useful for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPuuWz4Lp4LVg90H21EOLACvtfcHk0ljC-MIRG-vaYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWkur%252FN&md5=d17de0d4667b5565c5715a956549c456</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fnp400374w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400374w%26sid%3Dliteratum%253Aachs%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DMacDonough%26aufirst%3DM.%2BT.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DSriram%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DB.%2BL.%26aulast%3DHall%26aufirst%3DJ.%2BJ.%26aulast%3DKessler%26aufirst%3DR.%2BJ.%26aulast%3DShirali%26aufirst%3DA.%2BR.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGarner%26aufirst%3DC.%2BM.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26atitle%3DSynthesis%2520of%2520a%25202-Aryl-3-aroyl%2520Indole%2520Salt%2520%2528OXi8007%2529%2520Resembling%2520Combretastatin%2520A-4%2520with%2520Application%2520as%2520a%2520Vascular%2520Disrupting%2520Agent%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2013%26volume%3D76%26spage%3D1668%26epage%3D1678%26doi%3D10.1021%2Fnp400374w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tron, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Combretastatin A4: Present and Future Directions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3044</span><span class="refDoi"> DOI: 10.1021/jm0512903</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512903" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3033-3044&author=G.+C.+Tronauthor=T.+Piraliauthor=G.+Sorbaauthor=F.+Pagliaiauthor=S.+Busaccaauthor=A.+A.+Genazzani&title=Medicinal+Chemistry+of+Combretastatin+A4%3A+Present+and+Future+Directions&doi=10.1021%2Fjm0512903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of combretastatin A4: Present and future directions</span></div><div class="casAuthors">Tron, Gian Cesare; Pirali, Tracey; Sorba, Giovanni; Pagliai, Francesca; Busacca, Sara; Genazzani, Armando A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3033-3044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with refs.  A review on the medicinal chem. of combretastatin A4 (CA-4), a compd. with antitumor properties.  The mechanism of action of CA-4, including its ability to inhibit tubulin polymn., is discussed, along with selected analogs of CA-4 modified on the arom. rings A and B, substituted Ph rings, heterocycling rings, non-substituted arom. rings, modifications on the double bond, and analogs where the olefinic group is replaced by a ring.  Some issues related to the pharmacol. of CA-4 and future directions in research are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNHvpiUH4mbVg90H21EOLACvtfcHk0ljcf50dQIZ1FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyjuro%253D&md5=be023d8f1f059f952308bb06196459da</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0512903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512903%26sid%3Dliteratum%253Aachs%26aulast%3DTron%26aufirst%3DG.%2BC.%26aulast%3DPirali%26aufirst%3DT.%26aulast%3DSorba%26aufirst%3DG.%26aulast%3DPagliai%26aufirst%3DF.%26aulast%3DBusacca%26aufirst%3DS.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Combretastatin%2520A4%253A%2520Present%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3033%26epage%3D3044%26doi%3D10.1021%2Fjm0512903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Siebert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gensicka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cholewinski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzierzbicka, K.</span><span> </span><span class="NLM_article-title">Synthesis of Combretastatin A-4 Analogs and their Biological Activities</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.2174/1871520616666160204111832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.2174%2F1871520616666160204111832" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=942-960&author=A.+Siebertauthor=M.+Gensickaauthor=G.+Cholewinskiauthor=K.+Dzierzbicka&title=Synthesis+of+Combretastatin+A-4+Analogs+and+their+Biological+Activities&doi=10.2174%2F1871520616666160204111832"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160204111832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160204111832%26sid%3Dliteratum%253Aachs%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DGensicka%26aufirst%3DM.%26aulast%3DCholewinski%26aufirst%3DG.%26aulast%3DDzierzbicka%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Combretastatin%2520A-4%2520Analogs%2520and%2520their%2520Biological%2520Activities%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D942%26epage%3D960%26doi%3D10.2174%2F1871520616666160204111832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nguyen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermone, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span> </span><span class="NLM_article-title">A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6107</span><span class="NLM_x">–</span> <span class="NLM_lpage">6116</span><span class="refDoi"> DOI: 10.1021/jm050502t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050502t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6107-6116&author=T.+L.+Nguyenauthor=C.+McGrathauthor=A.+R.+Hermoneauthor=J.+C.+Burnettauthor=D.+W.+Zaharevitzauthor=B.+W.+Dayauthor=P.+Wipfauthor=E.+Hamelauthor=R.+Gussio&title=A+Common+Pharmacophore+for+a+Diverse+Set+of+Colchicine+Site+Inhibitors+Using+a+Structure-Based+Approach&doi=10.1021%2Fjm050502t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach</span></div><div class="casAuthors">Nguyen, Tam Luong; McGrath, Connor; Hermone, Ann R.; Burnett, James C.; Zaharevitz, Daniel W.; Day, Billy W.; Wipf, Peter; Hamel, Ernest; Gussio, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6107-6116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small mols. that bind to tubulin and cause mitotic arrest are of immense interest.  A large no. of synthetic and natural compds. with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly.  Using the recently detd. x-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to det. the binding modes of a set of structurally diverse colchicine site inhibitors.  These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with mol. dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40uoXQZMHULVg90H21EOLACvtfcHk0ljcf50dQIZ1FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1WitL8%253D&md5=443f25ca9212b379813d91ccdf820c5a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050502t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050502t%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BL.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DHermone%26aufirst%3DA.%2BR.%26aulast%3DBurnett%26aufirst%3DJ.%2BC.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DDay%26aufirst%3DB.%2BW.%26aulast%3DWipf%26aufirst%3DP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DGussio%26aufirst%3DR.%26atitle%3DA%2520Common%2520Pharmacophore%2520for%2520a%2520Diverse%2520Set%2520of%2520Colchicine%2520Site%2520Inhibitors%2520Using%2520a%2520Structure-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6107%26epage%3D6116%26doi%3D10.1021%2Fjm050502t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">De Martino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edler, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure-Activity Relationships and Molecular Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.1021/jm050809s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050809s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=947-954&author=G.+De+Martinoauthor=M.+C.+Edlerauthor=G.+La+Reginaauthor=A.+Colucciaauthor=M.+C.+Barberaauthor=D.+Barrowauthor=R.+I.+Nicholsonauthor=G.+Chiosisauthor=A.+Brancaleauthor=E.+Hamelauthor=M.+Articoauthor=R.+Silvestri&title=New+Arylthioindoles%3A+Potent+Inhibitors+of+Tubulin+Polymerization.+2.+Structure-Activity+Relationships+and+Molecular+Modeling+Studies&doi=10.1021%2Fjm050809s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure-Activity Relationships and Molecular Modeling Studies</span></div><div class="casAuthors">De Martino, Gabriella; Edler, Michael C.; La Regina, Giuseppe; Coluccia, Antonio; Barbera, Maria Chiara; Barrow, Denise; Nicholson, Robert I.; Chiosis, Gabriela; Brancale, Andrea; Hamel, Ernest; Artico, Marino; Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">947-954</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylthioindoles (ATIs) that possess a 3-methoxyphenylthio or a 3,5-dimethoxyphenylthio moiety at position 2 of the indole ring were effective tubulin assembly inhibitors, but weak inhibitors of MCF-7 cell growth.  ATIs bearing a 3-(3,4,5-trimethoxyphenyl)thio moiety were potent tubulin polymn. inhibitors, with IC50s in the 2.0 (35) to 4.5 (37) μM range.  They also inhibited MCF-7 cell growth at nanomolar concns.  The 3,4,5-trimethoxy substituted ATIs showed potencies comparable to those of the ref. compds. colchicine and combretastatin A-4 in both tubulin assembly and cell growth inhibition assays.  Dynamics simulation studies correlate well with the obsd. exptl. data.  Furthermore, from careful anal. of the biol. and in silico data, we can now hypothesize a basic pharmacophore for this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-C6vrzb-eFLVg90H21EOLACvtfcHk0lh5ELaNu3Kg_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ktw%253D%253D&md5=a3dc1f35656374edab6b6546972337a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm050809s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050809s%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DEdler%26aufirst%3DM.%2BC.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DBarbera%26aufirst%3DM.%2BC.%26aulast%3DBarrow%26aufirst%3DD.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DNew%2520Arylthioindoles%253A%2520Potent%2520Inhibitors%2520of%2520Tubulin%2520Polymerization.%25202.%2520Structure-Activity%2520Relationships%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D947%26epage%3D954%26doi%3D10.1021%2Fjm050809s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sanghai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohapatra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priyadarshani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashyap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satapathy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddharth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guchhait, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharatam, P. V.</span><span> </span><span class="NLM_article-title">Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span><span class="refDoi"> DOI: 10.1039/c3md00357d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1039%2Fc3md00357d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=766-782&author=N.+Sanghaiauthor=V.+Jainauthor=R.+Preetauthor=S.+Kandekarauthor=S.+Dasauthor=N.+Trivediauthor=P.+Mohapatraauthor=G.+Priyadarshaniauthor=M.+Kashyapauthor=D.+Dasauthor=S.+R.+Satapathyauthor=S.+Siddharthauthor=S.+K.+Guchhaitauthor=C.+N.+Kunduauthor=P.+V.+Bharatam&title=Combretastatin+A-4+inspired+novel+2-aryl-3-arylamino-imidazo-pyridines%2Fpyrazines+as+tubulin+polymerization+inhibitors%2C+antimitotic+and+anticancer+agents&doi=10.1039%2Fc3md00357d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fc3md00357d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00357d%26sid%3Dliteratum%253Aachs%26aulast%3DSanghai%26aufirst%3DN.%26aulast%3DJain%26aufirst%3DV.%26aulast%3DPreet%26aufirst%3DR.%26aulast%3DKandekar%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DMohapatra%26aufirst%3DP.%26aulast%3DPriyadarshani%26aufirst%3DG.%26aulast%3DKashyap%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSatapathy%26aufirst%3DS.%2BR.%26aulast%3DSiddharth%26aufirst%3DS.%26aulast%3DGuchhait%26aufirst%3DS.%2BK.%26aulast%3DKundu%26aufirst%3DC.%2BN.%26aulast%3DBharatam%26aufirst%3DP.%2BV.%26atitle%3DCombretastatin%2520A-4%2520inspired%2520novel%25202-aryl-3-arylamino-imidazo-pyridines%252Fpyrazines%2520as%2520tubulin%2520polymerization%2520inhibitors%252C%2520antimitotic%2520and%2520anticancer%2520agents%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26spage%3D766%26epage%3D782%26doi%3D10.1039%2Fc3md00357d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1<i>H-</i>Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0128710</span><span class="refDoi"> DOI: 10.1371/journal.pone.0128710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1371%2Fjournal.pone.0128710" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0128710&author=Q.+Xuauthor=H.+Qiauthor=M.+Sunauthor=D.+Zuoauthor=X.+Jiangauthor=Z.+Wenauthor=Z.+Wangauthor=Y.+Wuauthor=W.+Zhang&title=Synthesis+and+Biological+Evaluation+of+3-Alkyl-1%2C5-Diaryl-1H-Pyrazoles+as+Rigid+Analogues+of+Combretastatin+A-4+with+Potent+Antiproliferative+Activity&doi=10.1371%2Fjournal.pone.0128710"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0128710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0128710%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DZuo%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25203-Alkyl-1%252C5-Diaryl-1H-Pyrazoles%2520as%2520Rigid%2520Analogues%2520of%2520Combretastatin%2520A-4%2520with%2520Potent%2520Antiproliferative%2520Activity%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0128710%26doi%3D10.1371%2Fjournal.pone.0128710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Burja, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Čimbora-Zovko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomić, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelušić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kočevar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmak, M.</span><span> </span><span class="NLM_article-title">Pyrazolone-Fused Combretastatins and Their Precursors: Synthesis, Cytotoxicity, Antitubulin Activity and Molecular Modeling Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.bmc.2010.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=20338766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2375-2387&author=B.+Burjaauthor=T.+%C4%8Cimbora-Zovkoauthor=S.+Tomi%C4%87author=T.+Jelu%C5%A1i%C4%87author=M.+Ko%C4%8Devarauthor=S.+Polancauthor=M.+Osmak&title=Pyrazolone-Fused+Combretastatins+and+Their+Precursors%3A+Synthesis%2C+Cytotoxicity%2C+Antitubulin+Activity+and+Molecular+Modeling+Studies&doi=10.1016%2Fj.bmc.2010.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies</span></div><div class="casAuthors">Burja, Bojan; Cimbora-Zovko, Tamara; Tomic, Sanja; Jelusic, Tihana; Kocevar, Marijan; Polanc, Slovenko; Osmak, Maja</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2375-2387</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pyrazolone-fused combretastatins and precursors were synthesized and their cytotoxicity as well as antitubulin potential was evaluated.  The hydrazide 9f and the pyrazolone-fused combretastatins 12a, 12b and 12c were highly cytotoxic against various tumor cell lines including cisplatin resistant cells.  The same compds. were also the best inhibitors of tubulin polymn.  Mol. modeling results showed that they bind the colchicine binding site at the tubulin heterodimer.  The hydrazide 9f arrested HeLa cells in the G2/M phase of the cell cycle and strongly affected cell shape and microtubule network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm219DOix7w7Vg90H21EOLACvtfcHk0lgCNPepkY4nfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejs7c%253D&md5=e1f34ada02e5c3fbb979c0365ee7b575</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DBurja%26aufirst%3DB.%26aulast%3D%25C4%258Cimbora-Zovko%26aufirst%3DT.%26aulast%3DTomi%25C4%2587%26aufirst%3DS.%26aulast%3DJelu%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DKo%25C4%258Devar%26aufirst%3DM.%26aulast%3DPolanc%26aufirst%3DS.%26aulast%3DOsmak%26aufirst%3DM.%26atitle%3DPyrazolone-Fused%2520Combretastatins%2520and%2520Their%2520Precursors%253A%2520Synthesis%252C%2520Cytotoxicity%252C%2520Antitubulin%2520Activity%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2375%26epage%3D2387%26doi%3D10.1016%2Fj.bmc.2010.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span> </span><span class="NLM_article-title">Search for MDR Modulators: Design, Syntheses and Evaluations of <i>N</i>-substituted Acridones for Interactions with <i>p</i>-glycoprotein and Mg<sup>2+</sup></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2427</span><span class="refDoi"> DOI: 10.1016/j.bmc.2009.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.bmc.2009.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2423-2427&author=P.+Singhauthor=J.+Kaurauthor=P.+Kaurauthor=S.+Kaur&title=Search+for+MDR+Modulators%3A+Design%2C+Syntheses+and+Evaluations+of+N-substituted+Acridones+for+Interactions+with+p-glycoprotein+and+Mg2%2B&doi=10.1016%2Fj.bmc.2009.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DKaur%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DKaur%26aufirst%3DS.%26atitle%3DSearch%2520for%2520MDR%2520Modulators%253A%2520Design%252C%2520Syntheses%2520and%2520Evaluations%2520of%2520N-substituted%2520Acridones%2520for%2520Interactions%2520with%2520p-glycoprotein%2520and%2520Mg2%252B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2423%26epage%3D2427%26doi%3D10.1016%2Fj.bmc.2009.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lamberth, C.</span><span> </span><span class="NLM_article-title">Pyrazole Chemistry in Crop Protection</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span><span class="refDoi"> DOI: 10.3987/REV-07-613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.3987%2FREV-07-613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1467-1502&author=C.+Lamberth&title=Pyrazole+Chemistry+in+Crop+Protection&doi=10.3987%2FREV-07-613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole chemistry in crop protection</span></div><div class="casAuthors">Lamberth, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1467-1502</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">A review.  An overview is given of the significance of pyrazole derivs. in crop protection chem.  The main herbicidally, fungicidally and insecticidally active pyrazole classes are presented, together with their synthetic routes, their modes-of-action and their biol. efficacies.  Indazoles and other bicyclic pyrazole derivs. are also covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8_VLb2dv2rVg90H21EOLACvtfcHk0lgCNPepkY4nfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFWjtr0%253D&md5=783057731513897b2bf8e7d53d41ee5b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3987%2FREV-07-613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FREV-07-613%26sid%3Dliteratum%253Aachs%26aulast%3DLamberth%26aufirst%3DC.%26atitle%3DPyrazole%2520Chemistry%2520in%2520Crop%2520Protection%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D71%26spage%3D1467%26epage%3D1502%26doi%3D10.3987%2FREV-07-613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Recent Developments in the Chemistry of Sydnones</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1016/j.tet.2009.10.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.tet.2009.10.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=553-568&author=D.+L.+Browneauthor=J.+P.+A.+Harrity&title=Recent+Developments+in+the+Chemistry+of+Sydnones&doi=10.1016%2Fj.tet.2009.10.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the chemistry of sydnones</span></div><div class="casAuthors">Browne, Duncan L.; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent times, sydnones have gained significant interest through the discovery of their useful biol. properties (i.e., antibacterial, antineoplastic and antiinflammatory agents), which have driven the development of new functionalization methods.  In addn., sydnones act as useful and novel precursors for pyrazoles (via cycloaddn. with alkynes).  This report provides an overview of the recently developed chem. of sydnones with particular emphasis on useful reactions for the synthesis of these biol. interesting mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMqIRaChOnurVg90H21EOLACvtfcHk0lip5vmOtRRTeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnu7zM&md5=f2602f4ebebc43ef241de753d08d43e7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2009.10.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2009.10.085%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Chemistry%2520of%2520Sydnones%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D553%26epage%3D568%26doi%3D10.1016%2Fj.tet.2009.10.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Decuypere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Specklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabillet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plougastel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodych, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">Copper(I)-Catalyzed Cycloaddition of 4-Bromosydnones and Alkynes for the Regioselective Synthesis of 1,4,5-Trisubstituted Pyrazoles</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.1021/ol503482a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol503482a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=362-365&author=E.+Decuypereauthor=S.+Specklinauthor=S.+Gabilletauthor=D.+Audisioauthor=H.+Liuauthor=L.+Plougastelauthor=S.+Kolodychauthor=F.+Taran&title=Copper%28I%29-Catalyzed+Cycloaddition+of+4-Bromosydnones+and+Alkynes+for+the+Regioselective+Synthesis+of+1%2C4%2C5-Trisubstituted+Pyrazoles&doi=10.1021%2Fol503482a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I)-Catalyzed Cycloaddition of 4-Bromosydnones and Alkynes for the Regioselective Synthesis of 1,4,5-Trisubstituted Pyrazoles</span></div><div class="casAuthors">Decuypere, Elodie; Specklin, Simon; Gabillet, Sandra; Audisio, Davide; Liu, Hui; Plougastel, Lucie; Kolodych, Sergii; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">362-365</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Copper-catalyzed cycloaddn. of alkynes with 4-bromosydnones provides a convenient, mild, and regioselective method for the synthesis of a wide range of bromopyrazoles.  The broad functional group tolerance of the cycloaddn. reaction and further palladium-catalyzed cross-coupling reactions allowed the prepn. of polyfunctionalized 1,4,5-pyrazoles e. g., I, that are otherwise difficult to obtain by conventional methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq90U7CvRb7KLVg90H21EOLACvtfcHk0lip5vmOtRRTeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLvO&md5=0c74338f868b720243fd891437981300</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol503482a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol503482a%26sid%3Dliteratum%253Aachs%26aulast%3DDecuypere%26aufirst%3DE.%26aulast%3DSpecklin%26aufirst%3DS.%26aulast%3DGabillet%26aufirst%3DS.%26aulast%3DAudisio%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DPlougastel%26aufirst%3DL.%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DCopper%2528I%2529-Catalyzed%2520Cycloaddition%2520of%25204-Bromosydnones%2520and%2520Alkynes%2520for%2520the%2520Regioselective%2520Synthesis%2520of%25201%252C4%252C5-Trisubstituted%2520Pyrazoles%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D362%26epage%3D365%26doi%3D10.1021%2Fol503482a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kolodych, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasolofonjatovo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumontet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevers, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Créminon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">Discovery of Chemoselective and Biocompatible Reactions Using a High-Throughput Immunoassay Screening</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">12056</span><span class="NLM_x">–</span> <span class="NLM_lpage">12060</span><span class="refDoi"> DOI: 10.1002/anie.201305645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fanie.201305645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WmtbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12056-12060&author=S.+Kolodychauthor=E.+Rasolofonjatovoauthor=M.+Chaumontetauthor=M.-C.+Neversauthor=C.+Cr%C3%A9minonauthor=F.+Taran&title=Discovery+of+Chemoselective+and+Biocompatible+Reactions+Using+a+High-Throughput+Immunoassay+Screening&doi=10.1002%2Fanie.201305645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Chemoselective and Biocompatible Reactions Using a High-Throughput Immunoassay Screening</span></div><div class="casAuthors">Kolodych, Sergii; Rasolofonjatovo, Evelia; Chaumontet, Manon; Nevers, Marie-Claire; Creminon, Christophe; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12056-12060</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A method for high-throughput screening for identification and optimization of potential "click" reactions, particularly dipolar cycloaddns., using an immunoassay is described.  Reactive groups attached to either homovanillic amide or histamine groups were reacted on nanomolar scale with a variety of metal catalysts; treatment with surface-linked anti(homovanillamide) monoclonal antibodies and antihistamine monoclonal antibodies in soln. led to a color change only when cycloadducts (contg. both homovanillamide and histamine tags) were formed and immobilized on the surface.  Reactions that generated product were then optimized using the same assay format; four of the reactions were then performed using nontagged substrates.  A rhodium-catalyzed cycloaddns. of pyridiniumacetates to nitriles to form imidazolopyridinecarboxylates, an iridium-catalyzed cycloaddn. of benzyl azide with bromoalkynes to form bromo-1,2,3-triazoles, a palladium-catalyzed and copper-mediated oxidative Heck reaction of a phenylsydnone with alkenes to yield alkenylsydnones, and a copper-catalyzed cycloaddn. of arylsydnones with alkynes to form arylpyrazoles were discovered using this method.  In particular, copper-catalyzed cycloaddn. of arylsydnones with alkynes to form arylpyrazoles was found to be applicable to a variety of biol. relevant substrates, was performed successfully in human blood plasma, and was used to label bovine serum albumin with a fluorescent tag.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1VcQhA-O_9rVg90H21EOLACvtfcHk0lip5vmOtRRTeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WmtbvF&md5=fd99fb5fdf15e10d8b9078ce2dc90491</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305645%26sid%3Dliteratum%253Aachs%26aulast%3DKolodych%26aufirst%3DS.%26aulast%3DRasolofonjatovo%26aufirst%3DE.%26aulast%3DChaumontet%26aufirst%3DM.%26aulast%3DNevers%26aufirst%3DM.-C.%26aulast%3DCr%25C3%25A9minon%26aufirst%3DC.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Chemoselective%2520and%2520Biocompatible%2520Reactions%2520Using%2520a%2520High-Throughput%2520Immunoassay%2520Screening%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12056%26epage%3D12060%26doi%3D10.1002%2Fanie.201305645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Specklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decuypere, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plougastel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taran, F.</span><span> </span><span class="NLM_article-title">One-Pot Synthesis of 1,4-Disubstituted Pyrazoles from Arylglycines via Copper-Catalyzed Sydnone–Alkyne Cycloaddition Reaction</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7777</span><span class="refDoi"> DOI: 10.1021/jo501420r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo501420r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=7772-7777&author=S.+Specklinauthor=E.+Decuypereauthor=L.+Plougastelauthor=S.+Alianiauthor=F.+Taran&title=One-Pot+Synthesis+of+1%2C4-Disubstituted+Pyrazoles+from+Arylglycines+via+Copper-Catalyzed+Sydnone%E2%80%93Alkyne+Cycloaddition+Reaction&doi=10.1021%2Fjo501420r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Synthesis of 1,4-Disubstituted Pyrazoles from Arylglycines via Copper-Catalyzed Sydnone-Alkyne Cycloaddition Reaction</span></div><div class="casAuthors">Specklin, Simon; Decuypere, Elodie; Plougastel, Lucie; Aliani, Soifia; Taran, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7772-7777</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A robust method for constructing 1,4-pyrazoles e. g., I, from arylglycines was developed using the copper-catalyzed sydnone-alkyne cycloaddn. reaction.  The procedure offers a straightforward and general route to the pyrazole heterocycle through a three-step one-pot procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM8RhZ6lPO57Vg90H21EOLACvtfcHk0li0XV-xmW4EGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbfE&md5=d1dffdf698762842c8f6c4e61714ca20</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo501420r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo501420r%26sid%3Dliteratum%253Aachs%26aulast%3DSpecklin%26aufirst%3DS.%26aulast%3DDecuypere%26aufirst%3DE.%26aulast%3DPlougastel%26aufirst%3DL.%26aulast%3DAliani%26aufirst%3DS.%26aulast%3DTaran%26aufirst%3DF.%26atitle%3DOne-Pot%2520Synthesis%2520of%25201%252C4-Disubstituted%2520Pyrazoles%2520from%2520Arylglycines%2520via%2520Copper-Catalyzed%2520Sydnone%25E2%2580%2593Alkyne%2520Cycloaddition%2520Reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D7772%26epage%3D7777%26doi%3D10.1021%2Fjo501420r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helm, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">A Sydnone Cycloaddition Route to Pyrazole Boronic Esters</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">8656</span><span class="NLM_x">–</span> <span class="NLM_lpage">8658</span><span class="refDoi"> DOI: 10.1002/anie.200703767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fanie.200703767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2rsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=8656-8658&author=D.+L.+Browneauthor=M.+D.+Helmauthor=A.+Plantauthor=J.+P.+A.+Harrity&title=A+Sydnone+Cycloaddition+Route+to+Pyrazole+Boronic+Esters&doi=10.1002%2Fanie.200703767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A sydnone cycloaddition route to pyrazole boronic esters</span></div><div class="casAuthors">Browne, Duncan L.; Helm, Matthew D.; Plant, Andrew; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8656-8658</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Regioselective 1,3-cycloaddn. of N-methylsydnone with alkynylboronates gave 4-pyrazolylboronic acids.  Cycloaddn. of pinacol alkynylboronate R1C≡CB(OCMe2)2 with 3-R1-5-oxy-1,2,3-oxadiazole (N-R1-sydnone) in xylene at reflux gave 1-R1-3-R2-4-B(OCMe2)-1H-pyrazoles (3a-12a; R1 = Ph, 4-MeOC6H4, 4-NO2C6H4; R2 = Ph, Bu, Me3Si, H) together with their regioisomeric 1-R1-4-R2-3-B(OCMe2)-1H-pyrazoles (3b-12b, same R1, R2) with 54-83% yields and 2:1 to 100% a/b regioselectivity.  Functionalization of the products by Suzuki coupling and N-deprotection processes highlight the potential synthetic utility of these species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHAPl57nDUD7Vg90H21EOLACvtfcHk0li0XV-xmW4EGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2rsrfJ&md5=939484bae67c840afd1dfc6f66a2dac8</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fanie.200703767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200703767%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DPlant%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DA%2520Sydnone%2520Cycloaddition%2520Route%2520to%2520Pyrazole%2520Boronic%2520Esters%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D8656%26epage%3D8658%26doi%3D10.1002%2Fanie.200703767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Browne, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivat, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Bengoa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Investigation of the Scope and Regiochemistry of Alkynylboronate Cycloadditions with Sydnones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">7762</span><span class="NLM_x">–</span> <span class="NLM_lpage">7769</span><span class="refDoi"> DOI: 10.1021/ja902460n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902460n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVGms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=7762-7769&author=D.+L.+Browneauthor=J.+F.+Vivatauthor=A.+Plantauthor=E.+Gomez-Bengoaauthor=J.+P.+A.+Harrity&title=Investigation+of+the+Scope+and+Regiochemistry+of+Alkynylboronate+Cycloadditions+with+Sydnones&doi=10.1021%2Fja902460n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the scope and regiochemistry of alkynylboronate cycloadditions with sydnones</span></div><div class="casAuthors">Browne, Duncan L.; Vivat, Jerome F.; Plant, Andrew; Gomez-Bengoa, Enrique; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7762-7769</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Di-, tri-, and tetrasubstituted 3- and 4-pyrazolylboronates were prepd. by a convenient and highly regioselective procedure comprising cycloaddn. of alkynylboronates to sydnones.  Addn. of 3-R1-4-R2-5-oxy-1,2,3-oxadiazolium with 2-alkynyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolanes R3C≡CB(OCMe2)2 in 1,2-dichlorobenzene at 180° gave 1-R1-3-R3-4-X-5-R2-1H-pyrazoles (20a-30a; X = 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl; R1 = Ph, Me, 4-NO2C6H4; R2 = Ph, Me, iPr; R3 = Ph, Me3Si); the corresponding regioisomers, 1-R1-4-R3-3-X-5-R2-1H-pyrazoles, were formed in less than 2% amts.  However, regioselectivity (a:b) of the reaction of 3-Ph-5-oxy-1,2,3-oxadiazolium with R4C≡CB(OCMe2)2 giving 1-R1-3-R4-4-X- and 1-R1-4-R4-3-X-1H-pyrazoles (8a-13a, 8b-13b, resp., R1 = Ph, Me, PhCH2, R4 = H, Bu, Me3Si) was lower (1:7, 5:2 and 2:1, resp.).  The origins of an obsd. regiochem. divergence in the reactions of terminal alkynylboronates with their more substituted analogs have been studied by DFT methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5i5kaEKPo_rVg90H21EOLACvtfcHk0li0XV-xmW4EGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVGms7s%253D&md5=1cde7f18d95179d9e57cf1aa6faac1ee</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja902460n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902460n%26sid%3Dliteratum%253Aachs%26aulast%3DBrowne%26aufirst%3DD.%2BL.%26aulast%3DVivat%26aufirst%3DJ.%2BF.%26aulast%3DPlant%26aufirst%3DA.%26aulast%3DGomez-Bengoa%26aufirst%3DE.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520Scope%2520and%2520Regiochemistry%2520of%2520Alkynylboronate%2520Cycloadditions%2520with%2520Sydnones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D7762%26epage%3D7769%26doi%3D10.1021%2Fja902460n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Comas-Barceló, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Bengoa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Cu-Promoted Sydnone Cycloadditions of Alkynes: Scope and Mechanism Studies</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3257</span><span class="NLM_x">–</span> <span class="NLM_lpage">3263</span><span class="refDoi"> DOI: 10.1002/chem.201406118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fchem.201406118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=25557473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3257-3263&author=J.+Comas-Barcel%C3%B3author=R.+S.+Fosterauthor=B.+Fiserauthor=E.+Gomez-Bengoaauthor=J.+P.+A.+Harrity&title=Cu-Promoted+Sydnone+Cycloadditions+of+Alkynes%3A+Scope+and+Mechanism+Studies&doi=10.1002%2Fchem.201406118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cu-Promoted Sydnone Cycloadditions of Alkynes: Scope and Mechanism Studies</span></div><div class="casAuthors">Comas-Barcelo, Julia; Foster, Robert S.; Fiser, Bela; Gomez-Bengoa, Enrique; Harrity, Joseph P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3257-3263</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cu salts have been found to promote the cycloaddn. reaction of sydnones and terminal alkynes, providing significant redn. in reaction times.  Specifically, the use of Cu(OTf)2 is found to provide 1,3-disubstituted pyrazoles, whereas simply switching the promoter system to Cu(OAc)2 allows the corresponding 1,4-isomers to be produced.  The mechanism of the Cu-effect in each case has been investigated by exptl. and theor. studies, and they suggest that Cu(OTf)2 functions by Lewis acid activation of the sydnone, whereas Cu(OAc)2 promotes formation of reactive CuI acetylides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-FXg3iQuJbVg90H21EOLACvtfcHk0liwKZ9u5QbTsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFU%253D&md5=c23cce1544edb1e34dad67d8e5b5ced3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fchem.201406118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201406118%26sid%3Dliteratum%253Aachs%26aulast%3DComas-Barcel%25C3%25B3%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DR.%2BS.%26aulast%3DFiser%26aufirst%3DB.%26aulast%3DGomez-Bengoa%26aufirst%3DE.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DCu-Promoted%2520Sydnone%2520Cycloadditions%2520of%2520Alkynes%253A%2520Scope%2520and%2520Mechanism%2520Studies%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26spage%3D3257%26epage%3D3263%26doi%3D10.1002%2Fchem.201406118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Brown, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, J. P. A.</span><span> </span><span class="NLM_article-title">Direct Arylation of Sydnones with Aryl Chlorides toward Highly Substituted Pyrazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2472</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=2467-2472&author=A.+W.+Brownauthor=J.+P.+A.+Harrity&title=Direct+Arylation+of+Sydnones+with+Aryl+Chlorides+toward+Highly+Substituted+Pyrazoles&doi=10.1021%2Facs.joc.5b00143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BW.%26aulast%3DHarrity%26aufirst%3DJ.%2BP.%2BA.%26atitle%3DDirect%2520Arylation%2520of%2520Sydnones%2520with%2520Aryl%2520Chlorides%2520toward%2520Highly%2520Substituted%2520Pyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D2467%26epage%3D2472%26doi%3D10.1021%2Facs.joc.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Lunt, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Aldasoro, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span> </span><span class="NLM_article-title">Vascular Effects Dominate Solid Tumor Response to Treatment with Combretastatin A-4-phosphate</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1979</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span><span class="refDoi"> DOI: 10.1002/ijc.25848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1002%2Fijc.25848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=21154772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKlsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=1979-1989&author=S.-J.+Luntauthor=S.+Akermanauthor=S.+A.+Hillauthor=M.+Fisherauthor=V.+J.+Wrightauthor=C.+C.+Reyes-Aldasoroauthor=G.+M.+Tozerauthor=C.+Kanthou&title=Vascular+Effects+Dominate+Solid+Tumor+Response+to+Treatment+with+Combretastatin+A-4-phosphate&doi=10.1002%2Fijc.25848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate</span></div><div class="casAuthors">Lunt, Sarah Jane; Akerman, Simon; Hill, Sally A.; Fisher, Matthew; Wright, Victoria J.; Reyes-Aldasoro, Constantino C.; Tozer, Gillian M.; Kanthou, Chryso</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1979-1989</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Vascular-targeted therapeutics are increasingly used in the clinic.  However, less is known about the direct response of tumor cells to these agents.  We have developed a combretastatin-A-4-phosphate (CA4P) resistant variant of SW1222 human colorectal carcinoma cells to examine the relative importance of vascular vs. tumor cell targeting in the ultimate treatment response.  SW1222Res cells were generated through exposure of wild-type cells (SW1222WT) to increasing CA4P concns. in vitro.  Increased resistance was confirmed through analyses of cell viability, apoptosis and multidrug-resistance (MDR) protein expression.  In vivo, comparative studies examd. tumor cell necrosis, apoptosis, vessel morphol. and functional vascular end-points following treatment with CA4P (single 100 mg/kg dose).  Tumor response to repeated CA4P dosing (50 mg/kg/day, 5 days/wk for 2 wk) was examd. through growth measurement, and ultimate tumor cell survival was studied by ex vivo clonogenic assay.  In vitro, SW1222Res cells showed reduced CA4P sensitivity, enhanced MDR protein expression and a reduced apoptotic index.  In vivo, CA4P induced significantly lower apoptotic cell death in SW1222Res vs. SW1222WT tumors indicating maintenance of resistance characteristics.  However, CA4P-induced tumor necrosis was equiv. in both lines.  Similarly, rapid CA4P-mediated vessel disruption and blood flow shut-down were obsd. in both lines.  Cell surviving fraction was comparable in the two tumor types following single dose CA4P and SW1222Res tumors were at least as sensitive as SW1222WT tumors to repeated dosing.  Despite tumor cell resistance to CA4P, SW1222Res response in vivo was not impaired, strongly supporting the view that vascular damage dominates the therapeutic response to this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXfeiOzwb1brVg90H21EOLACvtfcHk0liwKZ9u5QbTsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKlsrvI&md5=155f50bc021c9117845b47f4b63268b8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fijc.25848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.25848%26sid%3Dliteratum%253Aachs%26aulast%3DLunt%26aufirst%3DS.-J.%26aulast%3DAkerman%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DS.%2BA.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DV.%2BJ.%26aulast%3DReyes-Aldasoro%26aufirst%3DC.%2BC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DKanthou%26aufirst%3DC.%26atitle%3DVascular%2520Effects%2520Dominate%2520Solid%2520Tumor%2520Response%2520to%2520Treatment%2520with%2520Combretastatin%2520A-4-phosphate%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2011%26volume%3D129%26spage%3D1979%26epage%3D1989%26doi%3D10.1002%2Fijc.25848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">The Tumor Vascular Targeting Agent Combretastatin A-4-Phosphate Induces Reorganization of the Actin Cytoskeleton and Early Membrane Blebbing in Human Endothelial Cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2060</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span><span class="refDoi"> DOI: 10.1182/blood.V99.6.2060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1182%2Fblood.V99.6.2060" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=2060-2069&author=C.+Kanthouauthor=G.+M.+Tozer&title=The+Tumor+Vascular+Targeting+Agent+Combretastatin+A-4-Phosphate+Induces+Reorganization+of+the+Actin+Cytoskeleton+and+Early+Membrane+Blebbing+in+Human+Endothelial+Cells&doi=10.1182%2Fblood.V99.6.2060"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood.V99.6.2060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V99.6.2060%26sid%3Dliteratum%253Aachs%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DThe%2520Tumor%2520Vascular%2520Targeting%2520Agent%2520Combretastatin%2520A-4-Phosphate%2520Induces%2520Reorganization%2520of%2520the%2520Actin%2520Cytoskeleton%2520and%2520Early%2520Membrane%2520Blebbing%2520in%2520Human%2520Endothelial%2520Cells%26jtitle%3DBlood%26date%3D2002%26volume%3D99%26spage%3D2060%26epage%3D2069%26doi%3D10.1182%2Fblood.V99.6.2060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Strecker, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odutola, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidmore, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton-Sevcik, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonough, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadimani, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinney, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trawick, M. L.</span><span> </span><span class="NLM_article-title">The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span><span class="refDoi"> DOI: 10.1016/j.canlet.2015.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1016%2Fj.canlet.2015.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=26325604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVent77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2015&pages=229-241&author=T.+E.+Streckerauthor=S.+O.+Odutolaauthor=R.+Lopezauthor=M.+S.+Cooperauthor=J.+K.+Tidmoreauthor=A.+K.+Charlton-Sevcikauthor=L.+Liauthor=M.+T.+Macdonoughauthor=M.+B.+Hadimaniauthor=A.+Ghatakauthor=L.+Liuauthor=D.+J.+Chaplinauthor=R.+P.+Masonauthor=K.+G.+Pinneyauthor=M.+L.+Trawick&title=The+vascular+disrupting+activity+of+OXi8006+in+endothelial+cells+and+its+phosphate+prodrug+OXi8007+in+breast+tumor+xenografts&doi=10.1016%2Fj.canlet.2015.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts</span></div><div class="casAuthors">Strecker, Tracy E.; Odutola, Samuel O.; Lopez, Ramona; Cooper, Morgan S.; Tidmore, Justin K.; Charlton-Sevcik, Amanda K.; Li, Li; MacDonough, Matthew T.; Hadimani, Mallinath B.; Ghatak, Anjan; Liu, Li; Chaplin, David J.; Mason, Ralph P.; Pinney, Kevin G.; Trawick, Mary Lynn</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">229-241</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study describes the vascular disrupting ability and the mechanism of action of the indole-based tubulin-binding compd., OXi8006, and its water-sol. phosphate prodrug OXi8007.  Treatment of rapidly proliferating human umbilical vein endothelial cells (HUVECs), used as a model for the tumor vasculature, with OXi8006 or OXi8007, caused potent microtubule disruption followed by extensive reorganization of the cytoskeletal network.  The mechanism of action involved an increase in focal adhesion formation assocd. with an increase in phosphorylation of both non-muscle myosin light chain and focal adhesion kinase.  These effects were dramatically diminished by an inhibitor of RhoA kinase, a downstream effector of RhoA.  Cell cycle blockade at G2/M and cytotoxicity toward rapidly proliferating HUVECs were also obsd.  Capillary-like networks of HUVECs were disrupted by the action of both OXi8006 and OXi8007.  The prodrug OXi8007 exhibited potent and rapid dose-dependent antivascular activity assessed by dynamic bioluminescence imaging (BLI) in an MDA-MB-231-luc breast cancer xenograft mouse model.  By 6 h post treatment, over 93% of the BLI signal was abolished with only a slight recovery at 24 h.  These findings were confirmed by histol.  The results from this study demonstrate that OXi8007 is a potent vascular disrupting agent acting through an anti-microtubule mechanism involving RhoA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDurrLSPKWdLVg90H21EOLACvtfcHk0ljfhLe3M8wkZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVent77J&md5=043667a926725754e893c022e807a159</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DStrecker%26aufirst%3DT.%2BE.%26aulast%3DOdutola%26aufirst%3DS.%2BO.%26aulast%3DLopez%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DM.%2BS.%26aulast%3DTidmore%26aufirst%3DJ.%2BK.%26aulast%3DCharlton-Sevcik%26aufirst%3DA.%2BK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMacdonough%26aufirst%3DM.%2BT.%26aulast%3DHadimani%26aufirst%3DM.%2BB.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DMason%26aufirst%3DR.%2BP.%26aulast%3DPinney%26aufirst%3DK.%2BG.%26aulast%3DTrawick%26aufirst%3DM.%2BL.%26atitle%3DThe%2520vascular%2520disrupting%2520activity%2520of%2520OXi8006%2520in%2520endothelial%2520cells%2520and%2520its%2520phosphate%2520prodrug%2520OXi8007%2520in%2520breast%2520tumor%2520xenografts%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D369%26spage%3D229%26epage%3D241%26doi%3D10.1016%2Fj.canlet.2015.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Chalkley, H. W.</span><span> </span><span class="NLM_article-title">Method for the Quantitative Morphologic Analysis of Tissues</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1943</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1093/jnci/4.1.47</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1093%2Fjnci%2F4.1.47" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1943&pages=47-53&author=H.+W.+Chalkley&title=Method+for+the+Quantitative+Morphologic+Analysis+of+Tissues&doi=10.1093%2Fjnci%2F4.1.47"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F4.1.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F4.1.47%26sid%3Dliteratum%253Aachs%26aulast%3DChalkley%26aufirst%3DH.%2BW.%26atitle%3DMethod%2520for%2520the%2520Quantitative%2520Morphologic%2520Analysis%2520of%2520Tissues%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1943%26volume%3D4%26spage%3D47%26epage%3D53%26doi%3D10.1093%2Fjnci%2F4.1.47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Williams, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Aldasoro, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanthou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span> </span><span class="NLM_article-title">An <i>in vivo</i> Role for Rho Kinase Activation in the Tumour Vascular Disrupting Activity of Combretastatin A-4 3-O-phosphate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">4902</span><span class="NLM_x">–</span> <span class="NLM_lpage">4913</span><span class="refDoi"> DOI: 10.1111/bph.12817</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1111%2Fbph.12817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=24930520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=4902-4913&author=L.+J.+Williamsauthor=D.+Mukherjeeauthor=M.+Fisherauthor=C.+C.+Reyes-Aldasoroauthor=S.+Akermanauthor=C.+Kanthouauthor=G.+M.+Tozer&title=An+in+vivo+Role+for+Rho+Kinase+Activation+in+the+Tumour+Vascular+Disrupting+Activity+of+Combretastatin+A-4+3-O-phosphate&doi=10.1111%2Fbph.12817"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate</span></div><div class="casAuthors">Williams, L. J.; Mukherjee, D.; Fisher, M.; Reyes-Aldasoro, C. C.; Akerman, S.; Kanthou, C.; Tozer, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4902-4913</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Combretastatin A-4 3-O-phosphate (CA4P) is in clin. trial as a tumor vascular disrupting agent (VDA) but the cause of blood flow disruption is unclear.  We tested the hypothesis that activation of Rho/Rho kinase (ROCK) is fundamental to the effects of this drug in vivo.  Mouse models of human colorectal carcinoma (SW1222 and LS174T) were used.  Effects of the ROCK inhibitor, Y27632, alone or in combination with CA4P, on ROCK activity, vascular function, necrosis and immune cell infiltration in solid tumors were detd.  Mean arterial BP (MABP) was measured to monitor systemic interactions and the vasodilator, hydralazine, was used to control for the hypotensive effects of Y27632.  Y27632 caused a rapid drop in blood flow in SW1222 tumors, with recovery by around 3 h, which was paralleled by MABP changes.  Y27632 pretreatment reduced CA4P-induced ROCK activation and partially blocked CA4P-induced tumor vascular effects, in both tumor types.  Y27632 also partially inhibited CA4P-induced tumor necrosis and was assocd. with reduced immune cell infiltration in SW1222 tumors.  Hydralazine caused a similar hypotensive effect as Y27632 but had no protective effect against CA4P treatment.  These results demonstrate that ROCK activity is crit. for full manifestation of the vascular activity of CA4P in vivo, providing the evidence for pharmacol. intervention to enhance the anti-tumor efficacy of CA4P and related VDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb3sOB9jdFIrVg90H21EOLACvtfcHk0ljfhLe3M8wkZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsLbF&md5=044a7f085749c5ca6d8f3eac8438375d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fbph.12817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12817%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DL.%2BJ.%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DReyes-Aldasoro%26aufirst%3DC.%2BC.%26aulast%3DAkerman%26aufirst%3DS.%26aulast%3DKanthou%26aufirst%3DC.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26atitle%3DAn%2520in%2520vivo%2520Role%2520for%2520Rho%2520Kinase%2520Activation%2520in%2520the%2520Tumour%2520Vascular%2520Disrupting%2520Activity%2520of%2520Combretastatin%2520A-4%25203-O-phosphate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D4902%26epage%3D4913%26doi%3D10.1111%2Fbph.12817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Guidelines for the Welfare and Use of Animals in Cancer Research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1577</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6605642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+H.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Guidelines+for+the+Welfare+and+Use+of+Animals+in+Cancer+Research&doi=10.1038%2Fsj.bjc.6605642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eaApl7xEV-CN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%2BH.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DGuidelines%2520for%2520the%2520Welfare%2520and%2520Use%2520of%2520Animals%2520in%2520Cancer%2520Research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577%26doi%3D10.1038%2Fsj.bjc.6605642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01128">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40823"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01128">10.1021/acs.jmedchem.6b01128</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C NMR spectra for selected compounds and HPLC results of final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_001.pdf">jm6b01128_si_001.pdf (5.3 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01128/suppl_file/jm6b01128_si_002.csv">jm6b01128_si_002.csv (2.85 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01128&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-20%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01128%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01128" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998f52be353d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
